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General introduc  on
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From Stockholm to Malawi: recent developments 
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* Note: Adapta  on of this chapter from the original published ar  cle concerns textual and 
fi gure adjustments. The text has been updated with novel data from the literature un  l 
mid-2014. Figures 2, 7 and 8 are updated with novel polyomaviruses. Figures 3, 5 and 6 




Un  l a few years ago, the polyomavirus family (Polyomaviridae) included only a dozen vi-
ruses mostly iden  fi ed in avian and mammalian hosts. Two of these, the JC and BK-polyo-
maviruses isolated a long  me ago, are known to infect humans and cause severe illness in 
immunocompromised hosts. Since 2007, tens of new polyomaviruses were iden  fi ed, inclu-
ding at least eleven that infect humans. Among them is the polyomavirus associated with 
trichodysplasia spinulosa (TSPyV). In this introductory chapter, the recent developments 
in studying the novel human polyomaviruses un  l mid-2014 are summarized, which sets 





General introduc  on
Historical background
Polyomaviruses have been recognized as a separate virus family (Polyomaviridae) since 1999. Before that  me, they formed the genus Polyomavirus in the Papovavir-idae family that also contained the genus Papillomavirus [1, 2]. The fi rst members of the polyomavirus family, mouse polyomavirus (MPyV) and SV40, were iden  fi ed 
halfway through the last century as fi lterable agents that caused tumors in newborn mice 
and hamsters [3 - 5]. Subsequently, the fi rst two human polyomaviruses were discovered in 
1971. The JC-polyomavirus (JCPyV) was iden  fi ed in a brain  ssue extract from a progressive 
mul  focal leukoencephalopathy (PML) pa  ent with the ini  als J.C. [6]. The fi rst reported 
BK-polyomavirus (BKPyV) was isolated from the urine of a nephropathic kidney transplant 
pa  ent with the ini  als B.K. [7]. Both JCPyV and BKPyV have no oncogenic capability in 
humans despite being phylogene  cally closely related to SV40 that was associated with on-
cogenic proper  es in humans, but this issue remained controversial so far (Figure 1) [2, 8].
t Figure 1. Phylogene  c grouping of 25 polyomaviruses that were known up un  l October 2010, including 8 human viruses (red), as proposed to the Interna  onal Commi  ee on Taxonomy of Viruses (ICTV). The tree is based on the whole genomic nucleo  de sequences. Figure adapted from [2].
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Figure 2. A  me line is shown that indicates the discovery of mainly human (red) and a number of animal polyo-
maviruses un  l June-2014. Addi  onally discovered mammal and bird polyomaviruses are indicated in Table 1. The 
year of discovery refers to the fi rst descrip  on of the virus, not necessarily to the year that the full DNA genome 
was sequenced. The abbreviated names of the viruses are explained in Table 1.
 Subsequently, more polyomaviruses were iden  fi ed in rodents, non-human pri-
mates, ca  le and birds, but not in humans un  l this century. From 2007 on, at least eleven 
addi  onal human polyomaviruses (HPyVs) were discovered. For three of those (i.e., MCPyV, 
TSPyV and NJPyV) involvement in disease development in immunosuppressed and/or el-
derly pa  ents seems highly likely [9 - 11]. They seem to fi t the ‘opportunis  c’ polyomavirus 
profi le already known for JCPyV and BKPyV characterized by symptoma  c reac  va  on a  er 
a long period of persistent latent infec  on. For the other novel HPyVs, disease associa  on 
has not been demonstrated and their pathogenicity is s  ll unknown.
 A  meline of a selec  on of polyomavirus discoveries is illustrated in Figure 2. A list 
of all polyomaviruses iden  fi ed up un  l mid-2014, which prototype the (tenta  ve) name-
sake species are shown in Table 1, including name abbrevia  ons and GenBank (RefSeq) 















































































Iden  fi ca  on of new human polyomaviruses
With the development of nucleic acid amplifi ca  on and detec  on techniques, the need for 
cytopathic changes observed in cell culture to detect the presence of a virus was bypassed. 
Recent versions of these molecular techniques allowed sensi  ve and high-throughput anal-
yses of large number of clinical samples that led to a revolu  on of virus discovery. These 
techniques are frequently combined with strategies to enrich the original sample for viral 
DNA or RNA by reducing the content of hosts genomic DNA. Here, recent discoveries of 
human polyomaviruses are summarized.
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* Year of fi rst descrip  on, not necessarily the year of fi rst complete genome sequencing
** Genome sequence according GenBank (RefSeq) number (h  p://www.ncbi.nlm.nih.gov/RefSeq/)
Host type Polyomaviruses Year* RefSeq** 
Human 
BK polyomavirus (BKPyV) 1971 [6] NC_001538 
JC polyomavirus (JCPyV) 1971 [7] NC_001699 
KI polyomavirus (KIPyV) 2007 [12] NC_009238 
WU Polyomavirus (WUPyV) 2007 [13] NC_009539 
Merkel cell polyomavirus (MCPyV) 2008 [9] NC_010277 
Human polyomavirus 6 (HPyV6) 2010 [10] NC_014406 
Human polyomavirus 7 (HPyV7) 2010 [14] NC_014407 
Trichodysplasia spinulosa-associated polyomavirus (TSPyV) 2010 [14] NC_014361 
Human polyomavirus type 9 (HPyV9) 2011 [15] NC_015150 
Malawi polyomavirus (MWPyV) 2012 [16] NC_018102 
Human polyomavirus type 10 (HPyV10) 2012 [17] JX262162 
Mexico polyomavirus (MXPyV) 2012 [18] JX259273 
St. Louis polyomavirus (STLPyV) 2013 [19] NC_020106 
Human polyomavirus type 12 (HPyV12) 2013 [20] NC_020890 
New Jersey polyomavirus (NJPyV) 2014 [11] KF954417 
Non-human  
primate 
Simian virus 40 (SV40) 1962 [3] NC_001669 
Baboon polyomavirus 1 (SA12) 1963 [21] NC_007611 
B-lymphotropic polyomavirus (LPyV) 1979 [22] NC_004763 
Squirrel monkey polyomavirus (SqPyV) 2008 [23] NC_009951 
Bornean orang-utan polyomavirus (OraPyV1) 2010 [24] NC_013439 
Sumatran orang-utan polyomavirus (OraPyV2) 2010 [24] FN356901 
Chimpanzee polyomavirus (ChPyV) 2010 [25] NC_014743 
Gorilla gorilla gorilla polyomavirus (GggPyV1) 2011 [26] HQ385752 
Pan troglodytes verus polyomavirus (PtvPyV1a) 2011 [26] HQ385746 
Pan troglodytes verus polyomavirus (PtvPyV2c) 2011 [26] HQ385749 
Cebus albifrons polyomavirus (CAPyV1) 2013 [27] NC_019854 
Ateles paniscus polyomavirus (AtPPyV1) 2013 [27] NC_019853 
Macaca fascicularis polyomavirus (MFPyV1) 2013 [27] NC_019851 
Piliocolobus rufomitratus polyomavirus (PRPyV1) 2013 [27] NC_019850 
Vervet monkey polyomavirus (VePyV1) 2013 [27] NC_019844 
Mammal 
(other) 
Murine pneumotropic virus (MptV) 1953 [28] NC_001505 
Murine polyomavirus (MPyV) 1953 [5] NC_001515 
Hamster polyomavirus (HaPyV) 1967 [29] NC_001663 
Bovine polyomavirus (BPyV) 1976 [30] NC_001442 
Bat polyomavirus (BatPyV) 2009 [31] NC_011310 
California sea lion polyomavirus (CSLPyV) 2010 [32] NC_013796 
Mastomys polyomavirus (MasPyV) 2011 [33] AB588640 
Equine polyomavirus (EPyV) 2012 [34] JQ412134 
Molossus molossus polyomavirus (MMPyV) 2012 [35] JQ958893 
Desmodus rotundus polyomavirus (DRPyV) 2012 [35] JQ958892 
Pteronotus parnellii polyomavirus (PPPyV) 2012 [35] JQ958891 
Pteronotus davi polyomavirus (PDPyV) 2012 [36] NC_020070 
Ar beus planirostris polyomavirus (APPyV2) 2012 [35] JQ958890 
Ar beus planirostris polyomavirus (APPyV1) 2012 [35] JQ958887 
Carollia perspicillata polyomavirus (CPPyV) 2012 [35] JQ958889 
Sturnira lilium polyomavirus (SLPyV) 2012 [35] JQ958888 
Chaerephon polyomavirus (CoPyV1) 2012 [36] NC_020065 
Cardioderma polyomavirus (CdPyV) 2012 [36] NC_020067 
Eidolon polyomavirus (EiPyV1) 2012 [36] NC_020068 
Miniopterus polyomavirus (MiPyV) 2012 [36] NC_020069 
Otomops polyomavirus (OtPyV1) 2012 [36] NC_020071 
Raccoon polyomavirus (RacPyV) 2013 [37] JQ178241 
 African elephant polyomavirus (AelPyV) 2013 [38] NC_022519 
Bird 
Avian polyomavirus (APyV) 1981 [39] NC_004764 
Goose hemorrhagic polyomavirus (GHPyV) 2000 [40] NC_004800 
Finch polyomavirus (FPyV) 2006 [41] NC_007923 
Crow polyomavirus (CPyV) 2006 [41] NC_007922 
Canary polyomavirus isolate (CaPyV) 2010 [42] GU345044 
Table 1: List of 58 polyomavirus names iden  fi ed up to mid-2014
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KI-polyomavirus (KIPyV) and WU-polyomavirus (WUPyV)
In 2007, almost coincidentally, two novel HPyVs were reported; the Karolinska Ins  tute pol-
yomavirus (KIPyV) iden  fi ed in Stockholm (Sweden), and the Washington University poly-
omavirus (WUPyV) iden  fi ed in St. Louis (USA). Both were discovered in respiratory tract 
samples from individuals with (acute) respiratory tract infec  ons, but by diff erent methods.
 KIPyV was iden  fi ed by pooling centrifuged and fi ltered supernatants from ran-
domly selected DNase-treated nasopharyngeal aspirates, from which DNA and RNA were 
extracted [12]. The nucleic acids served as a template for random-PCR, and the products 
were separated by gel electrophoresis, cloned and sequenced. This resulted in several se-
quence reads that were subsequently trimmed, clustered and sorted using dedicated so  -
ware. Finally, BLAST searches were performed to look for similari  es with known (viral) se-
quences listed in GenBank.
 For the iden  fi ca  on of WUPyV, a ‘shotgun sequencing’ strategy was used on a 
single nasopharyngeal aspirate that proved nega  ve for 17 known viral respiratory patho-
gens in diagnos  c PCR. Total nucleic acid isolated from the sample was randomly amplifi ed 
and PCR products were cloned and sequenced. The DNA sequence reads were analyzed in 
a comparable fashion to the above for KIPyV, which revealed several sequences that dis-
played signifi cant homology with JCPyV and BKPyV [13]. Subsequent analyses of the com-
piled WUPyV genome showed highest sequence homology to KIPyV.
Merkel cell polyomavirus (MCPyV)
The discovery of MCPyV proved the assump  ons of polyomavirus involvement in human 
oncogenesis fi nally to be true. Merkel cell carcinomas (MCC) are a rare but aggressive type 
of cutaneous tumors of neuroendocrine origin that typically develop in the elderly and im-
munocompromized pa  ents (see paragraph “The new human polyomaviruses and their 
associated diseases”). Using a technique called the digital transcriptome subtrac  on [43], 
MCPyV was iden  fi ed in 8 out of 10 analyzed MCC lesions [9]. This technique compares 
(subtracts) cDNA libraries generated with random RT-PCR from diseased and healthy  ssues 
and thus can iden  fy messengerRNA transcripts poten  ally unique for either or both. In 
this case, with the help of sophis  cated so  ware, unique and unknown sequences were 
followed-up, of which some displayed homology to the monkey B-lymphotrophic polyo-
mavirus (LPyV) and BKPyV. Through primer-genome-walking, subsequently the complete 
genome was sequenced. New to HPyVs, but known for oncogenic animal polyomaviruses 
detected in tumors, the MCPyV genome was found to be monoclonally randomly integrated 
into the genome of the analyzed MCC lesions [9, 44].
Human polyomavirus 6 and 7 (HPyV6 and HPyV7)
In order to detect free, non-integrated, MCPyV genomes on the skin, rolling-circle amplifi ca-
 on (RCA) was performed on forehead swab samples of healthy individuals. Performing the 
RCA technique on samples results into amplifi ca  on of circular double-stranded viral DNA 
17
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by using random primers and strand-displacement DNA polymerase (Figure 3) [45]. With 
some adjustments to boost the RCA sensi  vity, this approach revealed the iden  ty of a new 
polyomavirus, called the type 6 (HPyV6), on the skin of a healthy individual [14]. By using a 
newly developed degenerate PCR primer-set on the similar pre-treated DNA materials from 
those healthy skin samples to detect HPyV6- and WUPyV-like sequences, an addi  onal new 
polyomavirus sequence was iden  fi ed and completely sequenced, which was subsequently 
named HPyV7 [14].
DNA from clinical sample+Random Primers
A B C
Figure 3. The rolling-circle amplifi ca  on (RCA) technique exploits random hexamer primers and a DNA polymerase 
(Phi-29) with proofreading and strand-displacement capabili  es used on clinical DNA samples (A). If a sample 
contains a rela  ve excess of a par  cular small circular double-stranded DNA molecule, for instance a plasmid or a 
(small) viral genome, RCA will produce long, high-molecular DNA molecules with concatenated (linearized) stretch-
es of DNA of poten  al interest (B). These stretches will appear as sharp bands on gel when the RCA-product is cut 
with specifi c restric  on enzymes that can subsequently be cloned and sequenced (C). Figure adapted from [10, 45].
Trichodysplasia spinulosa-associated polyomavirus (TSPyV)
Trichodysplasia spinulosa (TS) is a rare skin disease of immunocompromized pa  ents, 
which will be described in more detail below and in Chapter 2. Already in 1999, Haycox 
and co-workers proposed that TS has a viral origin, because TS lesions contained clusters 
of small virus par  cles [46]. It was only in 2010 that the iden  ty of the virus was revealed 
[10], with the help of RCA technique (Figure 3) [45]. With specifi c primers used during prim-
er-genome-walking the en  re RCA product was sequenced, which revealed the en  re TSPyV 
genome in lesions of a TS pa  ent [10].
Human polyomavirus 9 (HPyV9)
Previously, several serological studies suggested the presence of ‘cross-reac  ve’ an  bodies 
in a percentage of human sera that recognized a non-human primate polyomavirus (LPyV 
isolated from an African green monkey) capsid-protein [47 - 49]. Furthermore, LPyV-derived 
sequences were obtained from human blood, indica  ng the occurrence of LPyV(-like) infec-
 ons in humans [50]. In 2011, a novel polyomavirus that closely resembled LPyV was iden-
 fi ed, independently, by two research groups in human serum and skin swabs, respec  vely, 
18
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and tenta  vely called HPyV9. One group used a degenerate polyomavirus PCR primer-set 
[26] to screen serum samples, which generated an unknown, puta  ve HPyV sequence, 
next to some known HPyV sequences. With primer-genome-walking, the rest of the HPyV9 
genome was sequenced [15]. The other group isolated DNA from healthy skin swabs and 
subjected the DNA to high-throughput sequencing, which resulted in millions of reads and 
several con  gs that matched MCPyV, HPyV6 and HPyV7, as well as many human papillo-
maviruses. Some of the con  gs showed the highest homology to LPyV and a  er fi lling the 
con  g sequence gaps by designing addi  onal primers, HPyV9 genome was iden  fi ed [51].
Malawi, Mexico and human polyomavirus 10 (MWPyV/MXPyV/HPyV10)
Another novel human polyomavirus was iden  fi ed in stool of a child from Malawi [16]. This 
virus was discovered by suspending a small amount of feces that subsequently was centri-
fuged and fi ltered through 0.45 mm and then 0.22 mm pores. A  er chloroform and DNase 
treatment, extrac  on-free-DNA was obtained. The solu  on that s  ll contained encapsidat-
ed DNA was SDS and Proteinase K-treated, and DNA was isolated. Finally, this DNA was 
subjected to RCA and pyrosequencing. Hundreds of reads were obtained, sequenced and 
aligned to sequences from the GenBank database. This revealed several polyomavirus-like 
reads and with the use of primer-genome-walking strategy the complete MWPyV genome 
sequence was fulfi lled [16].
 Shortly a  er, two almost iden  cal viruses were iden  fi ed, called the HPyV10 and 
Mexico polyomavirus (MXPyV). HPyV10 genome was isolated from an anal wart of an im-
munocompromized pa  ent with WHIM syndrome with the help of RCA and primer-ge-
nome-walking sequencing [17]. MXPyV was iden  fi ed in diarrheal stool collected from a 
child in Mexico [18]. From stool, viral par  cles were purifi ed in a PBS suspension, containing 
glass beads and chloroform, by mechanical shaking and centrifuga  on. Further process-
ing of the fi ltered supernatant was similar as for MWPyV genome iden  fi ca  on described 
above. Sequencing of the barcoded reads was performed with an Illumina HiSeq 2000. As-
sembled con  gs from 75bp reads were used to design primers directed outward for use in 
long-range PCR to amplify and sequence the whole genome. Because MWPyV, HPyV10 and 
MXPyV share at least 95% of their genome sequence, they most probably represent the 
same polyomavirus species.
St. Louis polyomavirus (STLPyV)
As part of a human gut-microbiome-survey study of healthy and malnourished children from 
Malawi performed by the same group that iden  fi ed the WUPyV and MWPyV, another new 
polyomavirus was discovered and called STLPyV [19]. Prior to DNA extrac  on, the stool was 
processed by CsCl ultracentrifuga  on to generically enrich for viral par  cles. A  er DNA was 
extracted and subsequently amplifi ed by a technique called mul  ple displacement amplifi -
ca  on (MDA), shotgun 454 pyrosequencing was performed. MDA technique is comparable 
to the RCA method exploi  ng random hexamer primers and a DNA polymerase (Phi-29) with 
19
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proofreading and strand-displacement capabili  es (Figure 3). A  er sequencing, two reads 
were iden  fi ed in this sample, which shared limited sequence iden  ty to known polyoma-
viruses. Employing these two ini  al reads, primers were designed to PCR amplify products 
that span the whole genome in either direc  on. STLPyV has a mosaic genome that probably 
shares an ancestral recombinant origin with the MWPyV because of its 64.2% genome sim-
ilarity to this polyomavirus.
Human polyomavirus 12 (HPyV12)
Very recently, a twel  h human polyomavirus was isolated (HPyV12) [20]. HPyV12 genome 
was tested posi  ve in 11% of liver  ssues analyzed in that study. Methods used for genome 
iden  fi ca  on and sequencing were iden  cal/comparable to the iden  fi ca  on of HPyV9 [15]. 
HPyV12 is distantly related to other viruses from the Orthopolyomavirus-I genogroup (see 
paragraph “Phylogeny and evolu  onary trends”). Whether this virus is involved in patho-
genesis of a liver disease, or other gastrointes  nal diseases, remains to be seen.
New Jersey polyomavirus (NJPyV)
The most recently iden  fi ed human polyomavirus, called the New Jersey polyomavirus 
(NJPyV), was isolated from an immunosuppressed pa  ent diagnosed with vasculi  c myopa-
thy and re  nopathy caused by microthrombosis. In tested biopsies, clusters of viral par  cles 
were observed in swollen nuclei of endothelial cells [11]. The authors iden  fi ed the viral 
genome a  er extrac  on of RNA from sec  ons of formalin-fi xed paraffi  n-embedded muscle 
 ssue, from which they generate cDNA libraries that were subsequently used for sequenc-
ing. The obtained sequence reads were all uninforma  ve by nucleo  de sequence analy-
sis (BLASTn), but when translated amino acid analysis (BLASTx) was performed, they found 
approximately 80% sequence homology with chimpanzee polyomaviruses. Future studies 
should inves  gate whether this virus has indeed a tropism for vascular endothelial cells and 
may be involved in vasculi  s in general. Interes  ngly, the pa  ent had to evacuate through 
fl oodwaters because of superstorm Sandy weeks prior to development of her symptoms, 
promp  ng specula  on about NJPyV contagion through sewage-contaminated waters.
Altogether, since 2007 an explosion in human polyomavirus discoveries took place, among 
which the discovery of TSPyV is evident. These discoveries are most likely due to im-
provement in viral DNA purifi ca  on and amplifi ca  on methods and par  cularly the use of 
high-throughput Next Genera  on Sequencing to iden  fy viral DNA with low copy-numbers 
in the background of excess host genomic DNA. Iden  fi ca  on of addi  onal viruses of the 
Polyomaviridae family and studies of their genome, epidemiology, pathogenicity and evolu-




The polyomavirus genome and its products
Genome organiza  on and transcrip  on
Viruses of the Polyomaviridae family, including the recently iden  fi ed human viruses, are 
among the smallest known to infect humans, both in par  cle size and in genome length [52]. 
The non-enveloped virions of about 45-nm harbour a circular double-stranded DNA genome 
of approximately 5000 basepairs that is divided into three regions; (i) the non-coding con-
trol region (NCCR) and in opposing direc  ons, (ii) the early (T-an  gen) and (iii) the late (VP) 
coding regions (Figure 4).
 The NCCR contains the origin of replica  on fl anked by several large T-an  gen-bind-
ing sites, transcrip  on promoters and regulatory elements. The novel human polyomavirus-
es display a similar NCCR organiza  on. In JCPyV- or BKPyV-diseased individuals, the NCCR 
of virus isolates found in diff erent body compartments can vary from what is called the ‘ar-
chetype’ NCCR that is present in transmissible virus found in urine for example. It is believed 
that the rearranged NCCR increases the T-an  gen transcrip  on and replica  on rate, as was 
shown for instance for JCPyV [53]. Systema  c comparisons of NCCR regions among diff erent 















Figure 4. Old schema  c representa  on of human polyomavirus circular double-stranded DNA genome organiza-
 on as proposed before, showing only the protein-expressing layer. Updated representa  ons, that include middle 
T-an  gen and ALTO protein, are shown in Chapter 2 and Chapter 6. Regions coding for the indicated proteins are 
depicted in diff erent colors. The agnoprotein (yellow) is encoded only by some HPyVs.
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 The T-an  gen coding region of most HPyVs encodes at least the small and large 
T-an  gens that are translated from an alterna  vely spliced pre-messengerRNA. In addi  on, 
shorter or alterna  vely spliced products of T-an  gens are expressed, such as 17kT, T4 and 
57kT [54, 55]. Rodent polyomaviruses are known to express an addi  onal T-an  gen, called 
middle T-an  gen [56]. The VP coding region found on the opposite strand codes for at least 
the VP1 and VP2 structural capsid proteins, and o  en VP3. The agnoprotein and VP4 ex-
pressed by JCPyV, BKPyV and several animal polyomaviruses, including birds, seem not to 
be encoded by the newly iden  fi ed HPyVs [57], but for most of these viruses the transcrip-
 on-pa  erns have not been solved yet.
 Besides the NCCR transcrip  on regula  on, for example shown for SV40, T-an  gen 
messengerRNAs are post-transcrip  onally regulated by microRNAs [58]. In addi  on to SV40, 
also for MCPyV and BKPyV a microRNA was iden  fi ed that poten  ally regulates early gene 
expression [59, 60].
T-an  gens
Polyomavirus T-an  gens play essen  al roles in viral transcrip  on and replica  on, as well as 
in host-cell tuning to enable effi  cient virus replica  on [52, 61]. As polyomaviruses are com-
pletely dependent on the host cell replica  on machinery, a signifi cant part of this tuning is 
aimed at inducing S-phase and bypassing cell cycle-control measures. In some cases, these 
features can derail and result in uncontrolled cell prolifera  on and eventually tumor forma-
 on. So far, MCPyV is the only (newly iden  fi ed) HPyV for which these phenomena have 
been noted [62]. Consequently, the T-an  gens of MCPyV have been studied already quite 
extensively (see next, and “MCPyV and MCC” paragraph), whereas for the other new HPyVs 
this knowledge is almost en  rely based on predicted mo  fs in protein sequences.
 The small and large T-an  gens share their N-terminus, while having C-terminal re-
gions of diff erent sizes encoded from diff erent reading frames (Figure 4). The novel human 
polyomaviruses seem no excep  on to this rule. This shared region occupied by the so-called 
J-domain contains important mo  fs, such as CR1 and DnaJ, for viral replica  on and cellular 
transforma  on [61]. Downstream, the small T-an  gen contains a PP2A subunit-binding mo-
 f probably involved in ac  va  on of the Akt-mTOR pathway related to (tumor) cell survival 
[63, 64]. The part of large T-an  gen, encoded by the second exon, includes many func  onal-
ly important domains or mo  fs such as: (i) a nuclear-localiza  on signal, (ii) an origin-binding 
domain, (iii) an ATPase-containing helicase domain [61, 65], (iv) a pRB-binding and (v) some-
 mes a p53-interac  on domain that both poten  ally play a crucial role in cellular transfor-
ma  on. Apart from MCPyV [55], the presence of (most of) these mo  fs and domains was 
iden  fi ed only by bioinforma  cs approach in TSPyV and HPyV9 [10, 15], but they remain to 
be characterized func  onally.
 Murine (MPyV) and hamster (HaPyV) polyomaviruses express also a middle T-an-
 gen, which serves as the prime oncoprotein during cellular transforma  on [56]. Middle 
T-an  gen has a C-terminal transmembrane domain, several Tyr, Ser and Thr phosphoryla-
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 on sites, and some other func  onally unknown conserved domains. Phosphoryla  on of 
the Tyr, Ser and Thr residues of middle T-an  gen results into binding and ac  va  on of sever-
al cellular signal transduc  on proteins (e.g., Src, PI3K, PLC-gamma1) that promotes cellular 
transforma  on and oncogenesis [56, 66 - 68].
VP capsid proteins
Together, SV40 encoded late VP structural proteins make up the approximately 45-nm pol-
yomavirus capsid [69]. VP1 molecules interact with VP2 or VP3 molecules to auto-assem-
ble into a full capsid-complex (Figure 5) [52]. Comparable VP1, VP2 and/or VP3 encoding 
sequences have been suggested for the novel polyomaviruses. So far, there is no reason 
to believe that the novel viruses will behave diff erently with respect to capsid forma  on, 
although there is debate whether MCPyV VP3 is expressed or is func  onal [70, 71]. The VP4 
protein, noted for SV40, is expressed very late in infec  on and serves probably as a porin of 
cellular membrane that facilitates the viral release [72, 73]. So far, this protein has not been 
predicted or reported for any of the newly iden  fi ed HPyVs.
 How the polyomaviruses recognize and infect their host target cells is partly known. 
Most of the known polyomaviruses interact by linkage of the major capsid protein VP1 with 
terminal sialic acids (alpha2,3 or alpha2,6) of mainly gangliosides on the host cell membrane 
[74], a  er which they are internalized using diff erent entry pathways. For MCPyV, it was 
shown that this virus uses glycosaminoglycans for the ini  al a  achment, while the sialic 
acids may be important later in the encounter [75]. Future research could reveal whether 
the other novel human polyomaviruses use similar strategies for host cell recogni  on.
Figure 5. Illustra  on of polyomavirus icosahedral capsid forma  on. Six VP1 proteins interact with either a VP2 or 
VP3 to assemble into a hexameric protomere. Five of these protomeres interact to form a capsomere, which sub-
sequently auto-assemble into a full capsid-complex [76].
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The new human polyomaviruses and their associated diseases
For two of the novel HPyVs a causal rela  onship with a specifi c clinical condi  on is highly 
probable. In both cases, the disease/cancer has lent its name to the virus, trichodysplasia 
spinulosa to TSPyV and Merkel cell carcinoma to MCPyV. For MCPyV, an addi  onal associa-
 on with chronic lymphocy  c leukemia that originates from B-cells was suggested, and for 
TSPyV an associa  on with pilomatricoma that represents a benign hair follicular skin tumor 
was speculated. However, evidence for these correla  ons is (yet) weak. For the recently 
iden  fi ed NJPyV associated with the vasculatory myosi  s, re  ni  s and derma   s, the evi-
dence is highly sugges  ve, but limited to one pa  ent observa  on so far. For the other new 
human polyomaviruses, the evidence for involvement in disease is too weak at the moment.
MCPyV and MCC
MCC is a rare and aggressive neuroendocrine tumor of epidermal origin with an increasing 
incidence of approximately 0.2 - 0.5 per 100,000 depending on age, skin type, (cumula  ve) 
sun exposure and immune status (Figure 6A) [77, 78]. The associa  on with fair skin and 
sun exposure suggests a direct eff ect of UV-radia  on in MCC development, but this has not 
been confi rmed experimentally. In 2008, the presence of MCPyV in MCC lesions was shown 
for the fi rst  me [9], a fi nding that has been confi rmed by many research groups worldwide 
showing that at least 75% of all MCCs have monoclonally integrated MCPyV genome [65].
 Several fi ndings indicate direct involvement of MCPyV in Merkel cell carcinogen-
esis. For instance, in almost all cancer cases MCPyV is found linearized and monoclonally 
integrated in the host tumor-cell genome, although the site of integra  on appears random 
[9, 44, 79]. Furthermore, the MCPyV large T-gene was found to carry ‘signature’ muta  ons 
specifi c for the carcinomas. Their expression results into truncated large T-an  gen that lacks 
the C-terminal helicase domain, the puta  ve p53-interac  on domain and the origin-bind-
ing domain [9, 55, 80], consequently rendering the virus inac  ve for replica  on. Therefore, 
the func  on of large T-an  gen in viral progeny produc  on is selec  vely impaired. Small 
T-an  gen is unaff ected by these muta  ons. Therefore, in an apparent parallel to other vi-
rus-associated cancers, e.g. human papillomavirus (HPV)-associated cervical cancer, also in 
MCPyV-posi  ve MCC there seems to be a strong associa  on with non-produc  ve MCPyV 
infec  on. Probably the strongest evidence of pathogenicity (oncogenicity) of MCPyV is pro-
vided by studies showing that expression of both small and (truncated) large T-an  gens are 
indispensable in the maintenance of cancer cell phenotype [81, 82].
TSPyV and trichodysplasia spinulosa
Trichodysplasia spinulosa (TS) is a rare skin disease exclusively found in severely immuno-
compromized hosts, especially the solid organ transplant recipients (Figure 6B) [85, 86]. 
TS is characterized by gradual development of papules and spicules (spines) on the face, 
some  mes accompanied by alopecia of the eyebrows and lashes [87]. Worldwide, some 30 
cases have been described so far [88, 89]. In 1999, Haycox and co-workers proposed for the 
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Figure 6. (A) Presenta  on of a 5-cm large Merkel cell carcinoma with concomitant nodal spread and highly vascu-
larized surface on the le   cheek of a 72-year-old man [83]. (B) Presenta  on of trichodysplasia spinulosa showing 
eyebrow alopecia, spiny spicule erup  ons and mul  ple infl ammatory papules on the face of a 5-year-old immuno-
compromized girl [84].
fi rst  me that trichodysplasia spinulosa concerns a viral-associated disease and showed the 
presence of intranuclear clusters of honeycomb-arranged viral par  cles in the distended 
and dysmorphic hair follicles [46]. Subsequent reports confi rmed the typical histological 
fi ndings of hyperplas  c hair bulbs and the presence of polyomavirus or papillomavirus-like 
par  cles [90 - 94]. A  empts to iden  fy the nature of this virus failed un  l TSPyV was iden  -
fi ed with the help of RCA in 2010 [10]. More detail about TSPyV’s virological and pathogenic 
proper  es, as well as epidemiologic, diagnos  c, and therapeu  c aspects will be presented 
in Chapter 2.
Prevalence, persistence, reac  va  on and spread of polyomavi-
rus infec  on
Seroprevalence
Cross-sec  onal, serological studies of JCPyV and BKPyV have shown that both infec  ons are 
highly prevalent in the general popula  on. The seroprevalence of JCPyV is approximately 
60% and of BKPyV approximately 90% [47]. Serological studies of the novel human polyo-
maviruses revealed a considerable varia  on in the presence of serum an  bodies [14, 47, 
95 - 101]. The lowest seroprevalence was detected for HPyV9 varying between 15% and 
45% [100, 102, 103], the highest for WUPyV, MCPyV, TSPyV and HPyV6 varying between 
60% and 95% [14, 47, 97, 98, 104]. In all serological studies, the strongest increase in sero-
prevalence is observed at a young age, indica  ng that primary infec  ons generally occur at 
(early) childhood [47, 96, 98, 99]. So far, the seroprevalences of the novel HPyVs measured 
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Persistence and reac  va  on
It is generally believed that primary polyomavirus infec  on is followed by a persistent, 
asymptoma  c (latent) infec  on with very low levels of viral replica  on, which could remain 
hidden in the body lifelong. For JCPyV and BKPyV reac  va  on from the latent state and 
manifesta  on of symptoma  c infec  on is observed only in the case of reduced immunity. 
For instance, nephropathy can develop in long-term immunosuppressed solid organ trans-
plant recipients caused by BKPyV, and PML in AIDS pa  ents and Natalizumab-treated mul  -
ple sclerosis pa  ents caused by JCPyV [52, 105, 106].
 For most polyomaviruses, in healthy individuals the detec  on rate of viral DNA is 
much lower than their seroprevalence. In urine of healthy blood donors for example, the 
detec  on rate of JCPyV and BKPyV DNA was approximately 3- and 10-fold lower than the se-
roprevalence measured within the same group, respec  vely [107]. In immunocompromized 
pa  ents, however, BKPyV can be detected in urine at very high loads indica  ve of massive 
reac  va  on of infec  on and shedding of the virus [108, 109].
 For the novel HPyVs, the associa  on between diminished immunity and reac  va-
 on is less clear. Only for TSPyV, with a seroprevalence of approximately 75% [97, 98, 103], 
clinical consequences are seen exclusively in severely immunocompromised hosts (see also 
Chapter 2) [85, 86]. However, the TSPyV DNA detec  on rate, on the skin at least, hardly 
varies among immunocompetents (2%) and immunocompromised hosts (4%) [10, 85]. Also 
for MCPyV, the DNA detec  on rates on the skin do not diff er much between immunocompe-
tents and immunocompromized, albeit they are generally much higher compared to TSPyV 
and resemble the seroprevalence of about 50% [110]. In general, it should be kept in mind 
that both MCC and TS are very rare condi  ons implying that (host) factors other than immu-
nity may also play a role in controlling these infec  ons. For KIPyV, WUPyV HPyV6, HPyV7, 
HPyV9, MWPyV, HPyV10, MXPyV, STLPyV, HPyV12 and NJPyV infec  ons, the rela  on with 
immunity is not (yet) solved. This is largely explained by weak disease associa  ons or the 
lack of an established clinical condi  on that could be a  ributed to one of these novel virus-
es and the unawareness of the organ where these viruses could latently persist.
Spread of infec  on
Earlier studies have shown that JCPyV and BKPyV are found in urine, feces and saliva. The 
excreted virus numbers are so high that these polyomaviruses even serve as markers of sew-
age pollu  on or recrea  onal waters [111]. Which route of virus excre  on primarily drives 
human infec  on is not precisely known, but the effi  ciency of infec  on seems clear from the 
high seroprevalence, for both the known and novel human polyomaviruses.
 Regarding possible routes of excre  on and transmission of cutaneous polyomavi-
ruses, a recent study showed the presence of MCPyV DNA on 75% of samples from environ-
mental surfaces (door handles,  cket machines etc.). Prior DNase treatment of the samples 
and subsequent viral load measurement suggested that about 5% of the detected MCPyV 
DNA was protected, most probably encapsidated, and therefore poten  ally infec  ous [112]. 
If this provides a solid clue regarding the virus transmission, remains to be seen.
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Phylogeny and evolu  onary trends
So far, the thirteen known HPyVs comprise the largest host-specifi c subset of iden  fi ed pol-
yomaviruses. This probably refl ects a bias of the virus discovery eff orts that increasingly 
focus on hun  ng for human viruses, par  cularly during the past several years as was de-
tailed above and shown in Figure 2. Pairwise divergence between HPyVs varies as much as 
in the en  re polyomavirus family. If measured for the combined conserved regions of VP1, 
VP2 and LT proteins it ranges from 15% (for BKPyV/JCPyV pair) to 74% (KIPyV/NJPyV), or, if 
repeated subs  tu  ons accounted, from 0.16 (BKPyV/JCPyV) to 2.08 (KIPyV/NJPyV) subs  tu-
 ons per posi  on on average (Figure 7). Apart from KIPyV/WUPyV, also the HPyV6/HPyV7 
and BKPyV/JCPyV pairs are among the most closely related, which correlates with puta  ve 
shared tropism for the respiratory tract, skin and the urinary tract infec  on, respec  vely. 
 In Figure 8, a tenta  ve polyomavirus phylogene  c tree is illustrated. In addi  on to 
the older tree shown in Figure 1 [2], the novel tree includes several newly iden  fi ed animal 
and human viruses that represent new puta  ve polyomavirus species. From this tree, it is 
KIPyV WUPyV HPyV6 HPyV7 BKPyV JCPyV TSPyV MCPyV HPyV9 STLPyV MWPyV HPyV12 NJPyV
KIPyV 0.23 0.55 0.52 0.57 0.60 0.62 0.61 0.61 0.62 0.61 0.63 0.74
WUPyV 0.27 0.54 0.53 0.56 0.57 0.62 0.60 0.62 0.59 0.61 0.61 0.73 0.00 - 0.49
HPyV6 0.92 0.91 0.23 0.63 0.62 0.64 0.59 0.63 0.61 0.63 0.62 0.71 0.50 - 0.99
HPyV7 0.87 0.88 0.26 0.61 0.62 0.62 0.60 0.62 0.61 0.61 0.63 0.71 1.00 - 2.10
BKPyV 1.04 0.99 1.26 1.19 0.15 0.44 0.48 0.46 0.49 0.47 0.48 0.69
JCPyV 1.12 1.02 1.20 1.19 0.16 0.45 0.49 0.47 0.49 0.47 0.46 0.69
TSPyV 1.21 1.20 1.29 1.19 0.64 0.66 0.39 0.35 0.47 0.42 0.38 0.63
MCPyV 1.17 1.12 1.13 1.12 0.74 0.76 0.54 0.42 0.51 0.49 0.41 0.61
HPyV9 1.17 1.19 1.26 1.21 0.71 0.71 0.47 0.60 0.47 0.45 0.41 0.68
STLPyV 1.21 1.12 1.18 1.17 0.76 0.76 0.70 0.81 0.69 0.33 0.48 0.70
MWPyV 1.16 1.16 1.23 1.16 0.72 0.71 0.60 0.76 0.67 0.42 0.45 0.69
HPyV12 1.21 1.16 1.22 1.23 0.72 0.70 0.51 0.58 0.56 0.72 0.67 0.67














Figure 7. Gene  c comparison between thirteen human polyomaviruses is shown. Two measures of gene  c distance 
are shown for the combined polyomavirus protein-iden  ty of conserved regions of VP1, VP2 and LT proteins. The 
upper-right triangle shows uncorrected dissimilarity percentages (1 corresponds to 100% dissimilarity; 0 means 
iden  cal sequences); the lower-le   triangle shows evolu  onary distances that correct for mul  ple subs  tu  ons 
at the same site (the scale is mean subs  tu  ons per sequence posi  on) under the WAG amino acid subs  tu  on 
model and rate heterogeneity among sites [113] (C. Lauber is acknowledged for upda  ng the fi gure).
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clear that the HPyVs do not form a monophyle  c cluster. Rather, they are distributed une-
venly among four out of fi ve distant lineages. Two lineages that include human polyomavi-
ruses belong to the genus Orthopolyomavirus [2], and are called Orthopolyomavirus-I and 
-II, respec  vely. The third lineage belongs to the genus Wukipolyomavirus, and the fourth 
comprising the genus Malawipolyomavirus includes MWPyV (as well as HPyV10 and MXPyV 
that are almost iden  cal to MWPyV) and STLPyV all isolated from human stool.
 The Malawipolyomavirus and Wukipolyomavirus lineages are the least populated 
and include exclusively HPyVs. In contrast, the Orthopolyomavirus-I and -II include 45 puta-
 ve species from which fi ve and two, respec  vely, are composed of HPyVs. Because of the 
observed phyle  c distribu  on of HPyVs among diff erent lineages, it may be envisaged that 
a number of human polyomaviruses emerged because of cross-species jumps of zoono  c 
viruses rather than of virus-host coevolu  on [114, 115]. Recently, the applicability of this 
virus-host coevolu  on model to two species of best-sampled polyomaviruses, BKPyV and 




































































































































Figure 8. Unrooted phylogene  c tree (up un  l June 2014) of known (puta  ve) polyomavirus species based on the 
alignment of concatenated VP1, VP2 and LT amino acid sequences. The obtained branching pa  ern (topology) of 
basal nodes in the tree matches that proposed by Johne and colleagues [2], shown in Figure 1. HPyVs are shown 
in red. The bar indicates number of subs  tu  ons per site. The numbers at branching events represent probability 
support values ranging from 0 (no support) to 1 (best support). Only support values lower than 1 are shown. The 
full polyomavirus names can be found in Table 1 (C. Lauber is acknowledged for upda  ng the fi gure).
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 Resolving the uncertainty about the origins of human polyomaviruses will require 
extending the virus discovery eff orts. For example, con  nua  on of hun  ng for human virus-
es and characteriza  on of other hosts should lead to considerable improvement in our un-
derstanding of polyomaviruses (host) evolu  on. Moreover, addi  onal polyomavirus studies 
regarding their gene expression and overprin  ng mechanisms will facilitate understanding 
of polyomavirus-specifi c pa  erns of specia  on and host adapta  on.
Concluding remarks
With the availability of sensi  ve molecular techniques to detect unknown genome sequenc-
es in the background of human genomic DNA, the discoveries of polyomaviruses have in-
creased signifi cantly over the past few years. It is expected that these discoveries will con-
 nue in the coming years. 
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Outline and Scope of this disserta  on
In Chapter 1, the focus was on the recent developments in studying the newly iden  fi ed hu-
man polyomaviruses, which reviewed several general aspects of virus iden  fi ca  on, patho-
genicity, epidemiology and complete Polyomaviridae family phylogeny. S  ll, detailed anal-
yses of these aspects for each virus are desperately needed. This disserta  on will address 
some of these issues in par  cular for TSPyV.
 In Chapter 2, the virological and clinical aspects of TS disease are discussed in more 
detail, including epidemiologic, diagnos  c, and therapeu  c aspects of TSPyV infec  on.
 To study causality between TSPyV infec  on and TS disease, in Chapter 3 the prev-
alence, load and localiza  on of TSPyV infec  on in a series of TS pa  ents is analyzed in com-
parison to healthy controls.
 In Chapter 4, it is inves  gated which cellular mechanisms are poten  ally disrupted 
by TSPyV, thereby contribu  ng to hyperprolifera  on of infected hair follicle cells and spicule 
forma  on. Furthermore, the puta  ve role of TSPyV Large T-an  gen in this process is stud-
ied.
 In Chapter 5, we (re)assessed in-silico the genome sequences of all available (re-
cently iden  fi ed) polyomaviruses known so far. A newly iden  fi ed ORF encoding MT/AL-
TO-an  gen is characterized in more detail, and its role in polyomavirus evolu  on and adap-
ta  on is addressed.
 In Chapter 6, whole genome sequences of TSPyV are obtained and analyzed from 
a series of TS cases described in Chapter 3, for the purpose of gaining insight into the evo-
lu  on of this polyomavirus. The phenomena regarding polyomavirus evolu  on described in 
Chapter 5 are employed on TSPyV evolu  on that acts as a unique in-silico model to study 
the molecular basis of amino-acid exchange and toggling in polyomavirus host adapta  on in 
general.
 Finally, in Chapter 7, the fi ndings described in this disserta  on will be discussed 
with regard to TSPyV infec  on, pathogenesis, evolu  on and host adapta  on, and compared 
to the exis  ng knowledge about polyomaviruses in a broader context. In addi  on, some 
thoughts about future research direc  ons will be shared in this chapter.
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Trichodysplasia spinulosa-associated polyomavirus (TSPyV) is one of the new species of the 
Polyomaviridae family discovered in 2010. TSPyV infects humans and is associated with the 
development of a rare skin disease called trichodysplasia spinulosa. Trichodysplasia spinulo-
sa is a disease of severely immunocompromized hosts characterized by follicular disten  on 
and kerato  c spine forma  on, most notably on the face. Electron microscopy, immunohisto-
chemistry, and viral load measurements suggest an e  ological role of ac  ve TSPyV infec  on 
in the development of this disfi guring disease. This chapter will address some clinical and 
virological proper  es of TSPyV, and touches upon epidemiologic, diagnos  c, and therapeu-
 c aspects of TSPyV infec  on.
2
Clinical and viral aspects of trichodysplasia spinulosa
45t
Pathogenic human polyomaviruses
Human polyomaviruses (HPyVs) are ubiquitous viruses that infect their host with-out causing apparent disease. A  er primary infec  on, they can persist asympto-ma  cally, some  mes producing small quan   es of detectable progeny. This state is o  en referred to as latency. In case of impaired immune func  on, for example 
because of AIDS or the use of immunosuppressive drugs, HPyVs can reac  vate from latency 
and cause severe disease. As the number of solid organ transplanta  ons gradually increases, 
as shown for instance by the United States Organ Procurement and Transplanta  on network 
(Figure 1) [1], the incidence of HPyV-associated disease in long-term immunosuppressed 
pa  ents is expected to rise.
 So far, at least four out of thirteen HPyVs have been associated with human dis-
ease. As pointed out in Chapter 1, this includes BKPyV (allogra   nephropathy [2, 3]), JCPyV 
(progressive mul  focal leukoencephalopathy [4 - 6]), MCPyV (Merkel cell carcinoma [7 - 10]) 
and TSPyV. TSPyV, iden  fi ed in our lab in 2010, is associated with a rare skin disease called 
trichodysplasia spinulosa (TS) [11]. This disease is observed exclusively in severely immuno-
compromized hosts [12, 13]. In this chapter, several clinical and virological aspects of TS and 
TSPyV are presented in more detail.
Figure 1. Overview of (solid) organ transplanta  ons in USA between 1988 and 2011. Bars depicted in black rep-
resent all solid organ transplanta  on, i.e., kidney, liver, heart, lung, pancreas, intes  ne, kidney+pancreas and 
heart+lung. Red colored bars represent the number of kidney transplanta  ons and green bars the number of heart 
transplanta  ons (source OPTN, data as of September 2012).
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The trichodysplasia spinulosa-associated polyomavirus
TSPyV genome and gene products
TSPyV genome consists of a rela  vely small double-stranded DNA of 5232 basepairs. Its 
genomic orienta  on is similar to other known polyomaviruses, with its early T-an  gen and 
late VP products encoded bidirec  onally on separate DNA strands. At least fi ve open read-
ing frames can be located, transcrip  on of which is regulated by the non-coding control 
region (NCCR) and is subject of alterna  ve splicing (Figure 2) [11].
 In analogy with other polyomaviruses, upon infec  on probably fi rst the T genes are 
expressed that code for small (ST) and large T-an  gen (LT), and possibly for middle T-an  -
gen (MT) and ALTO as well (van der Meijden, unpublished results). ST-, MT- and LT-an  gen 
ini  ate at the same start codon, but are a subject of alterna  ve splicing downstream. As 
a result, ST-, MT- and LT-an  gen share N-terminal region of approximately 80 amino acids 
which contain some highly conserved regions important for polyomavirus replica  on and 
cellular transforma  on (Figure 2) [11]. Furthermore, ST-an  gen contains a unique puta  ve 
PP2A-binding mo  f, MT-an  gen a membrane-spanning domain and several puta  ve Tyr, Ser 
and Thr phosphoryla  on sites, and LT-an  gen a number of mo  fs that puta  vely interact 
with tumor suppressor and cell cycle regulatory proteins like pRB and p53. Preliminary anal-
yses of messengerRNA and protein expression of the T-region confi rmed this pa  ern for 
TSPyV that includes ST-, MT-, LT-an  gen expression including an addi  onal ALTO product 
(van der Meijden, unpublished results). The func  on of TSPyV T-an  gens, individually and 
in concert, related to virus replica  on and possibly cellular transforma  on, remains to be 
studied.
 The opposing strand of the TSPyV genome encodes the late structural proteins 
VP1, VP2, and possibly VP3 that together form the viral capsid. VP1 is the major protein of 
the pentameric viral capsomere that likely incorporates one copy of either VP2 or VP3 [14]. 
The icosahedral capsid is constructed of 72 of such capsomers. An  gene  cally, VP1 is con-
sidered the immunodominant polyomavirus protein and therefore TSPyV VP1 represents an 
important an  gen in measuring host an  body seroreac  vity against TSPyV.
 From the late pre-messengerRNA, complementary to the early coding region, 
microRNAs can be encoded, which can regulate gene expression by direc  ng cleavage of 
the targeted T-an  gen messengerRNAs and thereby repressing transla  on. For BKPyV, this 
mechanism was recently experimentally iden  fi ed [15]. For MCPyV this mechanism was 
postulated as well [16, 17]. Preliminary bioinforma  cs data suggest that TSPyV may code 
as well for a microRNA that targets the transcripts of both LT-an  gen and MT-an  gen/ALTO 
(Figure 2).
TSPyV prevalence
For BKPyV and JCPyV it is suggested that the primary infec  on takes place some  me early in 
life and transmission probably occurs through the feco-oral, urino-oral, or respiratory route 
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[18]. However, for none of the HPyVs the exact route of transmission is known, including the 
TSPyV and MCPyV pathogenic viruses. Although these la  er two HPyVs cause skin disease, 
large diff erences in skin viral DNA prevalence suggest diff erent routes of infec  on, transmis-
sion, and/or persistence. MCPyV DNA can be detected on healthy and diseased skin in 30–
60% of individuals, regardless of the host immune status [19 - 27]. Studies that have looked 
at TSPyV prevalence in various samples (e.g., skin swabs, skin biopsies, plucked eyebrows, 
serum/plasma, tonsils, urine etc.) have found less than 5% DNA-posi  vity in asymptoma  c 
individuals, regardless of their immune status [11, 13, 28, 29] (Table 1). Higher TSPyV prev-
alence and high viral loads were only reported in TS pa  ents [13], which suggest that TSPyV 
is the causa  ve agent of TS disease (Chapter 3). Hypothe  cally, at some stage in life TSPyV 
infects the skin, to cause disease there in a small minority of immunocompromized hosts. 









    
    
    
     
      








    
    
    
     
     



























Figure 2. TSPyV genome map. The fi ve large open reading frames (ORFs) in diff erent reading frames are depicted 
by colored inner arrows (ORF1-ORF5). Addi  onal smaller ORFs are depicted by gray inner arrows. Transcrip  on of 
the early region results into a pre-messengerRNA that contains ORF1, ORF2 and ORF5. Upon alterna  ve splicing 
events (introns indicated by do  ed lines), small T-an  gen (light-green), large T-an  gen (light-green + pink) and 
middle T-an  gen (light-green + dark-green) transla  on of the indicated protein will be puta  vely ini  ated at the 
same start codon and all proteins will share the N-terminal region (light-green). Alterna  vely, internal start codons 
could be used in RF-1 that might result into transla  on of ALTO product(s) (dark green). The late coding region con-
tains ORF3 and ORF5 that encode VP1, VP2, and possibly VP3 viral capsid proteins. Puta  vely, a microRNA that is 
complementary to the early coding region targe  ng ORF2 and ORF4, is transcribed from a late pre-messengerRNA 
(red-lined arrow). The region before the early and late ORFs contains the non-coding control region and the origin 
of replica  on.
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the majority of infected (seroposi  ve) individuals are skin TSPyV-nega  ve. Whether TS is a 
manifesta  on of TSPyV reac  va  on from a yet uniden  fi ed (transplanted) organ reservoir 
[29], or an unfortunately  med primary infec  on in the midst of immunosuppression, is 
unknown.
Table 1: TSPyV prevalence
Abbrevia  ons: TS, trichodysplasia spinulosa; RTR, renal transplant recipients; TX, transplant pa-
 ent (not fully specifi ed in the cited study [28]); GE, gastroenteri  s.
Samples tested Number of samples 
Number of 
pos es (%) References 
Skin biopsy    
TS, Immunocompromized 1 1 (100) [11] 
TS, Immunocompromized 1 1 (100) [12] 
TS, Immunocompromized 11 11 (100) [13] 
TS, Immunocompromized 1 1 (100) [49] 
TS, Immunocompromized 1 1 (100) [50] 
TS, Immunocompromized 2 2 (100) [51] 
Various other skin disease,  193 0 (-) [52] 
Pilomatricoma 10 0 (-) [53] 
Plucked eyebrow hair    
Immunocompromized (TS) 1 1 (100) This study 
Immunocompromized (RTR) 69 3 (4) [11] 
Immunocompromized (RTR) 81 2 (2) This study 
Tonsillar ssue    
Immunocompetent 229 8 (4) [29] 
Nasopharyngeal swabs    
Immunocompromized (TX) 32 1 (3) [54] 
Feces    
Immunocompromized (TX) 32 1 (3) [54] 
Immunocompetent (GE) 38 0 (-) [28] 
Immunocompetent (GE) 160 2 (1) This study 
Kidney biopsy    
Immunocompromized (TS) 1 1 (100) [49] 
Urine    
Immunocompromized (TS) 1 0 (-) [49] 
Immunocompromized (TX) 179 2 (1) [28] 
Immunocompetent 17 0 (-) This study 
Serum/plasma    
Immunocompromized (TX) 88 0 (-) [28] 
Immunocompetent 19 0 (-) This study 
Cerebrospinal uid    
Immunocompromized (TX) 74 0 (-) [28] 
Immunocompetent 38 0 (-) This study 
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TSPyV seroprevalence
Epidemiological studies looking at polyomavirus seroprevalence in humans indicate that 
HPyV infec  ons of the general popula  on are highly prevalent and occur at early age, prob-
ably without clinical manifesta  on. In healthy, immunocompetent adults, seroprevalences 
of 80-100% for BKPyV [30 - 33], 40-70% for JCPyV [30 - 33], 55-90% for KIPyV [31, 32, 34, 
35], 70-100% for WUPyV [31, 32, 34, 35], 40-80% for MCPyV [19, 31, 32, 36 - 38], 60% for 
HPyV6 [19, 38], 35% for HPyV7 [19, 38], 35-50% for HPyV9 [38 - 40] and 17-23% for HPyV12 
[41] have been reported so far.
 Detec  on of serum an  bodies against TSPyV VP1 have been described in several 
studies using either a mul  plex serology method based on Glutathione-S-transferase (GST)-
VP1 fusion proteins [38, 42, 43] or VP1 VLP-based an  body detec  on by ELISA [44 - 46]. All 
these studies suggest that TSPyV circulate widely in humans, with seroprevalences of about 
75% in adults in all popula  ons tested, including a total of 528 Dutch, 371 and 394 Finn-
ish, 829 Italian, and 799 Australian healthy individuals [38, 42, 44 - 46]. Furthermore, age 
distribu  on analysis of TSPyV VP1 seroprevalences revealed an increase from about 41% 
in children aged 0–9 years to 75% in adults aged 30 years and older, and wane later in life 
comparable to BKPyV [38, 42]. This distribu  on pa  ern is in agreement with other HPyVs, 
although modest diff erences in age distribu  on pa  erns are observed some  mes [31, 39, 
41].
 The seroreac  vity of TSPyV VP1 an  body responses of seroposi  ve individuals 
shows a decline in the median seroreac  vity from 40 to 49 years of age onwards [38, 42], 
similar to what was reported before for BKPyV [47]. This waning of an  body levels in the 
elderly might be due to immunosenescence [45]. Serum cross-reac  vity between TSPyV 
and other (related) polyomaviruses, as shown for instance between HPyV9/LPyV [39, 40] 
and MCPyV/ChPyV [48], and to a lesser extent between HPyV6/HPyV7 [19, 38] and BKPyV/
JCPyV [31], was not observed [48].
 Earlier BKPyV serological studies have revealed increased VP1 an  body and sero-
posi  vity levels in immunocompromized transplant pa  ents, in accordance with intensity of 
BKPyV infec  on or reac  va  on post-transplanta  on [55 - 57]. Whether this pa  ern is also 
true for TSPyV remains to be seen. So far, only one study has shown a higher (89%) TSPyV 
VP1 seroprevalence in a renal-transplant pa  ent popula  on compared to healthy individu-
als (75%) [42]. How to interpret the puta  ve increase in TSPyV seroposi  vity concomitant 
with immunosuppressive treatment is not fully understood. Hypothe  cally, this may be ex-
plained by an increase in humoral immunity in response to TSPyV reac  va  on, possibly 
viremia, because of iatrogenic suppression of cellular immunity [11].
Altogether, seroepidemiological data indicate that TSPyV infec  on is common and occurs 
primarily at young age with a deteriora  on of an  body levels at the later stages of life. 
Knowledge about cellular immunity against TSPyV is scarce. A Finnish study suggested that 
TSPyV Th-cell responses correlate with TSPyV serological responses, but can some  mes also 




Clinical descrip  on and epidemiology
TS is a rare skin disease fi rst reported by Izakovic and colleagues in 1995 [59]. In 1999, Hay-
cox and colleagues fully described the disease and introduced the term “trichodysplasia 
spinulosa” [60]. They showed for the fi rst  me the presence of virus par  cles and suggested 
a viral e  ology for TS. Ever since, approximately 30 comparable cases were published (Table 
2). Many of these reports adopted the term “trichodysplasia spinulosa”, whereas others 
used diff erent terms for the same condi  on, such as ”trichodysplasia”, “pilomatrix dyspla-
sia of immune suppression”, “cyclosporine-induced folliculodystrophy” or “viral-associated 
trichodysplasia” [11 - 13, 49 - 51, 61 - 74].
 So far, TS has been observed in immunosuppressed organ transplant pa  ents and 
occasionally in chronic and acute lymphocy  c leukemia pa  ents. Despite the disparity in TS 
terminology, in all cases the disease was clinically characterized by spiny follicular papules 
distributed largely on the face and ears, and to a lesser extent on extremi  es, trunk, and 
scalp. In most pa  ents, non-scaring alopecia of the eyebrows was observed, upon which 
small hyperkerato  c white-yellowish spicules started to protrude the skin. At the same  me, 
these features manifested also on the nose and ears (Figure 3A). As the disease progressed, 
the skin of eyebrows, ears, and nose thickened to cause disfi gurement of the facial appear-
ance, some  mes resul  ng in a “leonine facies” [70], in combina  on with increased conspic-
uous spine expression [11, 71].
Histology and viral pathology
Histological analysis of TS skin biopsies reveals acanthosis of the epidermis in most cases. 
In addi  on, enlargement of the hair follicles with excessive number of prolifera  ve cells is 
observed [60]. Compared with normal skin, TS follicles are absent of hair sha  s, and papilla 
with abnormal corneocytes fi lling the infundibula of the follicles (Figure 3B). Some  mes a 
subtle perifollicular lymphocy  c infi ltrate is seen.
 Electron microscopical analyses of TS lesions repeatedly revealed intranuclear, 
crystalloid-organized, regularly spaced 38 - 45-nm virus par  cles (Figure 3E). The iden  ty 
of TSPyV remained unknown for many years [12, 60, 63, 64, 66, 67], un  l in 2010 when 
the double-stranded DNA viral genome was revealed with the help of rolling-circle ampli-
fi ca  on, cloning, primer-genome-walking, and sequencing [11]. By now, several research 
groups have confi rmed the presence of TSPyV DNA in lesional TS samples (Table 2) [12, 13, 
50, 51]. The given name of TSPyV was accepted by the interna  onal polyomavirus study 
group [79], while awai  ng offi  cial recogni  on by the ICTV.
 Development of TS may be caused by uncontrolled prolifera  on of TSPyV-infected 
inner root sheath (IRS) cells. The irregular IRS cells show enlarged, dystrophic and prominent 
eosinophilic perinuclear globules that probably represent the accumula  on of trichohyalin 
protein (Figure 3C and D) [13, 60]. Ki-67 staining of the aff ected cells suggests that the IRS 
cells, or a subpopula  on thereof, are hyperprolifera  ng [60].
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Publica on year Gender Age Medical history Country Reference 
1995 Male 31 Kidney transplant GER [59] 
1999 ** Male 44 Kidney-pancreas transplant USA [13, 60] 
2000 Female 13 Lung transplant USA [61] 
2004 Female 34 Kidney transplant USA [62] 
2004 Female 13 Kidney transplant USA [63] 
2005 (case 1) ** Male 19 ALL (Pre-B cell) USA [13, 64] 
2005 (case 2) Male 8 Kidney transplant USA [64] 
2006 Female 48 Kidney transplant USA [65] 
2007 (case 1) ** Male 8 ALL (T-cell) AUS [13, 67] 
2007 (case 2) Male 6 ALL (T-cell) AUS [67] 
2007 Male 68 non-Hodgkin’s lymphoma USA [66] 
2008 Male 70 CLL AUS [69] 
2008 ** Female 37 Heart transplant USA [13, 68] 
2010 ** Female 5 Heart transplant CAN [13, 71] 
2010 ** Male 5 Heart transplant USA [13, 70] 
2010 * Male 15 Heart transplant NLD [11] 
2011 ** Female 7 ALL (Pre-B cell) USA [12] 
2011 Female 27 Kidney transplant USA [72] 
2011 Female 9 ALL (Pre-B cell) CAN [73] 
2012 (case 1) ** Male 5 Kidney transplant USA [13] 
2012 (case 2) ** Female 63 Heart transplant USA [13] 
2012 (case 3) ** Male 62 Lung transplant USA [13, 51] 
2012 ** Male 48 Kidney transplant USA [49] 
2012 ** Female 57 CLL USA [50] 
2012 Female 46 Kidney transplant USA [74] 
2013 ** Female 49 Kidney transplant (Lupus) AUS [75] 
2013 ** Female 20 Lupus glomerulonephri *** FRA [76] 
2013 Male 5 ALL (Pre-B cell) LBN [77] 
2013 Female 14 Lung transplant USA [78] 
Table 2A: Overview of reported TS cases
* Iden  fi ca  on of TSPyV [11]
** Presence of TSPyV DNA confi rmed
*** Lupus glomerulonephri  s condi  on was treated with immunosuppression, shortly a  er pt died
Abbrevia  ons: USA, United states of America; AUS, Australia; CAN, Canada; NLD, The Netherlands; GER, Ger-
many; FRA, France; LBN, Lebanon; ALL, Acute lymphocy  c leukemia; CLL, Chronic lymphocy  c leukemia; M, 
Male; F, Female; TX, Transplant type; NHL, non-Hodgkin’s lymphoma; LGN, Lupus glomerulonephri  s






Transplant type (TX) or 
underlying disease  
(n, rela e %) 
Rela  percentage of 
Countries repor ng TS 
cases (n, rela  %) 
29 14:15 29  Kidney TX: (10, 34%) USA: (19, 66%) 
  Kidney-pancreas TX: (1, 3%) AUS: (4, 14%) 
  Heart TX: (5, 17%) CAN: (2, 7%) 
  Lung TX: (3, 10%) NLD: (1, 3%) 
  ALL (Pre-B cell): (4, 14%) GER: (1, 3%) 
  CLL: (2, 7%) FRA: (1, 3%) 
  ALL (T-cell): (2, 7%) LBN: (1, 3%) 
  NHL: (1, 3%)  
  LGN: (1, 3%)  
Table 2B: Summery of reported TS cases shown in Table 2A
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Pa  ents at risk and diagnosis
TS is exclusively observed in immunocompromized pa  ents, especially kidney(-pancreas) 
(37%), heart (17%) and lung (10%) transplant recipients (Table 2B). It can also develop in 
otherwise immunocompromized pa  ents, e.g., in pre-B cell (14%) and T-cell (7%) acute 
lymphocy  c leukemia pa  ents, chronic lymphocy  c leukemia pa  ents (7%), non-Hodgkin’s 
lymphoma pa  ent (3%), and Lupus glomerulonephri  s pa  ent treated with immunosup-
pression (3%). The solid organ transplant group, especially the kidney gra   recipients, seem 
the most hit by TSPyV. If this refl ects the numbers of suscep  ble immunosuppressed hosts 
(Figure 1), or rather is related pathogenically to the transplanted organ is unknown. For 
BKPyV it is known that the course and dose of immunosuppression is associated with pol-
yomavirus reac  va  on and accompanying complica  ons [80]. Whether this is also true for 
TSPyV remains to be seen.
 Diagnosis of TS is primarily established on clinical features, such as visual detec  on 
of the spiny follicular papules on the face (Figure 3A). The clinical diagnosis can be confi rmed 
by histopathologic analysis of a biopsy of the lesional skin showing enlarged dystrophic hair 
follicles with eosinophilic perinuclear globules of the IRS cells (Figure 3C). TSPyV VP1 stain-
ing, as illustrated in Figure 3D can be added to the immunohistochemical diagnosis.
 Electron microscopy has proven useful for visualiza  on of TSPyV par  cles in nuclei 
of IRS cells of aff ected hair follicles and provided the fi rst clue of TS having a viral e  ology. 
Figure 3. Clinical and (immuno)histopathological characteris  cs of TS disease. (A) Clinical features of the TS disease 
seen on the nose with hard small hyperkerato  c white-yellowish spicules protruding the skin. (B) H&E character-
is  cs of lesional skin showing the conspicuous papule and spicule protruding from the epidermis. (C) A magnifi ed 
picture of an aff ected hair follicle showing irregular inner root sheath cells with enlarged, dystrophic eosinophilic, 
and perinuclear globules. (D) Immunohistochemistry staining of an enlarged hair follicle showing colocaliza  on of 
trichohyalin (green) and TSPyV VP1 (red). (E) Electron microscopy of an inner root sheath cell with intranuclear, 
crystalloid-organized, regularly spaced 38 - 45-nm virus par  cles.
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Low sensi  vity and specifi city, however, as well as its cumbersomeness make this method 
less suitable for TSPyV detec  on in a clinical se   ng. Virus culture from fresh materials, in an 
a  empt to iden  fy the nature of the virus par  cles, was so far unsuccessful [64].
TSPyV PCR
In addi  on to the clinical and histopathological approach, TSPyV DNA detec  on and load 
measurement by quan  ta  ve PCR can be included in the TS diagnosis work-up. All lesional 
TS samples analyzed so far for TSPyV DNA content, were shown posi  ve with high average 
viral loads, as described in Chapter 3 [11, 13]. Normal skin samples of TS pa  ents, as well as 
skin swabs and plucked eyebrow hairs from unaff ected individuals were occasionally shown 
to be TSPyV DNA-posi  ve, but with low viral loads [11, 13]. Up un  l now, four primer and 
probe sets for (quan  ta  ve) PCR have been described for TSPyV, one located in the NCCR, 
one in VP1 and two in the T-an  gen coding regions [11, 49].
 Preferably, a lesional skin biopsy or plucked spicule is used for TSPyV detec  on in 
TS pa  ents [11 - 13]. Proteinase-K treatment and total DNA extrac  on of the material prior 
to PCR analysis is indicated to remove excessive protein and protec  ve capsid structures. 
A non-invasive method to obtain clinical sample would be swabbing of the pa  ent’s face, 
for instance of the forehead that proved to bear high loads of TSPyV DNA in one TS pa  ent 
sampled in this way [11, 13], sugges  ng equal sensi  vity of skin swab and biopsy to detect 
viral DNA. However, for viral load calcula  ons normalized for cellular DNA content and the 
number of cells, only a biopsy or plucked spicule can be regarded a reliable specimen.
 PCR analysis of plucked eyebrow hairs has revealed the presence of TSPyV DNA 
in a small propor  on (4%) of asymptoma  c renal transplant recipients [11]. How forehead 
swabs and plucked eyebrow hairs compare with respect to the number of obtained cells, 
viral DNA detec  on and load measurement is unknown. Interes  ngly, in a study a 13-year-
old immunocompromized heart transplant pa  ent without TS symptoms sampled 1 month 
a  er his immunosuppression, TSPyV DNA was detected in his stool and in a nasopharyngeal 
swab. Repeated analysis in the following months remained nega  ve [54]. Occasionally also 
urine and kidney samples of immunocompromized pa  ents were found to be posi  ve for 
TSPyV DNA [49]. The meaning of these fi ndings, in par  cular their role in TS diagnosis, re-
mains unclear.
Altogether, skin swabs, plucked hairs, and fresh or fi xed lesional biopsies of the aff ected 
skin can serve as a proper (diagnos  c) sample for viral detec  on and load measurements 
by (quan  ta  ve) PCR to confi rm TSPyV infec  on and TS diagnosis, and to monitor disease 
progression and/or treatment effi  cacy.
An  viral treatment
Improving the pa  ent’s immunity usually leads to complete resolu  on of TS symptoms. In 
case of TS in (organ) transplant recipients, reducing the dose of immunosuppressive drugs 
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should be considered, obviously without endangering the gra  ed organ by immune rejec-
 on. This strategy has been shown as the best op  on at the moment to improve the out-
come of BKPyV-associated nephropathy [81, 82].
 Next to reduc  on of immunosuppression, an  viral therapy should be considered 
a treatment op  on in controlling viral replica  on and TS progression without jeopardizing 
the transplanted organ. A number of TS pa  ents treated with topical cidofovir 1 - 3% cream, 
which serves as a cytosine analogue inhibi  ng human polymerase ac  vity needed for poly-
omavirus replica  on, have demonstrated signifi cant reduc  on in symptoms [11, 50, 63, 64, 
66]. Nephrotoxicity a  er topical use of this drug was monitored in some pa  ents, but this ef-
fect was not reported. Furthermore, oral valganciclovir, a guanosine analogue also inhibi  ng 
polymerase ac  vity, has been reported to have modest in some and strong ac  vity in other 
TS pa  ents [68, 70, 71]. The puta  ve mechanism of ac  on of this drug in the treatment of TS 
remains unclear at the moment, since valganciclovir requires (viral) thymidine kinase-medi-
ated modifi ca  ons to exert its polymerase-inhibi  ng eff ect, which are not expected to occur 
upon polyomavirus infec  on [83].
Concluding remarks
TSPyV is a ubiquitous virus, similar to most other HPyVs, as concluded from its 75% sero-
prevalence. When looking at its DNA prevalence in TS-asymptoma  c individuals, however, 
the virus appears diffi  cult to detect with a prevalence not exceeding 5% (Table 1). Whether 
TSPyV persists in human skin and replicates at undetectable levels, or alterna  vely has its 
latent reservoir in an extracutaneous site, like for instance the tonsils, remains to be seen. It 
is also not known how people acquire TSPyV infec  on, for instance by direct contact or by 
respiratory transmission, and whether TS symptoms are caused by reac  va  on as a result 
of poor immunity or by primary infec  on later in life in the midst of immunosuppression. In 
addi  on, the pathogenic mechanisms used by TSPyV are unknown, but likely include induc-
 on of hyperprolifera  on of IRS cells through its T-an  gens.
 With the iden  fi ca  on of TSPyV as the probable causa  ve infec  ous agent, im-
provement of TS diagnosis and clinical care can be achieved. This includes TSPyV-specifi c 
DNA detec  on and quan  fi ca  on, and immunohistochemistry or immunofl uorescence in 
the course of the diagnos  c process, and an  viral therapy as a treatment op  on. Because 
of the increasing number of immunocompromized pa  ents and the high TSPyV seroprev-
alence in healthy popula  ons, it is expected that TS will be diagnosed and reported more 
o  en in immunocompromized pa  ents than it is at this moment. For this reason, clinicians, 
in par  cular nephrologists, dermatologists, and pathologists, should become more aware of 
this condi  on, knowing that appropriate viral diagnosis and treatment is at hand.
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In this chapter, we aimed to corroborate the rela  onship between TSPyV infec  on and TS 
disease by analyzing the presence, load, and precise localiza  on of TSPyV infec  on in TS 
pa  ents and in controls. For this purpose, archived TS lesional and non-lesional skin samples 
were retrieved from TS pa  ents through a PubMed search. Samples were analyzed for the 
presence and load of TSPyV DNA with quan  ta  ve PCR, and for expression and localiza  on 
of viral protein with immunofl uorescence. Findings obtained in TS pa  ents (n = 11) were 
compared to those obtained in healthy controls (n = 249). TSPyV DNA detec  on was signifi -
cantly associated with disease (P < 0.001), with 100% posi  vity of the lesional and 2% of the 
control samples. Quan  fi ca  on revealed high TSPyV DNA loads in the lesional samples (~106 
copies/cell), and low viral loads in the occasionally TSPyV-posi  ve non-lesional and control 
samples (<102 copies/cell). TSPyV VP1 protein expression was detected only in lesional TS 
samples, restricted to the nuclei of inner root sheath cells overexpressing trichohyalin. Al-
together, the high prevalence and load of TSPyV DNA only in TS lesions, and the abundant 
expression of TSPyV protein in the aff ected hair follicle cells demonstrate a  ght rela  onship 
between TSPyV infec  on and TS disease, and indicate involvement of ac  ve TSPyV infec  on 
in TS pathogenesis.
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Introduc  on
As indicated in the previous chapters, TS is a rare follicular skin disease observed only in immunocompromized solid organ transplant and lymphocy  c leukemia pa  ents. To our knowledge, approximately 30 cases of TS have been reported in the literature (Chapter 2) [1 - 3]. TS is characterized by follicular papules and 
kerato  c protrusions (spicules), most commonly no  ced on the face [4 - 6], some  mes ac-
companied by alopecia of the eyebrows and eyelashes [6]. Histopathology of the aff ected 
skin shows enlarged and dysmorphic hair follicles predominantly populated by trichohya-
lin-overproducing inner root sheath (IRS) cells. A viral cause of TS was suspected since the 
ini  al descrip  on of TS in 1999 by Haycox et al. [5], but a  empts to iden  fy the virus from 
plucked spicules of TS pa  ents failed un  l the isola  on of TSPyV genome by the use of roll-
ing-circle DNA amplifi ca  on technique [4].
 To confi rm the associa  on between TSPyV infec  on and the development of TS, in 
this chapter we studied the presence and ac  vity of TSPyV infec  on in a series of TS pa  ents 
and in healthy controls, comparing presence and load of viral DNA, as well as expression and 
localiza  on of viral protein.
Methods and Materials
Study popula  ons and sample collec  on
Through a PubMed search on April 2010, we iden  fi ed twelve ar  cles repor  ng TS cases 
(search terms can be requested from the authors). Authors of eligible cases were contacted, 
asked to collaborate and to provide archival TS samples for addi  onal analyses in our labo-
ratory. This strategy resulted in the inclusion of six TS cases. The remaining six did not reply 
(n = 4), no longer possessed samples (n = 1) or declined collabora  on (n = 1). The sample set 
was completed with an unpublished case brought forward by one of the contacted authors 
[7], three new cases sent to us for TSPyV analysis of which one was subsequently published 
[1], and the TS pa  ent from which TSPyV was originally isolated [4].
 From a total of 11 pa  ents, formalin-fi xed paraffi  n-embedded (FFPE) lesional biop-
sies or sec  ons were obtained, numbered TS1 - TS11 according to the  me of arrival at our 
laboratory (Table 1). From TS4 and TS5, we also received a non-lesional skin sample (NLS4 
and NLS5). From TS1, also a forehead skin swab was obtained.
 Forehead skin swabs were included from a control group of 249 individuals (age 4 - 
79 years) par  cipa  ng in a clinical trial that monitored the eff ects of treatment against com-
mon skin warts (Clinical Trial Gov. registra  on number ISRCTN42730629) [8]. The samples 
were collected prior to treatment with a co  on-  p brushing uninvolved skin of the central 




The Ins  tu  onal Review Board (IRB) of the Leiden University Medical Center (LUMC) stated 
that no medical ethical approval was needed to analyze the archival pa  ent samples collect-
ed for TS diagnosis for the presence of the TS-associated pathogen.
 Medical ethical approval to use skin swabs collected from the healthy controls for 
TSPyV analysis was obtained from the LUMC IRB. Informed consent (child as well as parental 
informed consent for par  cipants less than 18 years of age) was obtained from each par  c-
ipant.
DNA extrac  on and PCR
FFPE  ssue sec  ons were received in sterile Eppendorf tubes (TS2, TS3, TS6, TS7 and TS11) 
or on glass slides (TS8 and TS10). TS4, TS5, NLS4 and NLS5 were received as paraffi  n blocks 
and 5-μm sec  ons were cut using a clean blade for each  ssue block. One sec  on each was 
treated with Proteinase-K lysis buff er in a total volume of 100 μL. Upon processing, the 
supernatants were used for PCR analysis. Samples of TS1 and TS9 consisted of previously 
extracted DNA. The forehead skin swabs were used directly for PCR analysis.
 To detect and quan  fy TSPyV DNA, three previously described real-  me quan  -
ta  ve PCRs were performed with primers and probes located in VP1 and LT open reading 
frames, and in the non-coding control region (NCCR) [4]. In parallel, a pUC19 plasmid-series 
containing the TSPyV genome  trated in a background of 5 ng/μL human genomic DNA 
(Promega) was analyzed. To normalize for input DNA and calculate input cell numbers, a 
β-ac  n household gene PCR was conducted on the same samples [12]. For the skin swabs 
no normaliza  on with β-ac  n household gene was performed, because of lack of suffi  cient 
human genomic DNA in the collected skin swabs. In these samples, TSPyV copies are indi-
cated as copies per PCR reac  on.
TS Case Ref Sex Age Underlying Disease TS onset Descrip on Country 
TS1 [4] Male 15 Heart transplant 2009 TS NLD 
TS2 [9] Male 8 ALL (T cell) 2003 TS AUS 
TS3 [10] Male 19 ALL (pre-B cell) 2004 VATS USA  
TS4 This study Male 5 Renal transplant 2009 TS USA  
TS5 This study Female 63 Heart transplant 2010 TS USA  
TS6 This study Male 62 Lung transplant 2002 TS USA  
TS7 [7] Female 37 Heart transplant 1997 TOI USA  
TS8 [6] Female 5 Heart transplant 2007 TS CAN 
TS9 [1] Female 7 ALL (pre-B cell) 2010 TS USA  
TS10 [11] Male 5 Heart transplant 2008 VATD USA  
TS11 [5] Male 43 Renal transplant 1997 TS USA  
Table 1: Overview of TS cases analyzed in this study
Abbrevia  ons: ALL, acute lymphocy  c leukemia; TS, trichodysplasia spinulosa; VATS, virus associated trichodyspla-
sia spinulosa; TOI, trichodysplasia of immunosuppression; VATD, viral-associated trichodysplasia of immunosup-
pression; NLD, The Netherlands; AUS, Australia; USA, United states of America; CAN, Canada.
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Histology, immunofl uorescence and electron microscopy
Hematoxylin and eosin (H&E) staining for histology and immunofl uorescence (IFA) to detect 
trichohyalin (1:250, AE15 (sc-80607), Santa Cruz) and TSPyV VP1 protein (1:1000), was per-
formed on deparaffi  nized 4-μm sec  ons. To detect VP1, a polyclonal rabbit an  serum was 
raised against a synthe  c TSPyV VP1 pep  de (TGNYRTDYSANDKL). As a TSPyV VP1-specifi c-
ity control, serum from the same rabbit was used collected prior to VP1 pep  de immuniza-
 on. The sec  ons were incubated in a dark chamber with a secondary Donkey-α-Rabbit-Cy3 
an  body (1:1000, Invitrogen), a Goat-α-Mouse-Alexafl uor488 an  body (1:300, Jackson) and 
Hoechst nuclear staining (1:100), and analyzed under a fl uorescence microscope.
 For electron microscopy (EM), a 50-μm FFPE sec  on from lesional sample TS5 was 
treated as described [13], with slight modifi ca  ons. In short, the sec  on was deparaffi  nized, 
rehydrated and washed with cacodylate buff er. Upon O/N fi xa  on in 2% glutaraldehyde plus 
2% paraformaldehyde, it was post-fi xated with 1% osmium tetroxide and transferred in an 
Epon capsule. One-hundred-nm sec  ons were cut and placed on carbon/formvar-coated 
copper grids, poststained in 7% uranyl acetate/lead citrate, and analyzed with a Tecnai-12 
electron microscope (Model Eagle, Fei Company, The Netherlands).
Results
Confi rma  on of trichodysplasia spinulosa in TS4, TS5 and TS6
TS-compa  ble clinical and histological fi ndings were previously described for pa  ents TS1 
- TS3 and TS7 - TS11, including spicules on the face, disten  on of hair follicles and increase 
of trichohyalin-overexpressing IRS cells [1, 4 - 7, 9 - 11]. To verify TS in the unpublished 
cases (Table 1), histology was performed on TS4, TS5 and TS6. H&E staining of these sam-
ples showed enlarged hair follicles with numerous IRS cells containing large cytoplasmic eo-
sinophilic granules (Figure 1A). The non-lesional samples did not display these histological 
features. In ultra-thin lesional sec  ons of TS5, we confi rmed the presence of intranuclear 
38 - 42-nm virus par  cles in nuclei of IRS cells (Figure 1B) [10, 14]. These cells also contained 
electron-dense cytoplasmic protein accumula  ons, probably trichohyalin [5, 15, 16].
Presence of TSPyV DNA in TS pa  ents and controls
The presence of TSPyV DNA was assessed by PCR in the lesional and non-lesional TS sam-
ples, and in the healthy control samples. TSPyV DNA was detected in all lesional samples (11 
of 11, 100%), in one of two non-lesional samples, and in 6 out of 249 healthy controls (2%) 
(Table 2). This revealed a sta  s  cally signifi cant associa  on between the presence of TSPyV 
DNA and symptoma  c TS (P < 0.001, Chi-square test).
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TSPyV DNA load in TS pa  ents and controls
As a measure of viral replica  on, we calculated TSPyV DNA load in TSPyV DNA-posi  ve sam-
ples. High viral loads above 104 copies/cell were measured in all, except one, lesional TS 
samples (91%), with an average of ~106 (Figure 2A, Table 2). The non-lesional TSPyV-posi-
 ve sample NLS5 contained less than 5 copies/cell, a 1,000,000-fold reduc  on compared to 
the lesional sample from the same pa  ent (TS5, Figure 2A). In the six TSPyV DNA-posi  ve 
healthy control skin swabs, the average amount of detectable TSPyV DNA copies was 33, 
being 10,000–100,000-fold lower compared to the forehead skin swab of TS1 (Figure 2B).
Figure 1. Histology and electron microscopy of non-lesional and lesional TS  ssues. Panel A shows the H&E staining 
of non-lesional (NLS) and lesional (TS) skin from pa  ents TS4, TS5 and TS6. The non-lesional sample NLS4 appears 
normal and shows absence of enlarged hair follicles. The lesional  ssues contain distended and dysmorphic hair 
(follicles) with increased numbers of IRS cells. The insets show magnifi ca  ons of IRS cells in TS4 with eosinophilic 
granules in their cytoplasm (arrowheads). The inset of TS6 shows abrupt cornifi ca  on and protrusion of an eosin-
ophilic spicule. Panel B shows electron micrographs of TS5. Asterisks indicate electron-dens protein accumula  on 
within IRS cells (EM1). EM2 and EM3 show intranuclear crystalloid-structured arrangements of viral par  cles within 
an IRS cell.
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Expression and localiza  on of TSPyV protein
To elaborate on the ac  vity of TSPyV infec  on in TS pa  ents, expression and localiza  on of 
the TSPyV major capsid protein VP1 was assessed in lesional and non-lesional TS samples. In 
all of the lesional samples available for this purpose (TS3 - TS5, TS8, TS10 and TS11), TSPyV 
VP1 was easily detectable within the distended hair follicles with dystrophic morphology 
(Figure 3, and data not shown). In every case, VP1 was observed almost exclusively within 
the nuclei of IRS cells that overexpressed trichohyalin. In the non-lesional TS samples, no 
TSPyV VP1 was detected and trichohyalin expression was not increased.
Table 2: Overview of TSPyV DNA-PCR results
* Viral copy numbers were calculated per cell for the lesional and non-lesional TS samples, and per PCR reac  on 
for the healthy control samples
Group TSPyV DNA-positive TSPyV DNA-load * n (%) average copy number (range) 
Lesional TS samples (n=11) 11 (100) 1226845 (78.0 - 4479917.9) 
Non-lesional TS samples (n=2) 1 5 
Healthy control samples (n=249) 6 (2) 33 (13.6 - 67.3) 
Figure 2. Quan  fi ca  on of TSPyV DNA in TS pa  ents and healthy controls. Bars in graph A illustrate the amount 
of TSPyV genome copies per cell measured in the lesional (TS1 - TS11) and non-lesional (NLS4 and NLS5) samples. 
The bars in graph B show the amount of TSPyV genome copies per PCR-reac  on measured in skin swabs from TS 
pa  ent 1 (TS1) and from the six TSPyV DNA-posi  ve healthy individuals (A019-C087). The graphs are shown in a 
Log10 scale. The error bars represent the standard devia  on of the mean viral load calculated with three diff erent 




In previously published reports, diff erent names have been used to describe TS, such as 
trichodysplasia or pilomatrix dysplasia of immunosuppression [7, 15, 17] cyclosporine-in-
duced folliculodystrophy [18] or viral/virus-associated trichodysplasia [1, 5, 9 - 11, 14, 19]. 
However, despite terminology diff erences, all cases represented immunocompromized pa-
 ents that had follicular papules and spiny lesions predominantly on the face histological-
ly characterized by enlarged, dysmorphic hair follicles consis  ng of IRS cells packed with 
trichohyalin. By assembling the fi rst representa  ve series of TS samples from almost half of 
all previously described cases grouped under diff erent names, we provided evidence that 
these pa  ents indeed suff ered from the same disease with TSPyV infec  on as a shared fea-
ture.
 When one reasons about the involvement of a certain pathogen in the pathogen-
esis of a certain disease, the prevalence of the puta  ve pathogen should be considerably 
higher in the pa  ent group than in healthy controls [20]. As polyomaviruses cause lifelong 
Figure 3. TSPyV VP1 protein expression in lesional and non-lesional TS samples. TS non-lesional (NLS4) and lesional 
(TS3 - TS5) skin sec  ons were co-stained for TSPyV VP1 (red), trichohyalin (green) and chroma  n (blue). In the 
non-lesional sample, no TSPyV VP1 was detected, whereas the lesional samples showed abundant intranuclear 
VP1 staining of the aff ected hair follicles (upper row). Staining with a pre-immune rabbit serum collected prior to 
TSPyV VP1 immuniza  on (inset in TS4), revealed no staining of the lesional samples underscoring the specifi city 
of TSPyV VP1 an  serum. Overexpression of trichohyalin was observed in IRS cells in the lesional samples but not 
in the non-lesional sample (middle row). Co-localiza  on of both signals was frequently observed in the lesional 
samples (lower row).
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latent infec  ons with shedding of small amounts of detectable virus, here the present 
amount of virus should also be taken into account. TSPyV was detected in all of the lesional 
TS samples, in one of two non-lesional TS samples and in a minority of controls, resul  ng in 
a highly signifi cant sta  s  cal associa  on between TSPyV infec  on and TS. High TSPyV DNA 
loads were measured exclusively in lesional TS samples indica  ng that ac  ve TSPyV infec  on 
with a high rate of replica  on is only seen in TS-aff ected skin, sugges  ng its involvement in 
the e  ology of the disease. Preliminary sequence analysis revealed subtle TSPyV nucleo  de 
subs  tu  ons in each of the lesional samples ruling out the possibility of TSPyV plasmid or 
sample contamina  on as a source of the posi  ve fi ndings. The observed TSPyV prevalence 
of 2% in the control swabs is comparable to the 4% prevalence that we measured in plucked 
eyebrows from a group of asymptoma  c immunosuppressed renal transplant pa  ents [4]. 
This probably refl ects latent TSPyV infec  ons, as indicated by serological studies [21, 22]. 
Unfortunately, we were unable to test the TSPyV DNA status of healthy skin biopsies. How-
ever, because comparable load measurements were obtained with the healthy skin swabs 
and the non-lesional biopsies, and a high TSPyV load was measured in the skin swab of TS1, 
we feel that skin swabs provide an appropriate sample for TSPyV analysis. Whether TSPyV 
load measurements in non-invasive skin swabs can be used as a TS diagnos  c tool needs 
further inves  ga  on.
 In every posi  ve sample, the presence of TSPyV DNA was detected with all three 
PCRs, each located in a diff erent region of the TSPyV genome (LT, VP1 and NCCR). With all 
of them comparable viral loads were measured indica  ng that, if detectable, the whole 
TSPyV genome was present. Host genomic integra  on of the viral DNA, as has been shown 
for MCPyV [23], was not inves  gated in this study but seems unlikely considering the high 
TSPyV loads that were measured.
 Another indica  on that ac  ve TSPyV infec  on is involved in the development of 
TS was found in the presence of VP1 in all lesional TS samples tested, especially because 
the staining was restricted to the trichohyalin-overexpressing IRS cells that are known to be 
hyperprolifera  ve in TS and are held responsible for the growth of the characteris  c spines 
[4]. Taken together, with the TSPyV DNA prevalence and load data, despite the limited study 
size, these fi ndings provide strong evidence that ac  ve TSPyV infec  on is associated with 
TS and probably involved in the pathogenesis of TS. Further in vitro studies are needed to 
confi rm this hypothesis and to reveal the pathogenic mechanisms involved. Furthermore, 
the use of an  viral treatment, for example with topical cidofovir 1% cream that proved suc-
cessful in trea  ng some TS pa  ents in the past [4, 10, 18], deserves serious considera  on.
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Prior data suggested that hair follicle cells in trichodysplasia spinulosa are highly prolifera-
 ve, but the underlying pathogenic mechanism imposed by TSPyV infec  on has not been 
solved yet. By analogy with other polyomaviruses, such as the Merkel cell polyomavirus as-
sociated with Merkel cell carcinoma, we hypothesized that TSPyV T-an  gen promotes proli-
fera  on of infected IRS cells. Therefore, we analyzed TS biopsy sec  ons for markers of cell 
prolifera  on (Ki-67) and cell cycle regula  on (p16ink4a, p21waf, pRB, phosphorylated pRB), and 
the puta  vely transforming TSPyV early large tumor (LT) an  gen. Intense Ki-67 staining was 
detected especially in the margins of TS hair follicles, which colocalized with TSPyV LT-an  -
gen detec  on. In this area, staining was also noted for pRB and par  cularly phosphorylated 
pRB, as well as p16ink4a and p21waf. Healthy control hair follicles did not or hardly stained for 
these markers. Trichohyalin was par  cularly detected in the center of TS follicles that stain-
ed nega  ve for Ki-67 and TSPyV LT-an  gen. In summary, we provide evidence for clustering 
of TSPyV LT-an  gen-expressing and prolifera  ng cells in the follicle margins that overpro-
duce nega  ve cell cycle regulatory proteins. These data are compa  ble with a scenario of 
TSPyV T-an  gen-mediated cell cycle progression, poten  ally crea  ng a pool of prolifera  ng 
cells that enable viral DNA replica  on and drive papule and spicule forma  on.
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Introduc  on
It is well known that best-studied polyomaviruses, such as SV40 and Merkel cell polyo-mavirus (MCPyV), encode proteins that counteract host regulatory cellular factors and induce cellular transforma  on [1, 2]. The polyomavirus large tumor (LT) an  gen is gener-ally considered the most potent viral transforming protein that revokes many func  ons 
of cellular factors, to the benefi t of the virus life cycle [3, 4]. One of its important func-
 ons is to induce cell cycle progression by inac  va  on of the re  noblastoma protein family 
members (e.g., pRB) [5]. Through its conserved LXCXE mo  f, LT-an  gen interacts with pRB 
tumor-suppressor protein and deprives it from its cell cycle inhibitory func  on by inducing 
pRB hyperphosphoryla  on [6, 7].
 This mechanism of cell cycle deregula  on is not exclusive to polyomaviruses, as 
other DNA viruses like human papillomavirus 16 (HPV16) exploit similar regulatory func  on 
through the viral oncogenes E6 and E7 [8, 9]. HPV16-posi  ve cervical cancers are highly 
prolifera  ve as a result of pRB cell cycle control inhibi  on that consequently leads to p16ink4a 
and p21waf overexpression, and Cyclin-D1 downregula  on [10]. p16ink4a and p21waf are inhibi-
tors of cyclin dependent kinases (CDK), such as CDK4 and CDK6 that promote pRB phospho-
ryla  on and G1 to S phase cell cycle transi  on [11].
 Elabora  ng on a puta  ve interac  on between LT-an  gen and pRB, in order to ex-
plain the prolifera  ve nature of TS, we sought immunohistological evidence of TSPyV LT-an-
 gen-induced hyperprolifera  on of TS-aff ected hair follicles. Within a representa  ve set of 
archived TSPyV DNA-posi  ve TS sec  ons, prolifera  on, diff eren  a  on and cell cycle pro-
gression were assessed by analyzing the presence of cell cycle regula  on and prolifera  on 
markers Ki-67, pRB, p16ink4a and p21waf. Staining pa  erns of these markers were correlated 
with detec  on of TSPyV LT-an  gen and trichohyalin locally, as markers for viral infec  on and 
TS disease. The observed staining pa  erns that indicate disrup  on of the follicular cell cycle 
pathway are discussed with regard to the underlying disease mechanism, possibly involving 
TSPyV LT-an  gen, and with regard to histological and clinical symptoms of TS.
Materials and Methods
Pa  ents and materials
A set of six formalin-fi xed paraffi  n-embedded (FFPE) TS lesional skin biopsies was retrieved 
as described previously (Table 1) [12]. The FFPE sec  ons of healthy skin biopsies from three 
healthy donors were used as nega  ve (normal) staining controls. These skin samples were 
collected a  er informed wri  en consent and handled according to the declara  on of Hel-
sinki principles [13]. As a posi  ve staining control for assessment of cellular prolifera  on 
and transforma  on, sec  ons of previously generated human papillomavirus 16 (HPV16) E6/
E7 organotypic ra   cultures were used [14]. In brief, these organotypic ra   cultures were 
produced using a dermal-like 3T3-fi broblast-containing collagen-gel matrix that was seeded 
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with primary human kera  nocytes (PHK) stably expressing HPV16 E6/E7 proteins from the 
plasmid pLZRS [15, 16]. A  er 10 days in culture, the organotypic ra   cultures were fi xed with 
paraformaldehyde, processed for embedding in paraffi  n and sec  oned a  erwards.
Histology and immunofl uorescence analysis
Four μm paraffi  n sec  ons were cut for histological and marker-specifi c immunofl uorescence 
(IFA) analyses. The sec  ons were heated overnight at 60ᵒC on glass slides and the next day 
deparaffi  nized in xylene and rehydrated through descending grades of ethanol to dis  lled 
water. Slides for histological assessment were directly stained with Hematoxylin and Eosin 
(H&E). Sec  ons for IFA analysis were subjected to an  gen retrieval in citrate-buff er. A  er 
blocking, the sec  ons were incubated overnight with the primary an  bodies, listed in Table 
2, in a moist chamber at 4ᵒC. The day a  er, the slides were incubated with secondary an  -
bodies at dilu  ons indicated in the table, and supplemented with Hoechst for DNA staining. 
Slides were kept in dark and analyzed under a fl uorescence microscope and representa  ve 
pictures were taken with Axiovision so  ware (Carl ZEISS Vision, USA).
Results
General histological skin features of trichodysplasia spinulosa
To start, the dermis, epidermis and hair follicles of TS-aff ected and healthy skin were com-
pared. H&E staining of healthy skin sec  ons demonstrated normal, slim, hair follicles and 
epidermal stra  fi ca  on (Figure 1, A1-A3). In agreement with the literature [12, 17 - 19], in 
the TS samples enlarged dysmorphic hair follicles were observed (Figure 1, B1 and B3). In 
the center, the TS follicles were inhabited by cells producing eosinophilic protein deposits, 
possibly trichohyalin protein in the IRS cells. In most TS cases, acanthosis of the epidermis 
was noted (Figure 1, B2).
Table 1: List of analyzed TS samples 
*, Viral copies per cell measured as described (all) and reported (TS4-TS11) by Kazem et al. [1].
**, TS13 concerned a kidney transplanta  on pa  ent immunosuppressed with tacrolimus, mycophenolate, and 
prednisone. TS was diagnosed 10 months a  er the rash was noted. Symptoms improved a  er reduc  on of immu-
nosuppression and remained absent ever since.
Case ID Ref Age Sex History Collected Country TSPyV load * 
TS4 [12] 5 Male Kidney Tx 2009 USA  1.2E+05 
TS5 [12] 63 Female Heart Tx 2010 USA  4.4E+06 
TS8 [17] 5 Female Heart Tx 2007 Canada 5.1E+04 
TS10 [18] 5 Male Heart Tx 2008 USA  5.6E+05 
TS11 [19] 43 Male Kidney Tx 1997 USA  1.7E+06 
TS13 ** 43 Female Kidney Tx 2012 USA  2.1E+04 
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Table 2: Primary and secondary an  bodies used for immunofl uorescence
Primary an bodies (origin) Clone Dilu ons Company 
TSPyV LT-an gen (rabbit) * V5264 1:1000 GenScript, USA 
   Pre-immune (rabbit) V5264 1:1000 GenScript, USA 
TSPyV VP1-an gen (rabbit) ** V581 1:1000 GenScript, USA 
   Pre-immune (rabbit) V581 1:1000 GenScript, USA 
Trichohyalin (mouse) AE15 1:250 Santa Cruz, USA 
Trichohyalin (rabbit) TCHH 1:500 Sigma-Aldrich, USA 
Ki-67 (mouse) MIB-1 1:250 Abcam, USA 
p21waf (mouse) 6B6 1:250 BD Biosciences, USA 
pRB (mouse) G3-245 1:250 BD Biosciences, USA 
Phospho-pRB (Ser807-811) (rabbit) D20B12 1:250 Cell Signaling Tech., USA 
p16ink4a (mouse) JC8 1:250 Santa Cruz Biotech, USA 
Secondary an bodies (origin) Clone Dilu ons Company 
An -mouse Alexa488-labeled (goat) A-11001 1:300 Invitrogen, USA 
An -rabbit Alexa488-labeled (goat) A-11008 1:300 Invitrogen, USA 
An -rabbit Cy3-labeled (donkey) 711-165-152 1:1000 Jackson, USA 
*, Rabbit immunized with two TSPyV LT-an  gen-derived synthe  c pep  des FSSQHDVPTQDGRD (AA, 77-90) and 
NSRRRRAAPPEDSP (AA, 151-164)
**, Rabbit immunized with TSPyV VP1-an  gen-derived synthe  c pep  de TGNYRTDYSANDKL (AA, 170-183) [12, 20].
Figure 1. Histological features of trichodysplasia spinulosa. Le   column illustrates H&E staining of a low power 
fi eld of healthy skin (A1) and TS lesional skin (B1). High power fi elds of healthy (A2) and TS (B2) epidermis and hair 
follicles (A3 and B3). Note the hair follicle shown in B3 is enlarged and dysmorphic, containing eosinophilic granular 
protein deposits in the cytoplasm of the cells (arrowheads in inset) with abrupt cornifi ca  on in the center of the 
follicle. Bars depict 100μm.
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Trichohyalin and Ki-67 staining
To detect the presence of IRS cells and to pinpoint areas of prolifera  on in the TS-aff ected 
 ssue, the sec  ons were stained for trichohyalin and Ki-67, respec  vely. As expected, in 
healthy skin trichohyalin staining was detected only along the IRS and absent in the epi-
dermis (Figure 2, A1 and B1). Ki-67-staining in healthy skin was restricted to the epidermal 
basal layer, and to the follicle bulb and the suprabulbar (stem) area (Figure 2, A2 and B3). 
Posi  ve staining of the top cornifi ed layer of the epidermis observed in some of the stained 
sec  ons in Figures 1 and 2 was considered nonspecifi c.
 In the TS sec  ons, excessive amounts of trichohyalin were observed in the aff ected 
follicles, whereas the acantho  c epidermis did not stain for trichohyalin (Figure 2, C1 and 
D1). A substan  al increase in Ki-67-posi  ve nuclei was observed both in the follicles and in 
the TS epidermis, in the la  er in basal as well as in suprabasal layers. At the follicle base, a 
signifi cant increase in Ki-67 expression was evident (Figure 2, C2 and D2). Trichohyalin and 
Ki-67 costaining of a cross-sec  oned TS follicle showed trichohyalin staining especially in the 
follicle center, whereas Ki-67 staining was primarily detected at the follicle margins (Figure 
2, E1-E3).
Figure 2. Trichohyalin and Ki-67 expression in healthy and lesional skin. This fi gure illustrates staining of trichohyalin 
(TCHH) and Ki-67 in healthy (A and B) and in TS skin (C, D and E). In the le   panel, trichohyalin (A1) and Ki-67 (A2) 
staining in healthy epidermis and in healthy hair follicles (B1 and B2) are shown, with the corresponding levels of 
the follicle illustrated in B2. In the middle panel, trichohyalin (TCHH) and Ki-67 staining in TS lesional skin are shown 
with TS epidermis on top (C1 and C2) and ver  cal sec  ons of TS hair follicle beneath (D1 and D2). Do  ed lines 
indicate the dermoepidermal junc  on. Costaining for trichohyalin (green) and Ki-67 (red) of a TS follicle cross-sec-
 oned at the suprabulbar region is shown in the right panel (E1-E3). Bars depict 100μm.
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Cell cycle regula  on markers and TSPyV LT-an  gen expression
To explore the nature of the hyperprolifera  on in the TS-aff ected skin, as demonstrated by 
the increased Ki-67 staining, we inves  gated locally the expression of major cell cycle regu-
latory proteins p16ink4a, p21waf and pRB. Sec  ons of HPV16 E6/E7-transformed ra   cultures 
were used as posi  ve staining controls (Supplementary Figure S1). Despite occasional faint 
suprabasal nuclear pRB staining in the TS epidermis, none of these markers were detected 
in the epidermis of healthy controls or TS cases (Figure 3, A1-A3 and C1-C3). A comparable 
staining pa  ern was observed in healthy hair follicles, although some  mes faint nuclear 
staining for p21waf and pRB was observed (Figure 3, B1-B3).
 In the TS-aff ected hair follicles, expression of p16ink4a, p21waf and pRB was increased 
(Figure 3, D1-D3). For p16ink4a, especially cytoplasmic staining was observed and nuclear 
staining was seen for p21waf and pRB. These analyses were completed by determining the 
presence of TSPyV. LT-an  gen was detected only in aff ected hair follicles (Figure 3, D4), 
which also stained posi  ve for p16ink4a, p21waf and pRB, sugges  ve of colocaliza  on of these 
markers.
Figure 3. Cell cycle regula  on markers and TSPyV LT-an  gen expression. Sec  ons of healthy epidermis (A1-A4), 
healthy hair follicle (B1-B4), TS epidermis (C1-C4) and TS follicle (D1-D4) are stained for p16ink4a (fi rst panel), p21waf 
(second panel), pRB (third panel) and TSPyV (fourth panel). Insets in the fourth panel depict the same region with 
Hoechst DNA staining (blue). Do  ed lines indicate the dermoepidermal junc  on. Bar depicts 100μm.
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Colocaliza  on of TSPyV LT-an  gen, Ki-67 and phosphorylated pRB
Finally, we inves  gated whether TSPyV LT-an  gen expression in the TS sec  ons colocalize 
with staining of Ki-67 and phosphorylated pRB, in order to explain prolifera  on induc  on.
 Double staining for Ki-67 and TSPyV LT-an  gen of a ver  cal-sec  oned follicle illus-
trated that Ki-67-posi  ve cells colocalized with TSPyV LT-an  gen expression in the margins 
of the extended bulbar and suprabulbar region (Figure 4, A1-A3). The same colocaliza  on 
was observed in a suprabulbar cross-sec  oned hair follicle (Figure 4, B1-B3). When ana-
lyzing Ki-67 in combina  on with phosphospecifi c pRB, we observed colocaliza  on of Ki-67 
and phosphorylated pRB in TS hair follicle margins, indica  ng hyperphosphoryla  on of pRB 
in the prolifera  ng cells (Figure 4, C1-C3). A summary of all our histological fi ndings using 
these markers in individual TS-samples is shown in Table 3.
Figure 4. Colocaliza  on of TSPyV LT-an  gen, Ki-67 and phosphorylated pRB. TSPyV LT-an  gen (red) (A1) with Ki-
67 (green) (A2) and merge (yellow) (A3) in a ver  cal sec  on of hair follicle of TS10 is shown in the upper row. A 
higher magnifi ca  on of TSPyV LT-an  gen (B1) with Ki-67 (green) (B2) and merge (yellow) (B3) in a suprabulbar 
cross-sec  oned hair follicle region of TS5 is shown in the middle. B3 inset depicts the same region with Hoechst 
DNA staining (blue). Ki-67 (red) (C1) with phosphospecifi c (Ser807/811) pRB (green) (C2) and merge (yellow) (C3) 
in a suprabulbar cross-sec  oned hair follicle region of TS5 is shown in the last row. A higher magnifi ca  on of TS5 
margin (C3, asterisk) is shown in the inset. Do  ed lines indicate the dermoepidermal junc  on. Bars depict 100μm.
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Discussion
In a previous study, in a group of 11 TS pa  ents we established that presence and high 
load of TSPyV DNA was strongly associated with TS disease [12]. In the same sample-set 
we showed that viral capsid protein (VP1) expression was exclusively present in distended 
dysmorphic trichohyalin-posi  ve TS hair follicles [12]. In this fi rst systema  c immunohisto-
chemical study of its kind, we analyzed lesional sec  ons from six of these TS pa  ents, which 
is roughly one fi  h of all TS cases reported worldwide [21]. S  ll, we were unable to perform 
every staining on all pa  ents, because we were limited in the number of TS sec  ons availa-
ble for analysis.
 Intense Ki-67 staining was detected in the TS-aff ected hair follicles, especially in the 
bulbar and suprabulbar marginal regions, indica  ve of hyperprolifera  on in these areas. The 
observed pa  ern of Ki-67-rich and trichohyalin-poor follicle margins and trichohyalin-rich 
and Ki-67-poor follicle centers may suggest arrest of prolifera  on in ‘mature’ IRS cells along 
central, terminal diff eren  a  on of these cells. However, we cannot exclude that diff erent 
(IRS) [22] cell types explain the diff erence in margin and center staining.
 In addi  on to increased prolifera  on of follicular cells, we observed increased Ki-
67-staining within the overlying acantho  c epidermis of every TS-pa  ent analyzed. This was 
observed in par  cular in the suprabasal layers. To our knowledge, this observa  on has not 
been reported previously and possibly implies that TS is not confi ned to the hair follicles 
but involves other parts of the skin as well. Whether the observed epidermal hyperpro-
lifera  on is seen only in the vicinity of a TS lesion, with visible papules and/or spicules, or 
represents a general feature of TS-pa  ents is not known. In the aff ected epidermis, we could 
not detect TSPyV LT-an  gen (and VP1-an  gen, as analyzed previously [12] (and data not 
shown)). Therefore, the rela  onship between epidermal hyperprolifera  on and acanthosis, 
and TSPyV infec  on remains unclear.
 Subsequent analyses of the prolifera  ve hair follicles for p16ink4a, p21waf and pRB 
demonstrated a pa  ern that is known for  ssues infected by small DNA viruses involved 
in cellular transforma  on, such as SV40 and HPV16 [23]. The staining pa  ern was indeed 
exemplifi ed by the staining pa  ern of the HPV16 E6/E7-expressing organotypic skin cul-
Table 3: Overview of cellular and virus markers detected in TS lesions
*, Reported by Kazem et al. [12] 
-, nega  ve; +, posi  ve; NA, not available
Cellular Markers Virus Markers 
Case ID TCHH p16 p21 pRB Phospho-pRB Ki-67 TSPyV VP1 * TSPyV LT 
TS4 + + + + + + + + 
TS5 + + + + + + + + 
TS8 + NA + NA NA + + + 
TS10 + NA + NA + + + + 
TS11 + NA + NA NA + + + 
TS13 NA NA + NA NA + NA + 
Chapter 4
84
tures included as a posi  ve control, where increased Ki-67 staining was seen together with 
increased detec  on of p16ink4a and p21waf (Supplementary Figure S1). This observed asso-
cia  on suggests that a comparable disrup  on of the pRB-dependent cell cycle regula  on 
pathway may be involved in TSPyV infec  on and TS development.
 Re  noblastoma family proteins (i.e., pRB, p107 and p130) are important regulators 
of the G1- (rest) to S-phase (DNA synthesis) transi  on of cells during cell cycle progression. 
For instance, hypophosphorylated pRB inhibits func  on of the E2F transcrip  on factor that 
regulates gene expression required for DNA synthesis. Hyperphosphoryla  on of pRB by 
complexes of Cyclin-D and cyclin-dependent kinases (CDKs) results into pRB–E2F complex 
dissocia  on and cell-cycle entry, which is reverted by several inhibitory proteins such as 
p16ink4a and p21waf [24]. Demonstra  on of phosphorylated pRB colocalized with Ki-67 indi-
cates pRB-inac  va  on in the TS lesions and suggests progression into the S-phase (Figure 
5). The observed increased expression of p16ink4a and p21waf, factors that normally inhibit 
Cyclin-D1/CDK ac  vity, is explained as a nega  ve feedback mechanism to inhibit cell cycle 
progression [24]. Unfortunately, because of lack of addi  onal TS lesional samples/sec  ons, 
we were unable to look into other cell cycle-regulatory pathways, for example involving p53, 
which can be revoked by polyomaviruses as well [5, 25 - 27].
Figure 5. A hypothe  cal scenario of TSPyV LT-an  gen interference in cell cycle regula  on. An oversimplifi ed cell 
cycling scenario is shown that envisions the TSPyV LT-an  gen involvement in regula  on of pRB pathway ac  vity. In 
a normal physiological condi  on, hypophosphorylated pRB is complexed with transcrip  on factor E2F during early 
G1 (rest) phase of the cell cycle. When pRB is hyperphosphorylated at specifi c residues by Cyclin-dependent kinas-
es (CDK) coupled to Cyclin-D1, E2F is released that ac  vates expression of growth s  mulatory genes needed for 
the cells to enter the S (DNA synthesis) phase. pRB phosphoryla  on is under  ght regula  on of p16ink4a and p21waf. 
Hypothe  cally, through its conserved LXCXE mo  f TSPyV LT-an  gen interacts with pRB/E2F complex to dissociate 
these proteins via pRB hyperphosphoryla  on, resul  ng into S phase entry and subsequent increased expression of 
p16ink4a and p21waf as a nega  ve cell cycling feedback (red arrows).
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 The observed pa  ern of cell cycle deregula  on and S-phase progression through 
hyperphosphoryla  on/inac  va  on of pRB is also seen in HPV16-induced cervical dysplasia 
and neoplasia [8]. In that case, phosphoryla  on of pRB is mediated by the E7 viral oncopro-
tein, comparable to the ac  on of LT-an  gen of SV40 [23]. Crucial to the inac  va  on of pRB 
is binding by LT-an  gen and E7 through a conserved LXCXE mo  f found in these viral onco-
proteins, and in TSPyV LT-an  gen as well [3, 28]. Whether TSPyV LT-an  gen interacts with 
pRB and hampers its func  on, for instance by hyperphosphoryla  on, requires experimental 
confi rma  on. Especially, since in our analyses technical limita  ons (shared origin of the an-
 body, Table 2) prevented discrimina  on between TSPyV LT-an  gen and phosphorylated 
pRB, and therefore, the ability to demonstrate colocaliza  on of both markers. Since the TS 
follicles were pRB-posi  ve, it is unlikely that TSPyV LT-an  gen promotes pRB degrada  on 
next to hyperphosphoryla  on, as is known for HPV16 (Supplementary Figure S1).
Taken together, our fi ndings are compa  ble with a scenario of TSPyV LT-an  gen-induced cell 
cycle progression through disrup  on of pRB-regulatory pathways, thereby crea  ng a res-
ervoir of prolifera  ng IRS cells that enable viral DNA replica  on. Terminal diff eren  a  on of 
this large pool of IRS cells could explain the fi nal accumula  on of trichohyalin-posi  ve cells 
and the forma  on of TS-characteris  c spicules.
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Supplementary Figure S1. Organotypic ra   cultures used as staining controls. H&E staining (A1 and B1), tricho-
hyalin staining (TCHH) (A2 and B2) and Ki-67 staining (A3 and B3) in organotypic ra   cultures expressing empty 
vector (pLZRS) (Mock) or HPV16 oncogenes E6/E7 are shown in the upper group of fi gures. Note many suprabasal 
mito  c cells in B1 (inset). In the lower group of fi gures, staining for cell cycle regulatory proteins, p16ink4a (C1 and 
D1), p21waf (C2 and D2) and pRB (C3 and D3) in Mock ra  s and HPV16 ra  s are shown. Some (secondary an  body) 
nonspecifi c staining of the cornifi ed layer was present in all materials tested in this study. The dermoepidermal 
junc  on is indicated by do  ed lines. Bar depicts 100μm.
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It is common knowledge that conserved residues evolve slowly. We challenge generality 
of this central tenet of molecular biology by describing the fast evolu  on of a conserved 
nucleo  de posi  on that is located in the overlap of two open reading frames (ORFs) of poly-
omaviruses. The de novo ORF is expressed through either the ALTO protein or the Middle T 
an  gen (MT/ALTO), while the ancestral ORF encodes the N-terminal domain of helicase-con-
taining Large T (LT) an  gen. In the la  er domain the conserved Cys codon of the LXCXE 
pRB-binding mo  f constrains codon evolu  on in the overlapping MT/ALTO ORF to a binary 
choice between Val and Ala codons, termed here as codon-constrained Val-Ala (COCO-VA) 
toggling. We found the rate of COCO-VA toggling to approach the specia  on rate and to 
be signifi cantly accelerated compared to the baseline rate of chance subs  tu  on in a large 
monophyle  c lineage including all viruses encoding MT/ALTO and three others. Importantly, 
the COCO-VA site is located in a short linear mo  f (SLiM) of an intrinsically disordered regi-
on, a typical characteris  c of adap  ve responders. These fi ndings provide evidence that the 
COCO-VA toggling is under posi  ve selec  on in many polyomaviruses, implying its cri  cal 
role in interspecifi c adapta  on, which is unprecedented for conserved residues.
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Introduc  on
Intrinsically disordered regions (IDRs), which are either not structured or may become structured upon interac  on with diverse partners [1], have been iden  fi ed in many pro-teins and implicated in various biological processes as adap  ve responders [2 - 5]. They have a biased amino acid residue composi  on and evolved faster than structured pro-
teins [6, 7], with excep  on of very small islands of rela  ve conserva  on, known as short 
linear mo  fs (SLiM), that mediate protein-protein interac  ons [8].
 IDRs are frequently encoded by overlapping open reading frames (ORFs) that 
evolved de novo by overprin  ng the ancestral ORFs and are common in viruses [9 - 13]. This 
overlapping of ORFs is accompanied by suppression of synonymous subs  tu  on rate in the 
ancestral ORFs (nega  ve or purifying selec  on) compared to that of non-overlapping ORFs, 
indica  ve of codon constraints in the de novo ORFs due to their expression. The observed 
phenomenon has been extensively used for in silico iden  fi ca  on of func  onal de novo 
ORFs [12, 14, 15], which o  en led to the elucida  on of non-canonical expression mecha-
nisms of these ORFs (e.g., [16 - 19]). Suppression of synonymous subs  tu  on rate is also 
reciprocally imposed on de novo ORFs by the overlapping ancestral gene. These observa-
 ons led to analysis of rela  ve rate change of subs  tu  ons in the de novo genes compared 
to ancestral or non-overlapping genes [12, 20 - 23].
 This ORF-wide analysis has not been extended to individual codons of the de novo 
ORFs due to formidable technical challenges. A common approach to characterize site-spe-
cifi c evolu  on is to es  mate devia  on from the subs  tu  on rate under a model of neutral 
evolu  on for each codon of an ORF. Suppression and accelera  on of the subs  tu  on rate is 
a  ributed to nega  ve and posi  ve selec  on, respec  vely, with posi  ve selec  on being seen 
as the hallmark signature of adapta  on during intra-species evolu  on [24]. One par  cular 
pa  ern of varia  on under posi  ve selec  on is the frequent exchange of residues with per-
vasive return to the wild-type state, dubbed residue toggling [25]. Iden  fi ca  on of codons 
under selec  on, either nega  ve or posi  ve, is part of the established evolu  onary-based 
pipeline that informs func  onal characteriza  on of proteins encoded in non-overlapping 
ORFs [2, 27]. However, the available techniques were not developed to untangle selec  on 
forces ac  ng on the overlapping ORFs, which constrain evolu  on of each other. This may 
explain the lack of iden  fi ca  on of de novo codon(s) under posi  ve selec  on, despite broad 
recogni  on of a prominent role that the overlapping ORFs play in adapta  on of viruses to 
host [12].
 One of the largest and poorly characterized pairs of proteins encoded by overlap-
ping ORFs is expressed by members of the fast growing Polyomaviridae family (Supplemen-
tary Table S1). These viruses cause latent infec  ons in diverse mammals and birds, and in 
humans, some of these viruses have been responsible for diff erent pathologies in immuno-
compromised individuals [28, 29]. Polyomaviruses employ mul  -ORF double-stranded DNA 
(dsDNA) genomes of approximately 5 kb [30, 31]. Genomes of a large subset of polyoma-
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viruses include two overlapping ORFs [15, 32, 33], designated here ORF2 and ORF5 (Figure 
1A; for other designa  ons see Supplementary Text S1 and Supplementary Table S2). ORF2 
encodes the second exon of the large T an  gen (LT) that includes a helicase domain [30, 
34]. ORF5 is expressed as a separate protein (ALTO) in Merkel cell polyomavirus (MCPyV) 
[15]; while it encodes the second exon of Middle T an  gen (MT) in murine and hamster 
polyomaviruses (MPyV and HaPyV) [33, 35, 36]. The ORF5-encoded part of MT an  gen is 
implicated in control of cell transforma  on [33, 35, 36], enriched with Pro residues [37, 38] 
and includes a C-terminal transmembrane domain [35] that is essen  al for the oncogenic 
func  on of MT [39]. This func  on and interac  on of MT with diff erent cellular proteins may 
be modulated by phosphoryla  on at several Ser, Thr and Tyr residues in rodent polyomavi-
ruses [36]. We will use ORF5-plus and ORF5-less to refer to respec  ve subsets of polyoma-
viruses; ORF5-plus viruses are also known as Almipolyomaviruses [15]. Likewise, and purely 
for the sake of uniformity, herea  er we have designated the ORF5-encoding product as MT/
ALTO for all ORF5-plus polyomaviruses. Because ORF5 is conserved in only ORF5-plus poly-
omaviruses, while the overlapping part of ORF2 is found in all mammalian polyomaviruses 
[15], these ORFs are defi ned as de novo (ORF5) and ancestral (ORF2), according to Sabath et 
al., [12]. ORF5-plus viruses form a large monophyle  c cluster in one of the main branches of 
polyomavirus tree [15], dubbed Orthopolyomaviruses I [Ortho-I]; with three other branch-
es being Orthopolyomaviruses II, Malawipolyomaviruses and Wukipolyomaviruses [40], al-
though branch delinea  on and designa  on may vary in diff erent studies [15, 41].
 To understand the evolu  on of overlapping ORFs, we studied ORF2 and ORF5 at 
codon resolu  on. We found that one of the most conserved ORF5 codons, located in a SLiM 
of ORF5, experienced an accelerated evolu  onary rate despite being strongly constrained to 
two amino acids by the overlapping ancestral ORF2. Using available and specially developed 
evolu  onary-based approaches we revealed an unprecedented frequent toggling between 
these two residues during large-scale mul  -species evolu  on in the Ortho-I clade of poly-
omaviruses. This analysis is, to our knowledge, the fi rst to iden  fy a conserved posi  on of 
de novo protein under posi  ve selec  on. Its results suggest a new IDR-mediated adapta  on 
mechanism employed by many mammalian polyomaviruses with poten  al relevance to un-
derstanding adapta  on of other viruses and organisms.
Materials and Methods
Datasets: viruses, sequences and alignments
Full-length genome sequences of 55 polyomaviruses available in the Genbank/RefSeq da-
tabase on February 2013 (Supplementary Table S1) were downloaded into the Viralis plat-
form [42]. When several genomes per species were available, the RefSeq sequence was 
chosen for presenta  on. The Muscle program [43] and ClustalW [44] were used to gener-
ate family-wide mul  ple amino-acid alignments for viral capsid protein (VP)1 encoded in 
ORF3, VP2 (ORF4) and LT (ORF2), followed by manual cura  on. For each of the three protein 
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alignments, strongly conserved blocks [45] were extracted using the Blocks Accep  ng Gaps 
Generator (BAGG) tool (www.genebee.msu.su/~antonov/bagg/cgi/bagg.cgi) to produce a 
concatenated mul  ple sequence alignment used for phylogene  c reconstruc  on and other 
analyses (see below). The ORF2-wide alignment was also mapped on the genome sequenc-
es, which were then translated in the alterna  ve reading frame (RF -3) encoding ORF5 in 
twenty-two viruses of the ORF5-plus group to produce an ORF5 alignment. ORF5 size varies 
from 441 nucleo  des (nts) to 846 nts, and ORF5 sequence conserva  on was detectable only 
in some subsets of polyomaviruses (Supplementary Table S3; data not shown; [15]). 
 For analysis of site-specifi c evolu  onary selec  on by Datamonkey programs, we 
used 10 alignments of selected posi  ons of the ORF5 and ORF2 (datasets, D1-D10). These 
10 alignments represented diff erent groups of viruses, including all mammalian polyomavi-
ruses (D1 and D2), Ortho-I viruses (D3 and D4), ORF5-plus viruses (D5 and D6), ORF5-less vi-
ruses (D7), and three non-overlapping lineages of ORF5-plus viruses (D8-D10), each analyz-
ed separately (see Supplementary Table S4 for details). Using conserva  on considera  ons, 
some codons of ORF5 and ORF2 were selected, so all datasets included ORF5 codons while 
D2, D4, D6 and D7 included also ORF2 codons. For ORF5 of D1-D7, those codons were cho-
sen whose overlapping codon in ORF2 (-1 frame) was aligned with no gaps across mamma-
lian polyomaviruses. For ORF5 of D8-D10 and ORF2, most conserved codons in respec  ve 
alignments were used a  er manual pruning of weakly aligned codons.
 Alignments of the conserved mo  fs in the N-terminal part of LT ORF2 and ORF5, 
par  ally described elsewhere [15], were produced and converted into logos. To produce 
alignments as input for the RNAz program, we converted codon ORF5-based alignments of 
four subsets of ORF5-plus and two subsets of ORF5-less polyomaviruses, into the respec  ve 
nucleo  de alignments (Supplementary Table S3).
Phylogeny reconstruc  on
Phylogene  c analyses were performed by using a Bayesian approach implemented in BEAST 
version 1.7.4 [46] and the Whelan and Goldman (WAG) amino acid subs  tu  on matrix [47]. 
Rate heterogeneity among sites was modeled using a gamma distribu  on with four catego-
ries, and a relaxed molecular-clock approach was tested against the strict molecular-clock 
approach [48] and was found to be superior. Markov chain Monte Carlo (MCMC) chains 
were run for 2 million steps and the fi rst 10% were discarded as burn-in. Convergence of the 
runs was verifi ed using the Tracer tool (h  p://beast.bio.ed.ac.uk/tracer).
Analysis of natural selec  on at codons 
We have used Mixed Eff ects Model of Evolu  on (MEME) [49] and Fast, Unconstrained 
Bayesian AppRoxima  on (FUBAR) [27] at the Datamonkey website (h  p://www.datamon-
key.org) [26] to test for natural selec  on at conserved ORF5 codons. In addi  on, we have 
screened for toggling at ORF5 residues using TOGGLE, an implementa  on of the residue 
toggling method developed for HIV-1 by Delport et al., [25]. We have analyzed in total ten 
diff erent datasets, D1-D10 (see above), capturing diff erent posi  ons and virus diversi  es 
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(see Supplementary Table S4). For each analyzed data set, selec  on of evolu  onary model 
was performed automa  cally at the Datamonkey web site using default parameters prior to 
the analysis.
Analysis of COCO-VA toggling by BayesTraits
Evolu  on of non-synonymous replacements at the Codon-Constrained Val-Ala (COCO-VA) 
site of ORF5 was analyzed by BayesTraits package using the Mul  state model (h  p://www.
evolu  on.rdg.ac.uk/BayesTraits.html) [50]. This codon is constrained to encode either Ala or 
Val in all mammalian polyomaviruses due to the overlapping Cys codon of the LXCXE mo  f 
that is expressed in the LT ORF2 of these viruses. The analyzed polyomaviruses were divid-
ed into two groups based on whether or not they express ORF5: ORF5-plus and ORF5-less 
viruses, respec  vely. The COCO-VA site is expressed as part of ORF5 in ORF5-plus, but not 
in ORF5-less viruses. 
 To test whether Ala-Val trait transi  ons are sta  s  cally more frequent in the ORF5- 
plus lineage compared to ORF5-less viruses, we applied the BayesTraits mul  state model 
using a single trait (Ala/Val). We ran the analysis for three virus datasets: the combined set 
of mammalian polyomaviruses as well as separately for ORF5-plus and ORF5-less viruses, 
with respec  ve posterior tree samples obtained through independent BEAST analyses. We 
then compared the es  mated Ala-to-Val and Val-to-Ala transi  on rates between the three 
datasets, including an average Ala-Val exchange rate (corresponding to the toggling rate) 
by plo   ng the distribu  ons. Sta  s  cal signifi cance of diff erences in Ala-Val exchange rates 
was assessed using log Bayes Factors that was calculated with the R package Bayes Factor 
(h  p://bayesfactorpcl.r-forge.r-project.org/). As Ala-Val exchange is equivalent to T-C ex-
change at the second codon posi  on of the COCO-VA codon (see “Results and Discussion”), 
we applied BayesTraits also to the third posi  on of that codon as a control. 
Sta  s  cal analyses of COCO-VA toggling using patris  c distances
For each virus the smallest pair-wise patris  c distance (SPAT) to a virus encoding the same 
amino acid (monomorphic pairs: Ala<->Ala and Val<->Val; monoSPAT) and to that encoding 
the diff erent amino acid (polymorphic pair: Ala<->Val, polySPAT) was calculated. Patris  c 
distances were extracted from the polyomavirus phylogeny using the package Analyses of 
Phylogene  cs and Evolu  on (APE) in R language [51].
 We es  mated the rate of COCO-VA toggling as the ra  o of monoSPAT to the sum 
of polySPAT and monoSPAT values; designated SPAT ra  o herea  er. Due to limited virus 
sampling at the intra-species level, we applied a sliding window approach to compare SPAT 
ra  os between ORF5-plus and ORF5-less viruses. A window size of 0.15 and a shi   of 0.05 
at the monoSPAT scale were used. A two-sample non-parametric Mann-Whitney U test was 
u  lized to test for sta  s  cally signifi cant diff erences between the two virus groups within a 
par  cular window. A devia  on of distribu  ons of SPAT ra  os from the average toggling rate 
of 0.5 was assessed using the Wilcoxon rank-sum test.
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 To independently assess the par   oning of mammalian polyomaviruses into ORF5- 
plus and ORF5-less virus groups, we determined the ranking of a predefi ned two-set par-
  oning among all possible two-set par   oning of the same type for the 30 viruses with 
monoSPAT values smaller than the derived threshold of 0.35. These 30 viruses comprise 14 
ORF5-plus and 16 ORF5-less viruses or 16 Ortho-I and 14 non-Ortho-I viruses. We calculated 
the diff erence of mean toggling rate values between the two groups in each of these par  -
 onings and determined its ranking among the diff erences of mean toggling rates obtained 
for all other 14-16 or 16-14 par   oning of the 30 viruses, whose total was 145,422,675 
possible par   onings (e.g. combina  ons).
General bioinforma  cs analyses
For selected phylogene  c lineages, alignments of ORF5 were converted HMM profi les and 
compared to each other using HHsearch [52] in both local and global alignment modes. 
 Sequence logos of selected alignments were produced using the WebLogo server 
[53, 54].
 Secondary structure and disorder predic  on of protein sequences were generated 
using the Disorder Predic  on MetaServer, which reports consensus results of eight protein 
disorder predictor tools: DISEMBL [55], DISOPRED [56], DISpro [57], FoldIndex [58], Glob-
Plot2 [59], IUPred [60], RONN [61], and VSL2 [62], and two protein secondary structure 
predictor tools: PROFsec [63] and PSIPred [64] (h  p://wwwnmr.cabm.rutgers.edu/bioin-
forma  cs/disorder/). The predic  on of disorder was considered signifi cant if at least four 
predictors gave a hit.
 Secondary RNA structures in ORF2/ORF5 overlapping region were predicted with 
the program RNAz in a region of about 300-900 bp fl anking the region encoding LXCXE mo  f 
sequence [65]. The server uses an algorithm that detects thermodynamically stable and 
evolu  onarily conserved RNA secondary structures in mul  ple RNA-sequence alignments 
on both RNA-strands, with number of sequences in alignments not exceeding six. If subsets 
were larger than six, they were reduced to a combina  on of six virus sequences. For struc-
ture predic  on the default RNAz parameters of “Standard Analysis” were u  lized, which 
scored in the overlapping windows of 120 alignment columns with step-size of 40 nucleo-
 des (h  p://rna.tbi.univie.ac.at/cgi-bin/RNAz.cgi?PAGE=1&TYPE=S).
 Proline enrichment in puta  ve ORF5-encoded protein sequences was analyzed by 
use of a custom R script that counts Proline residues and visualizes the counts with respect 
to loca  on in the protein sequence and premature stop codons in the case of ORF5-less 
viruses (www.R-project.org) [66].
Results and Discussion
Discovery of Codon-Constrained Val-Ala (COCO-VA) toggling in MT/ALTO





















































































































































Figure 1. Toggling at the COCO-VA site in mammalian ORF5-plus and ORF5-less polyomaviruses. (A) ORF organiza-
 on in three reading frames of the genomic region encoding the early genes is shown for Simian virus 40, SV-40 
(le  ; NC_001669) and Murine polyomavirus, MPyV (right; Genbank accession NC_001515) represen  ng ORF5-less 
and ORF5-plus polyomaviruses, respec  vely. The ORF2 frame was chosen as -1 frame for both viruses. ORF bor-
ders are defi ned here from stop to stop codon. Large expressed ORFs are boxed/outlined and named while other 
ORFs with a size of at least 75 nt are shown in grey. ORF5 of the ORF5-plus virus and one of its deriva  ves of the 
ORF5-less virus are highlighted in the -3 frame. The background highligh  ng indicates loca  on of the LXCXE mo  f 
(an essen  al mo  f found in polyomaviruses and other viruses, and cellular proteins that mediates binding and 
inac  va  on of the cellular tumour-suppressor protein pRB [82 – 84]). (B) Shown are sequence logos of the LXCXE 
mo  f (top), the corresponding nucleo  de sequence (middle) and the amino acid sequence translated from the 
ORF5 frame (bo  om) for mul  ple alignment of the 28 ORF5-less (le  ) and 22 ORF5-plus viruses (right) analysed in 
this study using Viralis pla  orm [42]. The asterisk indicates stop codons in the -3 frame of some ORF5-less viruses. 
See M&M sec  on for other details. (C) Shown are four possible scenarios of evolu  on of a polynucleo  de site 
under diff erent selec  on regimes. In scenarios 2 to 4 diff erent selec  on force(s) result in the same observed nucle-
o  de diversity restricted to C or T. Scenarios 3 and 4 depict the COCO-VA toggling in ORF5-less and -plus viruses, 
respec  vely. 
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four short conserved mo  fs, designated ORF5m1 to ORF5m4, were evident in the ORF5- 
wide alignment (Supplementary Figure S1) due to an extremely high residue and two-fold 
size varia  on (see also below and Carter et al., [15]). They are counterparts of four mo  fs of 
LT an  gen in the overlapping part of ORF2. Remarkably, the most conserved 3rd aa residue 
of ORF5m2, iden  fi ed in this study, has a restricted binary residue varia  on (Val/Ala) in both 
ORF5-plus and ORF5-less polyomaviruses (Figure 1A and 1B). Val and Ala are encoded by 
eight G(C/T)(A/G/C/T) triplets which are the only codons compa  ble with the two TG(C/T) 
codons for conserved Cys of the LT LXCXE mo  f in the ancestral ORF2 (the two-nucleo  de 
overlap between the Val/Ala and Cys codons is highlighted in bold). In other words, only var-
ia  on at the second codon posi  on of the COCO-VA codon (C or T) determines the encod-
ed amino acid (Ala or Val) (Figure 1B). We named the observed phenomenon Codon-Con-
strained Val-Ala (COCO-VA) toggling.
 The C/T varia  on represents only half of the full four-nucleo  de varia  on possible 
at a polynucleo  de posi  on (Figure 1C). When each kind of nucleo  de is equally frequent at 
a given posi  on, it is likely to evolve at no selec  on (neutral evolu  on) (Figure 1C1), which 
may be found in the third codon posi  ons of non-overlapping ORFs. In contrast, a restricted 
nucleo  de varia  on, like C/T, may emerge as a result of selec  on, either posi  ve (Figure 
1C2) or nega  ve (Figure 1C3), which is typically observed at the fi rst and second posi  ons of 
codons of non-overlapping ORFs. Evolu  onary interpreta  on of the nucleo  de varia  on is 
more complex in the overlapping ORFs, which may be subject to several evolu  onary forces 
ac  ng on each ORF. For instance, there is no doubt that the restricted C/T varia  on at the 
2nd codon posi  on of the COCO-VA site is due to nega  ve selec  on in the alterna  ve ORF2 
to maintain the Cys residue. On the other hand, this restricted varia  on would be equally 
compa  ble with no selec  on or posi  ve selec  on in ORF5, with the la  er scenario leading 
to accelerated toggling between C and T (compare Figure 1C3 and Figure 1C4). Therefore, 
we asked whether selec  on is involved in the COCO-VA toggling.
Phylogeny suggests accelerated COCO-VA toggling in ORF5-encoding poly-
omaviruses
First and in line with general reasoning [67], we note that conserva  on of the LXCXE Cys 
residue may not constrain the COCO-VA toggling. Second, if C and T nucleo  des at the third 
posi  on of the Cys codon are u  lized unevenly, addi  onal non-ORF2 selec  on pressure(s), 
for instance on RNA, must be taken into account when analyzing the toggling. Third, the 
ORF2 LXCXE conserva  on in both ORF5-plus and -less polyomaviruses provided us with two 
contras  ng virus groups that diff er in rela  on to the COCO-VA site expression through ORF5. 
Consequently, the COCO-VA site is not expected to be under selec  on pressure in ORF5-
less viruses (Figure 1C3 scenario), while its evolu  on in ORF5-plus viruses may or may not 
be driven by selec  on depending on the func  onal importance of these residues (either 
Figure 1C3 or Figure 1C4 scenario). Fourth, the restricted binary choice of aa residues at 
the COCO-VA site compared to the full 20 amino acid (aa) residue varia  on simplifi es the 
evolu  onary analysis of its residue varia  on.
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 Taking all these considera  ons into account, we reasoned that the rela  ve abun-
dance of either Ala or Val in ORF5-plus compared to ORF5-less polyomaviruses would be 
indica  ve of selec  on on residue type. Since Ala and Val are similarly and evenly abundant 
at the COCO-VA site in the known ORF5-plus and ORF5-less mammalian polyomaviruses: 
11 vs. 11 and 12 vs. 14 (Figure 2), respec  vely, no indica  on for selec  on is apparent. This 
observa  on indicates also that the COCO-VA site may not have experienced other, non- 
ORF2-related selec  on favoring one of the two nucleo  des. Accordingly, we have not found 
conserved RNA secondary structure elements in this region (see Supplementary Text S2 and 
Supplementary Table S3, Supplementary Figure S2 and S3), which, poten  ally, could have 
been an alterna  ve source of constraint on the non-synonymous subs  tu  on in ORF5. 
 Next, we inves  gated the frequency of COCO-VA toggling among polyomaviruses. 
In this and subsequent analyses, switching between Ala and Val residues was accounted 
with no regard to its direc  on: from Ala to Val or from Val to Ala. The analysis was limited 
to the interspecies comparisons. The rate of the COCO-VA toggling in the ORF5-less poly-
omaviruses provided a baseline rate of COCO-VA toggling that can be expected by chance 
muta  on (neutral evolu  on). Comparison of this rate with that of the ORF5-plus viruses 
informed us about direc  onal selec  on at the COCO-VA codon in the la  er viruses.
 In the framework of this comparison, we have fi rst mapped COCO-VA toggling on 
a Bayesian phylogene  c tree of polyomaviruses (Figure 2). Due to extreme sequence di-
vergence of the ORF2/ORF5 overlap region in mammalian polyomaviruses (see above and 
Carter et al., [15]), reliable alignment of this region is limited to four mo  fs of only ~30 resi-
dues in total (Supplementary Figure S1), which may not be suffi  cient for reliable phylogeny 
reconstruc  on. Therefore we choose to use a concatenated alignment of other conserved 
domains represen  ng LT, VP1 and VP2 proteins and accoun  ng for ~50% of genome for 
phylogeny inference. Large monophyle  c groups on this tree were formed by viruses, which 
were recognized as similar in the ORF2/ORF5 overlapping region. Addi  onally, we have ob-
served good agreement between topologies of separate branches of this tree, each repre-
sen  ng closely related polyomaviruses, with trees of these same viruses using alignments 
of the ORF2/ORF5 overlap region (Supplementary Figure S4). These observa  ons showed 
that the ORF2/ORF5 overlap region is likely to have coevolved with the LT, VP1 and VP2/3 
proteins, whose tree was thus considered suitable for analysis of the COCO-VA toggling.
 Subsequently, visual inspec  on of the tree revealed contras  ng pa  erns of phy-
logene  c grouping for Ala- and Val-specifi c viruses in ORF5-plus and ORF5-less subsets of 
mammalian polyomaviruses, respec  vely (Figure 2). While Ala- and Val-specifi c viruses 
were largely intertwined in the fi rst subset, they predominantly formed large residue-spe-
cifi c monophyle  c groups in the second subset. This result was indica  ve of accelera  on of 
the COCO-VA toggling in ORF5-plus viruses. To verify and extend this observa  on further, 
we have conducted addi  onal evolu  onary-based analyses using available and specially de-
signed approaches.
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Figure 2. Polyomavirus phylogeny and ORF5 characteris  cs. Shown is a Bayesian phylogeny using BEAST version 
1.7.4 [46] for 55 polyomaviruses (listed in Supplementary Table S1) based on conserved regions in the LT, VP1 and 
VP2 proteins (see M&M sec  on for details). The numbers plo  ed in the tree show posterior probability support 
values for internal branching events <1. The scale bar is in average number of amino acid subs  tu  ons. Asterisks in 
the virus column indicate viruses for which the ORF5 expression has been demonstrated experimentally. The ORF5 
column indicates the presence (+) or absence (−) of ORF5 in polyomaviruses genomes. The COCO-VA site column 
depicts the residue (Ala or Val) and corresponding codon at the COCO-VA site that is constrained by the Cys codon 
of the LT LXCXE mo  f in mammalian polyomaviruses (see Figure 1 and Supplementary Figure S1). The accelera  on 
column (accel.) labels viruses that experienced selec  on-driven accelera  on at the COCO-VA site. The geno-group 
column depicts the phylogene  c distribu  on of polyomaviruses according to Feltkamp et al., [40]. Please note that 
Carter et al., 2013 [15] divided all mammalian polyomaviruses into two groups, monophyle  c Almipolyomaviruses 
and paraphyle  c non-Almipolyomaviruses, which correspond to ORF5-plus and ORF5-less polyomaviruses, respec-
 vely. The tree was pseudorooted at the branch connec  ng mammalian and avian (Avi) polyomaviruses (see M&M 





























































































































































































































































































































No evidence for posi  ve selec  on at the COCO-VA site by conven  onal 
evolu  onary analyses
We started with employing two most advanced and widely used programs, MEME [49] and 
FUBAR [27], developed for evolu  onary analysis of residue varia  on. Also included was 
TOGGLE [25], which was specifi cally developed for analysis of residue toggling. These three 
programs are available through the Datamonkey website [26]. The employed programs dif-
fer in how they accommodate lineage- and site-specifi c varia  on in the analyzed dataset to 
infer pa  erns of evolu  on and deduce selec  on forces ac  ng on individual codons. Since 
these tools were developed for the analysis of non-overlapping ORFs, only a single evolu-
 onary force, if iden  fi ed, is reported. Consequently, we did not expect that these programs 
could infer both purifying selec  on (due to Cys conserva  on of LXCXE) and posi  ve selec-
 on (accelerated Val-Ala toggling) at the COCO-VA site of the ORF5-plus viruses as depicted 
in Figure 1C4. Rather, we asked whether the programs could provide evidence for either 
nega  ve or posi  ve selec  on at this site of ORF5-plus viruses and nega  ve selec  on at this 
site of ORF5-less viruses. This type of inferences depends on the number and diversity of 
alignment posi  ons under analysis. Due to the high sequence divergence of the ORF2/ORF5 
overlapping region, we thus analyzed diff erent subsets of mammalian polyomaviruses, in 
order to facilitate iden  fi ca  on of selec  on forces. Specifi cally, the programs were applied 
to ten diff erent alignments of ORF5, D1-D10, represen  ng selected ORF5 codons, which 
may or may not be merged with ORF2 codons for diff erent subsets (see M&M and Sup-
plementary Table S4). In none of the thirty conducted analyses, the COCO-VA codon was 
iden  fi ed to be under posi  ve/diversifying selec  on, including toggling. Also the COCO-VA 
codon was not found to be nega  vely selected in analyses that included only ORF5-plus 
viruses, neither in the en  re set nor its D5, D6, D8, D9 and D10 subsets. However, upon 
analysis of the other fi ve virus sets by FUBAR, either including all ORF5-plus viruses along 
with other viruses (D1-D4) or including only ORF5-less viruses (D7), the COCO-VA codon 
was iden  fi ed to be under purifying selec  on. In contrast, various other ORF5 codons were 
iden  fi ed as being posi  vely or nega  vely selected or be involved in toggling, in many of 
these analyses (Supplementary Table S4).
 The lack of evidence for posi  ve selec  on/toggling at the COCO-VA codon in ORF5- 
plus viruses according to these analyses could be either a true nega  ve result (lack of the 
phenomenon) or a false nega  ve result (failure to detect a signal due to systema  c technical 
defi ciency). As detailed below, we believe that the la  er explana  on is most likely. Indeed, 
the employed three programs operate under the assump  on that the en  re codon table of 
61 varie  es is available for evolu  on at every site in the analyzed alignments. Consequently, 
the eight diff erent codons (four for Val and four for Ala) observed at the COCO-VA site were 
seen as severely restricted rather than represen  ng the full spectrum allowed at this site 
(imposed by Cys conserva  on in the overlapping ORF2 codon). This misreading of the ob-
served residue varia  on has profound implica  ons for its evolu  onary interpreta  on, since 
high diversity tends to be interpreted as a sign of posi  ve selec  on, while restricted diver-
sity is commonly associated with purifying selec  on during evolu  on of non-overlapping 
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ORFs. It is thus not surprising that the COCO-VA site evolu  on was qualifi ed to be under 
nega  ve selec  on in several tests by FUBAR. This result could be seen as evidence for the 
dominance of purifying selec  on at the COCO-VA site according to FUBAR.
Toggling at the COCO-VA site is signifi cantly accelerated
Due to the above considera  ons, we decided to con  nue our tes  ng of the toggling by ap-
plying an approach that could be free from the limita  ons of standard evolu  onary based 
programs developed for non-overlapping ORFs. First, we sought to verify the elevated fre-
quency of Ala-Val exchange in ORF5-plus compared to ORF5-less viruses that is apparent 
from polyomavirus phylogeny (Figure 2). To this end, we have applied the Mul  state meth-
od of the BayesTraits package [50] to compare the COCO-VA site varia  on in mammalian 
ORF5-plus and ORF5-less polyomaviruses. The program employs con  nuous-  me Markov 
models to es  mate the transi  on rates between mul  ple states for a single trait (Ala/Val 
for COCO-VA site in this case) while it traverses a tree. The produced es  mates take into 
account the uncertainty associated with tree reconstruc  on as it u  lizes the full posterior 
tree sample. The es  mated transi  on rate distribu  on was plo  ed for three virus datasets 
(Figure 3 le  ). From this plot it is evident that the es  mated Ala-Val exchange rate is more 
than 3  mes higher (13.6 vs 4.3) for ORF5-plus viruses compared to ORF5-less viruses, with 
a 25-75% interquar  le range of 9.5-19.1 and 2.5-7.7, respec  vely. This striking diff erence 
between the two datasets is strongly supported by a log Bayes Factor (logBF) of 3352.2, 
which is astronomically large and dwarfs the signifi cance threshold of 2. As expected, the es-
 mate for mammalian polyomaviruses was intermediate between those two with a 25-75% 
interquar  le range of 5.6-13.3 (Figure 3 le  ). As Ala-Val exchange at the COCO-VA posi  on is 
equivalent to C-T exchange at the second codon posi  on (see Figure 2 and M&M) we have 
compared its exchange rate to that at the third codon posi  on (Figure 3 right). This posi  on 
accepts all four nucleo  des and its varia  on is primarily driven by selec  on in the overlap-
ping ORF2 in which it occupies the fi rst codon posi  on of the subsequent residue. As may be 
expected, the exchange rate at this posi  on (now averaged over four instead of two nucleo-
 des) is comparable for ORF5-plus and ORF5-less viruses (median and 25-75% interquar  le 
range: 10.2 and 8.5-12.3 vs. 9.8 and 8.0-11.9, respec  vely). Of no  ce, these numbers are 
s  ll and consistently smaller than those of the Ala-Val exchange rate for ORF5-plus viruses.
 Importantly, the observed diff erence at the second codon posi  on (i.e., the Ala-
Val exchange) may not be a  ributed to diff erences in virus diversity of the compared two 
datasets, whose distribu  ons of smallest pair-wise patris  c distance (SPAT) values (median 
value and 25-75% inter-quar  le range: 0.23 and 0.13-0.32 vs. 0.28 and 0.12-0.46) were not 
diff erent at a sta  s  cally signifi cant level (Mann-Whitney U test; p=0.42). Consequently, we 
concluded that the COCO-VA toggling rate is signifi cantly and genuinely accelerated in the 
ORF5-plus compared to the ORF5-less polyomaviruses. Since the COCO-VA site is expressed 
in ORF5-plus but not ORF5-less viruses (although see below), this result implies posi  ve 























Figure 3. COCO-VA toggling is accelerated in ORF5-plus compared to ORF5-less viruses. Shown are results of 
BayesTraits mul  state analysis of COCO-VA toggling rate in three groups of viruses. The distribu  ons of es  mated 
exchange rates at second (le   side) and third (right side) codon posi  on of the COCO-VA codon is shown. The ex-
change rate at the second codon posi  on corresponds to the COCO-VA toggling while the rate at the third codon 
posi  on serves as a control. The distribu  ons are shown as Box-and-whisker graphs. The boxes span from the fi rst 
to the third quar  le and include the median (bold line), and the whiskers (dashed lines) extend to the extreme 
values.
Ra  o approach to study accelerated COCO-VA toggling
To study the accelerated COCO-VA toggling further, we have developed a ra  o approach 
remotely similar to that of comparing the ra  o of non-synonymous to synonymous subs  tu-
 ons. We used the ra  o of monoSPAT/(monoSPAT+polySPAT) values as a normalized meas-
ure of the COCO-VA toggling rate rela  ve to Ala/Ala or Val/Val persistence, with polySPAT 
and monoSPAT resembling es  ma  ons of non-synonymous and synonymous subs  tu  ons, 
respec  vely (for group designa  ons see M&M). Only the C/T varia  on at the 2nd codon posi-
 on that controls Val-Ala exchange, rather than the en  re codon for Ala/Val as it would have 
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been the case upon analysis of a non-overlapping ORF by a conven  onal technique, was 
analyzed in our test. We thus avoided complica  ons to the analysis that would otherwise 
be caused by the unaccounted evolu  onary pressure on the third posi  on of Ala/Val co-
dons by the ORF2 overlapping codon, where it occupies the fi rst posi  on of the subsequent 
residue (Figure 1B). An SPAT ra  o of 0.5 indicates that the Ala/Val exchange rate matches 
that of Ala/Ala or Val/Val persistence during evolu  on of a par  cular lineage (herea  er, 
matching rate). Since amino acid residue persistence at the COCO-VA site in a pair of viruses 
may involve either no gene  c change or synonymous subs  tu  on, the matching rate for 
toggling under the model of neutral evolu  on could be expected only at suffi  ciently large 
evolu  onary distances when chance muta  on, either synonymous or non-synonymous, is 
highly probable. Accordingly, persistence would dominate over toggling at smaller distances 
under this model, resul  ng in SPAT ra  os smaller than 0.5. If posi  ve selec  on is involved in 
toggling, increase of SPAT ra  os compared to those expected under neutral evolu  on could 
be observed at suffi  ciently small evolu  onary distances.
 The above considera  ons indicate that under the model of neutral evolu  on we 
could expect diff erent SPAT ra  os at small and large evolu  onary distances. To verify this 
and defi ne ranges for small and large evolu  onary distances separa  ng pairs of monomor-
phic viruses, we analyzed the diff erence between the matching rate and within-window 
distribu  ons of SPAT ra  os involving all mammalian polyomaviruses, which were plo  ed 
against monoSPAT values. Due to stochas  c reasons, the es  mated toggling rate may devi-
ate from the actual rate for a virus. To address this limita  on, we pooled SPAT ra  os within 
a predefi ned window that was slid along the monoSPAT axis. Our analysis revealed that the 
Ala/Val exchange rate of polyomaviruses varies considerably, with very diff erent median 
values being observed in two monoSPAT ranges (Figure 4A). In the monoSPAT range of 0- 
0.35, median SPAT ra  os were consistently smaller compared to the matching rate, while in 
the monoSPAT range of 0.35-0.75, they were consistently larger than the matching rate. Ac-
cordingly, the en  re monoSPAT range was split into two sub-ranges in our subsequent anal-
yses. For evolu  onary interpreta  ons of the ra  o test in subsequent analyses, we used the 
results obtained for ORF5-less viruses as a base-line, since Val-Ala toggling in these viruses 
is expected to experience no selec  on (Figure 1C3 scenario) over the en  re evolu  onary 
distance range.
Accelerated COCO-VA toggling is associated with interspecies diversifi ca-
 on of ORF5-plus polyomaviruses
Is the accelerated toggling a characteris  c of the en  re ORF5-plus viruses or its subsets? The 
diff erence between SPAT ra  os in the distribu  ons for ORF5-plus and ORF5-less viruses was 
sta  s  cally signifi cant over the monoSPAT range of 0-0.35 (MWU test p-value=7e-06), but 
not over the 0.35-1.2 range (MWU test p-value=0.829) (Figure 4B). Importantly, this result 
may not be due to biases of the virus sampling which was comparable for ORF5-plus and 
-less viruses in the two distribu  ons along the monoSPAT range (Supplementary Figure S5).
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 Consequently, the above observa  ons indicate a selec  on-driven accelera  on of 
COCO-VA toggling in the majority (fi  een out of twenty-two) of ORF5-plus polyomaviruses, 
each of which is separated from another monomorphic virus by a monoSPAT of 0.35 or 
smaller (Figure 4). For the remaining seven ORF5-plus viruses, each of which is separated 
from another monomorphic virus by a monoSPAT larger than 0.35, no accelerated COCO-VA 
toggling was observed. This could be either due to specifi cs of evolu  on or the unavailabil-
ity of close monomorphic rela  ves of these viruses in the current sampling. If the former 
is true, the viruses with accelerated COCO-VA toggling may be expected to cluster in the 
tree, while a random phyle  c distribu  on is likely otherwise. Figure 2 shows that the fi  een 
viruses with accelerated COCO-VA toggling are sca  ered across the en  re branch of ORF5-
plus viruses. This observa  on implies that the accelerated COCO-VA toggling may involve 
all ORF5-plus viruses (all terminal nodes in the respec  ve tree branch) thus presen  ng an 
extreme case of convergent evolu  on. An improved, much larger virus sampling, which in-
cludes closely related viruses for each analyzed virus species, will enable verifi ca  on of this 
implica  on. Also, it may facilitate addi  onal insights, including: a) refi ning the es  mate of 
the monoSPAT threshold at which the COCO-VA toggling accelera  on can be observed, and 
b) extending our analysis to poorly sampled intra-species diversity, in order to address the 
ques  on whether COCO-VA toggling drives specia  on or vice versa.
 Could the observed diff erence between ORF5-plus and ORF5-less viruses in the 
monoSPAT range of 0-0.35 (Figure 4B) have emerged also under the evolu  onary scenar-
io that is alterna  ve to that involving posi  ve selec  on on ORF5-plus and no selec  on on 
ORF5-less viruses? If the COCO-VA site was under strong nega  ve selec  on in ORF5-less 
viruses while being under either weak nega  ve or no selec  on in ORF5-plus viruses, SPAT 
ra  o of these viruses would diff er. The following considera  ons make this scenario unlikely 
to be applicable to explain the data obtained in our study. First, this scenario implies that the 
COCO-VA site must be expressed in all ORF5-less viruses. These viruses include some of the 
most well characterized polyomaviruses, e.g. SV40, with no evidence for the expression of 
the COCO-VA site, although some of the poorly characterized ORF5-less viruses may indeed 
express this site (see below). We could also recall that ORF5-less viruses were defi ned as a 
group not having the property (ORF5) rather than having one, which would be required to 
link strong nega  ve selec  on to the func  onal characteris  c. Second, SPAT ra  o of ORF5-
plus viruses in the monoSPAT range of 0-0.35 is comparable to the matching rate (p=0.390 in 
Wilcoxon rank sum test; see Supplementary Table S5). This result is in the excellent agree-
ment with posi  ve selec  on ac  ng on the COCO-VA site in ORF5-plus viruses, while it may 
not be reconciled with the weak nega  ve selec  on hypothesis. On the other hand, it would 
in principle be compa  ble with neutral evolu  on of the COCO-VA site in ORF5-plus viruses 
under the condi  on that polyomaviruses have very high muta  on rate. The es  mates of 
this rate vary greatly and generally this aspect has not been fully resolved [68]. However, we 
note that the Val-Ala varia  on is already observed in several monophyle  c subsets of ORF5-
plus viruses which otherwise diverged li  le or modestly. This observa  on indicates that the 
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Figure 4. Accelerated toggling at the COCO-VA site in ORF5-plus and Ortho-I viruses. For the purpose of this analysis 
a representa  ve set of 50 mammalian polyomaviruses (see Supplementary Table S1) was studied. Due to the lack 
of species demarca  on criteria for polyomaviruses, we chose to consider viruses with diff erent names as represent-
ing diff erent species (dots in the plot). The only excep  on was made for MX polyomavirus, Human polyomavirus 10 
and MW polyomavirus, which were represented only by the la  er because of the very small distances that separate 
these three viruses. Two pairs of virus par   oning (subsets) of the mammalian polyomaviruses, based on the ORF5 
presence and phylogeny, were considered. They and their colour codes are defi ned in the inset of panel B. (A) The 
par   oning of the monoSPAT scale at 0.35 was derived based on the drop of the mean diff erence of SPAT ra  os to 
the matching rate. Here, a sliding window (size 0.15, shi   0.05) star  ng at monoSPAT of 0.0 was moved along the 
monoSPAT range to calculate within-window mean diff erences (dots) and associated standard devia  ons (ver  cal 
lines). See also M&M sec  on and Supplementary Figure S5 for other details. (B) The curves show the fi t of a 3-pa-
rameter logis  c func  on to each of four diff erent subsets. The numbers below show P-values of Mann–Whitney U 
tests comparing the SPAT ra  o distribu  ons between ORF5-plus and ORF5-less viruses (Orthopolyomavirus-I and 
non-Orthopolyomavirus-I) for two monoSPAT ranges (0–0.35, 0.35–1.25). A horizontal do  ed line is drawn at the 
matching rate, whose evolu  onary interpreta  on is defi ned in the text.
Val-Ala varia  on may be among most frequent rather than average as would be expected 
under the neutral evolu  on scenario. This aspect could be studied most closely with the im-
proved virus sampling. In conclusion, based on the available data the accelerated COCO-VA 
toggling due to posi  ve selec  on is the most likely evolu  onary scenario.
Accelerated COCO-VA toggling is most strongly associated with monophy-
le  c Ortho-I viruses
The results described above provide evidence for accelerated COCO-VA toggling in the 0-0.35 
monoSPAT range for ORF5-plus viruses. However, it is also evident that the distribu  ons of 
ORF5-plus and –less SPAT ra  os overlap with two ORF5-less viruses devia  ng considerably 
from their group-mates and instead fi   ng into the other group rather well (Figure 4B, red 
dots in the 0-0.35 monoSPAT range). This grouping with ORF5-plus viruses received strong 
sta  s  cal support when analyzing all of the 145,422,675 possible 16-by-14 combina  ons 
of the 30 viruses with monoSPAT values in the range of 0-0.35 (Supplementary Text S3 and 
Supplementary Figure S6). Intriguingly, these two viruses along with another one for which 
no closely related monomorphic virus is available in the current virus sampling (Figure 4B, 
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red dot in the 0.35-1.20 monoSPAT range) form a sister lineage of ORF5-plus polyomavirus-
es at the root of the Ortho-I monophyle  c group (Figure 2) [15, 40]. These results suggest 
that the accelerated toggling is most strongly associated with the Ortho-I group. Since the 
observed accelerated toggling is indica  ve of posi  ve selec  on that may be realized only 
upon expression of the COCO-VA site in the two (three) poorly characterized basal Ortho-I 
viruses, such hypothesis must be considered. It could be achieved using a mechanism other 
than expression of the en  re ORF5, for instance, through alterna  ve splicing of mRNA(s) 
[69] that could fuse the COCO-VA site with other ORF(s). In the evolu  onary framework, 
such expression of the COCO-VA site would be ancestral to those used by ORF5-plus viruses, 
implying that the COCO-VA site and the associated sequence mo  f could be a nuclea  on 
site for the subsequent ORF5 origin by ORF expansion [15]. 
COCO-VA toggling is located in a SLiM of an intrinsically disordered region
What could be the structural basis of COCO-VA toggling? Bioinforma  cs analyses indicate 
that MT/ALTO is a Pro residue rich IDR, whose mo  fs could form SLiMs (Figures S1, S7, S8 
and S9) [15]. Thus, the interspecifi c toggling targets a SLiM, which is in line with the no  on 
that IDRs evolving diff erently than structured protein regions [6, 7]. Since SLiMs promote 
protein folding in rela  vely fl at energy landscapes [70] and mediate interac  ons with part-
ners that are rela  vely weak [71, 72], diff erence between physico-chemical proper  es of 
the just two possible COCO-VA residues, Val and Ala, could be of signifi cance. For instance, 
these residues have contras  ng structural propensi  es, favoring the forma  on of either 
α-helix (Ala) or β-sheet (Val) [73], which might be used to promote alterna  ve folding of 
MT/ALTO upon interac  on with partner(s). Unfortunately, this hypothesis may not be tested 
using the available computa  onal approaches. 
Concluding Remarks
In complex protein networks, SLiMs are emerging as evolu  onary adap  ve transmi  ers of 
intracellular signals involving mul  ple interac  ng partners [2, 3, 13, 74]. Here we present-
ed evidence for the evolu  onary signature of adapta  on in the otherwise uncharacterized 
SLiM of MT/ALTO. The eff ect of COCO-VA toggling on the SLiM may be similar to that of 
phosphoryla  on which could modulate SLiM ac  vity considerably [75]. MT an  gen of ro-
dent polyomaviruses has been shown to interact through its ORF5-encoded part with nu-
merous cellular targets involved in signal transduc  on [33, 35, 36, 39]. The func  on of ALTO, 
iden  fi ed just recently, has not been resolved yet [15]. The described COCO-VA toggling 
is notable because of a unique combina  on of proper  es: it involves one of the just few 
conserved posi  ons of the otherwise highly divergent MT/ALTO protein, and it may aff ect 
every species of Ortho-I polyomaviruses. These viruses are known to infect bats, rodents, 
monkeys, hominids and humans with apparently frequent host switching (Figure 2). Fu-
ture studies should iden  fy driving forces of the COCO-VA toggling to enable its comparison 
with intra-species residue toggling [25]. The la  er is likely driven by the cellular immune 
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response and occurs at much smaller  me and divergence scales, and with the exchange 
of many residues. Prac  cally, our study suggests that analysis of subs  tu  on rates can be 
applied to individual residues in overlapping ORFs. It extends the u  lity of the subs  tu  on 
rate analysis from mapping to dissec  ng func  onal elements in overlapping ORFs.
 The described phenomenon also challenges common percep  on of conserva  on 
of proteins, which is believed to be inversely and universally correlated with the rate of 
evolu  on. Accordingly, sites accep  ng rela  vely few residues are classifi ed conserved and 
evolving slowly under nega  ve selec  on. Typically, such residues are cri  cal for maintaining 
protein core and/or playing an essen  al role in the ac  ve site of structured proteins. Besides 
the sites that are strictly invariant, those that accept only two residues during large-scale 
evolu  on are among the most conserved. Exchange of these residues could happen due to 







Figure 5. Contras  ng modes of evolu  on at a conserved protein site accep  ng two residues. Shown are fi c  onal 
examples of evolu  on of a conserved protein site with two-residue varia  on in families of structured (le   panel) 
and unstructured (right) proteins, whose evolu  onary scale of replacement at all sites was considerable (bar 0.5) 
and whose phylogeny is described by iden  cal trees. In both cases, two residues are evenly distributed, each oc-
cupying 50% of terminal nodes. Residue type either clusters into two monophyle  c groups (le  ) or is intertwined 
(right). The le   panel depicts divergent evolu  on driven mostly by purifying selec  on as seen in many character-
ized structured proteins. The right panel depicts convergent evolu  on driven by posi  ve selec  on as discovered at 
the COCO-VA site in the presented chapter and may be experienced at other sites in unstructured proteins.
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or residue dri  . As a result, each of the two residues is likely to be associated with a large 
monophyle  c clade in the tree (Figure 5 le   panel), the pa  ern that can be recognized by 
available programs (e.g. [76]). Examples of this type of evolu  on are plenty in many protein 
families. For instance, rare exchange of the cataly  c nucleophile Cys and Ser residues in 
virus proteases with chymotrypsin-like fold [77] or phosphate-binding Ser and Thr residues 
in the Walker-box GKS/T mo  f of nucleo  de-binding proteins [78], are notable. The above 
considera  ons indicate that in structured proteins, limited residue varia  on may largely be 
imposed by the molecular environment in which these proteins operate. In contrast, con-
straints on the gene  c level is the chief factor determining residue varia  on in proteins 
encoded in overlapping ORFs. Consequently, this restricted residue varia  on in overlapping 
ORFs may not be linked to residue func  on in the manner described for structured proteins. 
Accordingly, overlapping ORFs predominantly encode unstructured proteins with their most 
conserved SLiMs media  ng adapta  on, a func  on that is commonly facilitated by the least 
conserved elements in structured proteins. Along the same line, we now provide evidence 
for the phylogene  c intertwining of viruses that employ, respec  vely, Val and Ala at the 
conserved COCO-VA site in the IDR of MT/ALTO. When depicted in a simplifi ed form, this 
phylogene  c pa  ern can be contrasted with the clade-specifi c associa  on of residues in a 
tree of structured proteins (compare right and le   panels of Figure 5). This contrast is par-
 cularly striking since it is not evident in the cumula  ve frequency of residues at terminal 
nodes (bo  om panels underneath of trees in Figure 5). Thus, this logos-style representa  on 
of residue conserva  on, which is very popular in func  onal studies, may not capture residue 
change and its role in adapta  on. Only analysis in the context of phylogeny could do it, as 
demonstrated in this study.
 Since Cys is one of the least frequent amino acid residues and none of the other 
residues can constrain evolu  on in the -3 RF (or +1 RF) to only two residues, the described 
codon-constrained accelerated toggling might be viewed as an extremely exo  c phenome-
non limited to polyomaviruses. We believe that this percep  on is biased for several reasons. 
First of all, the (unknown) diversity of the Virus Universe is expected to be many orders of 
magnitude larger than the number of currently recognized few thousand virus species [79, 
80]. This implies a good chance of discovering COCO-VA toggling in other viruses in the fu-
ture. Furthermore, accelerated toggling might involve more than two residues at a site that 
could s  ll be considered conserva  ve rela  ve to many other sites. Such constraint could be 
imposed by conserved amino acids other than Cys in the overlapping ORF or, if non-over-
lapping ORF is involved, by a diff erent gene  c mechanism, e.g. RNA structure, or even by 
a partner or partners interac  ng with an IDR site. Thus, the described COCO-VA toggling 
may represent an extreme case of common evolu  on of individual residues in IDRs of pro-
teins, making it poten  ally relevant to understanding biology and pathology of adapta  on 
of many organisms.
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Supplementary Text S1. Nomenclature of open reading frames of mamma-
lian polyomaviruses
Polyomaviruses use genomes with two non-overlapping protein-coding regions that are ex-
pressed either early or late in infec  on, respec  vely [1]. Each region includes open reading 
frames (ORFs) that produce – for some through alterna  ve splicing – early proteins Small, 
Middle and Large T an  gen (ST, MT and LT) and the late capsid proteins (VP2/VP3 and VP1), 
respec  vely (Supplementary Table S2) [2]. ST and LT are ubiquitous in all mammalian pol-
yomaviruses. MT, however, was known only for the mouse (MPyV) and hamster (HaPyV) 
polyomaviruses. Recently, a third early protein called ALTO was described for MCPyV that is 
homologous to the C-terminal domain of MT [3].
 Polyomaviruses use alterna  ve pre-messengerRNA (primary transcript) splicing to 
produce mRNAs that direct synthesis of proteins. The currently used nomenclature focuses 
on annota  on of proteins and the respec  ve transcripts. When ORFs are named, which 
happens only occasionally in literature, protein-based designa  on is used. The produced 
designa  on could be confusing for ORFs that encode more than one protein. For instance, 
the fi rst ORF in the early region is commonly called ST ORF, while it also encodes the fi rst 
exon of MT and LT protein. To address this complexity, we have used in this study a ra  onal 
nomenclature of ORFs designa  ons that is independent from names of proteins/transcripts. 
Its ra  onal is similar to that used to design ORFs nomenclature in other virus families with 
similarly complex rela  ons between ORFs, transcripts and proteins [4]. We defi ned regions 
fl anked by two stop codons as ORFs in three diff erent reading frames. Two pairs of ubiqui-
tous early and late ORFs were designated ORF1 and ORF2, and ORF3 and ORF4, respec  vely, 
while an op  onal early ORF was designated ORF5. In this regard, the early primary transcript 
can be alterna  vely spliced to merge (parts of) ORF1 and ORF2 for direc  ng the synthesis of 
LT, and (parts of) ORF1 and ORF5 for direc  ng the synthesis of MT. Alterna  vely, ORF1 and 
ORF5 can be translated directly through internal start codons, respec  vely, resul  ng into 
synthesis of ST and ALTO (Supplementary Table S2). The developed ORF nomenclature can 
accommodate the iden  fi ca  on of new alterna  vely spliced transcripts as well as proteins 
expressed by canonical and non-canonical mechanisms.
Supplementary Text S2. No conserved RNA secondary structure elements 
are evident around COCO-VA genomic site 
Conserved RNA secondary structures constrain evolu  on of the respec  ve genomic regions 
of viruses involved. To clarify whether toggling at the COCO-VA site was aff ected by the pres-
ence of conserved RNA secondary structures in polyomaviruses, we used the RNAz web-
based program to predict func  onal RNA structures based on two criteria: i) evolu  onary 
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conserva  on and ii) thermodynamic stability [5]. Due to overall poor conserva  on of ORF5 
in mammalian polyomaviruses, the analysis was conducted in monophyle  c subsets of pol-
yomaviruses for which reliable alignments were possible to produce (see also [3]). In total, 
nucleo  de alignments for six subsets of the ORF5-plus and ORF5-less polyomaviruses were 
generated (Supplementary Table S3 and Figure 3) and analyzed in a genomic region around 
the LXCXE overlapping COCO-VA site (see M&M for details).
 Several RNA secondary structures in the tested region with a probability higher 
than the cutoff  value of p=0.5 were predicted by the RNAz program in the subsets 1, 2 and 3 
of the ORF5-plus viruses (Supplementary Figure S2). Majority of these secondary structures 
were predicted on the nega  ve-strand of the input RNA-alignments. No conserved RNA 
secondary structures were iden  fi ed on the posi  ve or nega  ve-stands of other subsets. 
Importantly, one of the predicted RNA structures closely corresponds to the experimentally 
validated pre-microRNA located on the nega  ve-strand of MCPyV RNA [6, 7] (Supplemen-
tary Figure S3), lending further and independent support to the results of RNA structure 
analysis by RNAz. Since COCO-VA site is NOT base-paired in either of the predicted RNA 
structures, we concluded that the evolu  on of the COCO-VA site is not likely constrained by 
RNA secondary structure elements in mammalian polyomaviruses.
Supplementary Text S3. Accelerated COCO-VA toggling is most associated 
with monophyle  c Ortho-I viruses
In addi  on to assessing sta  s  cal signifi cance of diff erence between SPAT ra  o distribu-
 ons of ORF5-plus and ORF5-less viruses, we sought to assess the combinatory scale of 
14/16 par   oning that would give another, top-down perspec  ve on the probability value 
obtained for the diff erence. To this end, we ranked the diff erence among diff erences for 
all possible two-side par   oning of this type (14 vs. 16) for 30 viruses in the 0-0.35 mono-
SPAT range. In total, 145,422,675 values were obtained and plo  ed as a histogram revealing 
highly symmetrical bell-like distribu  on of values (Supplementary Figure S6), whose diff er-
ence of group means of toggling rate ra  os for all possible combina  ons was virtually zero 
(2.7e-17). The ORF5-plus/ORF5-less par   oning was ranked #284 (counted from the le   
side) with a diff erence of means of -0.2726 between the compared datasets. This high rank 
corresponds to a p-value of 1.95e-06 that was close to the 7e-06 value obtained in MWU 
test. The high ranking of the ORF5-plus/ORF5-less par   oning strongly supported the prior 
conclusions.
 In the view of such high ranking, why this par   oning did not outrank all other 
par   onings? Inspec  on of par   oning with higher ranks showed that, like ORF5-plus vi-
ruses, many of them and including the number 1 (diff erence of means of -0.3051), involved 
a large subset of phylogene  cally compact Ortho-I viruses, which was contrasted against 
mainly non-Ortho-I viruses. This observa  on prompted us to compare Ortho-I vs. non-Or-
tho- I viruses. Since this par   oning compares 16 to 14 viruses, its ranking could be de-
rived from the density distribu  on already used to rank ORF5-plus/ORF5-less par   oning 
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(14 vs. 16 viruses), now from its right tail (Supplementary Figure S6). Its analysis showed 
that the Ortho-I/non-Ortho-I par   oning had a diff erence of mean toggling rate values of 
0.2993 that ranked number three. This ranking is a two-order improvement over the ranking 
of ORF5-plus/ORF5-less par   oning and corresponded to a p-value of 2.1e-08, which was 
close to 5.5e-08 in the MWU test (Figure 4B). The diff erence in values of mean toggling 
rates for the Ortho-I/non-Ortho-I par   oning was only marginally worse than those for two 
top-ranking 16/14 par   oning, which had 0.3007 and 0.2996 values, respec  vely. This re-
sult showed that the accelerated toggling is most strongly associated with the tree-based 
Ortho-I/non-Ortho-I par   oning.
 Sequence alignments and the polyomavirus phylogeny used in this study can be 
found at h  ps://github.com/chrar  n/COCOVAtoggling . 
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           Supplementary Table S1. Polyomavirus representa  ves used in this study*
    
NC_001515 MPyV Murine polyomavirus Mouse 
NC_001663 HaPyV Hamster polyomavirus Hamster 
JQ178241 RacPyV Raccoon polyomavirus Raccoon 
NC_020068 EiPyV1 Eidolon polyomavirus-1 Bat 
NC_020071 OtPyV1 Otomops polyomavirus-1 Bat 
JQ958889 CPPyV Carollia perspicillata polyomavirus Bat 
JQ958887 APPyV1 Ar beus planirostris polyomavirus Bat 
NC_020067 CdPyV Cardioderma polyomavirus Bat 
HQ385749 PtvPyV2c Pan troglodytes verus polyomavirus-2c Chimpanzee 
HQ385752 GggPyV1 Gorilla gorilla gorilla polyomavirus-1 Gorilla 
NC_010277 MCPyV Merkel cell polyomavirus Human 
HQ385746 PtvPyV1a Pan troglodytes verus polyomavirus1a Chimpanzee 
NC_020065 CoPyV1 Chaerephon polyomavirus-1 Bat 
JQ958888 SLPyV Sturnira lilium polyomavirus Bat 
JQ958893 MMPyV Molossus molossus polyomavirus Bat 
NC_014743 ChPyV Chimpanzee polyomavirus Chimpanzee 
NC_019844 VePyV1 Vervet monkey polyomavirus-1 Monkey 
NC_019850 PRPyV1 Piliocolobus rufomitratus polyomavirus-1 Monkey 
FN356901 OraPyV2 Orangutan polyomavirus Orangutan 
NC_014361 TSPyV Trichodysplasia spinulosa-associated polyomavirus Human 
FN356900 OraPyV1 Orangutan polyomavirus Orangutan 
NC_019853 AtPPyV1 Ateles paniscus polyomavirus-1 Monkey 
NC_015150 HPyV9 Human polyomavirus-9 Human 
NC_019851 MFPyV1 Macaca fascicularis polyomavirus-1 Monkey 
NC_004763 LPyV African green monkey polyomavirus Monkey 
NC_020106 STLPyV STL polyomavirus Human 
JX259273 MXPyV MX polyomavirus Human 
JX262162 HPyV10 Human polyomavirus-10 Human 
JQ898291 MWPyV MW polyomavirus Human 
NC_009238 KIPyV KI polyomavirus Human 
NC_009539 WUPyV WU Polyomavirus Human 
NC_014407 HPyV7 Human polyomavirus-7 Human 
NC_014406 HPyV6 Human polyomavirus-6 Human 
JQ958890 APPyV2 Ar beus planirostris polyomavirus Bat 
JQ958891 PPPyV Pteronotus parnellii polyomavirus Bat 
NC_020070 PDPyV Pteronotus polyomavirus Bat 
JQ958892 DRPyV Desmodus rotundus polyomavirus Bat 
NC_013796 CSLPyV California sea lion polyomavirus Sea lion 
NC_001442 BPyV Bovine polyomavirus Cow 
NC_001505 MptV Murine pneumotropic virus Mouse 
NC_011310 BatPyV Myo s polyomavirus VM-2008 Bat 
AB588640 MasPyV Mastomys polyomavirus Mouse 
NC_019854 CAPyV1 Cebus albifrons polyomavirus-1 Monkey 
NC_009951 SqPyV Squirrel monkey polyomavirus Monkey 
NC_020069 MiPyV Miniopterus polyomavirus Bat 
NC_001669 SV40 Simian virus-40 Monkey 
NC_001699 JCPyV JC polyomavirus Human 
NC_001538 BKPyV BK polyomavirus Human 
NC_007611 SA12 Simian virus-12 Monkey 
JQ412134 EPyV Equine polyomavirus Horse 
NC_004800 GHPyV Goose hemorrhagic polyomavirus Goose 
NC_007922 CPyV Crow polyomavirus Crow 
GU345044 CaPyV Canary polyomavirus Canary 
NC_004764 APyV Budgerigar edgling disease virus-1 Parakeet 
NC_007923 FPyV Finch polyomavirus Finch 
Accession Abbrevia on Virus name Host
*Viruses are listed according to phylogene  c tree in Figure 2.
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Supplementary Table S2. ORF designa  ons used in this study and by others
Supplementary Table S3. Virus subset composi  ons whose alignments were 
used for RNA secondary structure predic  on
   
This study By others Encoding Reference 
 
ST-an gen Small T an gen [8] 
MT-an gen Middle T an gen 1st exon [9] 
LT-an gen Large T an gen 1st exon [10] 
 LT-an gen Large T an gen 2nd exon [10] 
 VP2 VP2  [11] VP3 VP3  [12] 
 VP1 VP1  [12] 
ORF5 MT-an gen Middle T an gen 2
nd exon [9] 
ALTO protein ALTO protein [3] 






  ORF5 
 GggPyV1, PtvPyV2c, PtvPyV1a, MCPyV APPyV1, CPPyV, CdPyV, OtPyV1, EiPyV1, RacPyV plus 
 VePyV1, ChPyV, PRPyV1, MMPyV, SLPyV, CoPyV1 plus 
 TSPyV, AtPPyV1, OraPyV1 plus 
 MPyV, HaPyV plus 
 HPyV9, MFPyV1, LPyV plus 
6 
KIPyV, WUPyV, HPyV6, HPyV7, STLPyV, HPyV10, 
MXPyV, MWPyV, JCPyV, SA12, SV40, BKPyV, 
APPyV2, PPPyV, DRPyV, PDPyV, CAPyV1, 













































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary Table S5. Shown are p-values of a Wilcoxon rank sum 
test for devia  on of the mean of a distribu  on of SPAT ra  os from the 
matching rate
Bold, sta  s  cally signifi cant p-values (α=0.05)
 MonoSPAT range 
 0 - 0.35 0.35 - 1.25 0 - 1.25 
0.390 0.039 0.656 
3.1e-5 0.064 0.003 
0.211 0.020 0.672 















Supplementary Figure S1. Conserved features of ORF5 of the Ortho-I group. (A) domain organiza  on of two dif-
ferent proteins, par  ally or fully encoded in ORF5, that were experimentally characterized in MPyV and MCPyV. 
The ORF1-encoded MT domain is not further specifi ed. The ORF5-encoded domain includes four conserved mo  fs, 
ORF5m1 - ORF5m4, colored diff erently and detailed in panel B. The ORF5 remains open upstream of the start 
codon for MCPyV ALTO. (B) Conserved mo  fs in the ORF5/ORF2 overlap. Presented are sequence logos of four 
conserved mo  fs in LT ORF2 (bo  om), their counterparts in MT/ALTO ORF5 (top), and the corresponding genome 
region (middle). The logos are based on alignments of the 22 viruses of the Ortho-I group (see M&M). Gray bars 
indicate the codon structure of the LT ORF2 and MT/ALTO ORF5 reading frames. The arrow indicates the COCO-VA 
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P=1.00 P=0.83
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Supplementary Figure S2. Predic  on of RNA secondary structure consensus using RNAz. ORF5-plus viruses from 
subset 1 (top panel), subset 2 (middle panel) and subset 3 (bo  om panel) alignment demonstrated regions of 
RNA secondary structures in several combina  on of viruses. The predicted secondary structures from the nega-
 ve-strand (green bars) and posi  ve-strand (red bars), within the given alignment of indicated viruses with a prob-
ability value higher than 0.5, are shown. Posi  on of the COCO-VA in the given alignment is illustrated by horizontal 
red line.
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Supplementary Figure S3. Pre-microRNA hairpin predic  on by RNAz. (A) Two overlapping predicted RNA second-
ary structures (orange arrows) in the input alignments of subset 1 covering the ORF2- ORF5 overlapping region of 
~800 nucleo  des, and the corresponding region rela  ve to the LXCXE mo  f/COCO-VA site, are shown. Blue arrow 
indicates ORF5 encoded amino acids, and green arrow depicts ORF2 encoded amino acids. The signifi cance levels 
of RNAz predicted secondary structure hits are color-coded. Colors indicate the number of diff erent types of base 
pairs that support stabilizing selec  on on the structures (inset: color table-combina  on). Circles indicate variable 
posi  ons in the stems, also known as loops. (B) Structure and color annotated output alignment of the two RNA 
secondary structures shown in A, which were predicted in MCPyV, GggPyV1, PtvPyV2c and PtvPyV1a input align-
ment. This region corresponds to the pre-microRNA shown experimentally for MCPyV [6, 7]. The dot-bracket nota-
 on on top of each alignment indicates loop-stem, respec  vely, of the RNA secondary structure consensus. Region 









































































Supplementary Figure S4. Congruence of lineage-specifi c phylogenies with the polyomavirus tree. Compared is the 
topology of the polyomavirus tree es  mated using LT, VP1, and VP2 proteins (A) with that of two ORF5-plus mono-
phyle  c lineages independently es  mated using ORF5 codon alignments (B) and of Ortho-II viruses es  mated using 
nucleo  de alignments of the ORF2-ORF5 overlapping genomic region (C). The lineages are indicated by color. The 
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Supplementary Figure S5. Virus sampling in rela  on to monoSPAT. The number of ORF5-plus and ORF5-less viruses 











Supplementary Figure S6. Ranking test. Shown are diff erences of mean SPAT ra  os between groups for all possible 
14-16 par   onings of the 30 viruses with monoSPAT values in the range of 0-0.35. These are 145,422,675 combi-
na  ons in total. Values for the Ortho-I/non-Ortho-I and for the ORF5-plus/ORF5-less par   onings are indicated by 
arrows and insets.
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Supplementary Figure S7. Enrichment of Proline residues near the COCO-VA site in ORF5-less (A) and ORF5-plus 
(B) viruses. Shown is the number and loca  on of Proline residues along the translated puta  ve MT polypep  de se-
quence of the mammalian polyomaviruses analyzed in this study. The green and red bars indicate the COCO-VA site 
and termina  on codons, respec  vely. The dashed line indicates the ORF1-ORF5 splice junc  on. ORF5-plus viruses 
show an enrichment of Proline residues at the ORF5-encoded part of MT, which is a characteris  c of intrinsically 
disordered protein regions.
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Supplementary Figure S8. The COCO-VA site is embedded in an intrinsically disordered protein region in ORF5-less 
(A) and ORF5-plus (B) viruses. Shown is the predica  on of protein disorder along the translated puta  ve MT pol-
ypep  de sequence of the mammalian polyomaviruses analyzed in this study. The green and red bars indicate the 
COCO-VA site and termina  on codons, respec  vely. The dashed line indicates the ORF1-ORF5 splice junc  on. Large 
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Supplementary Figure S9. Protein secondary structure and COCO-VA site in ORF5-less (A) and ORF5-plus (B) virus-
es. Consensus of two protein secondary structure predictors is shown along the translated puta  ve MT polypep  de 
sequence of the mammalian polyomaviruses. Red and green bars indicate termina  on codons and COCO-VA site, 
respec  vely, and dashed lines suggest the puta  ve ORF1-ORF5 splice junc  on. On top, a color-coded scoring table 
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Trichodysplasia spinulosa-associated polyomavirus (TSPyV) causes a rare disease in im-
munocompromised individuals, TS, while infec  ng up to 70% of the human popula  on. To 
gain insight into the evolu  on of TSPyV, we have analyzed thirteen mostly newly sequen-
ced TSPyV genomes represen  ng ~40% of reported TS cases world-wide. In TSPyV, genome 
varia  on was limited (≤0.6%) and accumulated along three phylogene  c lineages, whose 
topology correlated poorly with host age and residence, and the elapsed  me since sample 
collec  on. Consequently, the rate and recent  meframe of the TSPyV evolu  on were es  -
mated with large uncertainty. The observed subs  tu  ons were dispropor  onally frequent 
in the non-coding control region, with a substan  al frac  on being observed in networks of 
co-evolving sites across all major genome regions. In the coding region, non-synonymous 
subs  tu  ons (NSS) were only present in the open reading frames (ORFs) encoding small T 
(ST) and middle T (MT) an  gens. They included ORF1 (one NSS) and the newly iden  fi ed 
ORF5 (three NSS), which were under posi  ve selec  on. One NSS fi xed most early in TSPyV 
evolu  on involves a Val/Ala codon in a short linear mo  f of an intrinsically disordered, Proli-
ne-rich domain of MT-an  gen. In Chapter 5, we iden  fi ed this codon to be under strong po-
si  ve selec  on in ORF5-encoding polyomaviruses and named its varia  on Codon-Constrain-
ed Val-Ala (COCO-VA) toggling. Thus the combined results of this and Chapter 5 show that 
the COCO-VA toggling within MT-an  gen may drive both intra- and inter-host adapta  on of 
a large, monophyle  c group of polyomaviruses that includes TSPyV.
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The fast growing Polyomaviridae family includes viruses infec  ng diverse vertebrate species [1 - 3]. Humans are commonly infected with polyomaviruses at young age a  er which a persistent, latent infec  on sets in before virus reac  vates, typical-ly when the immune system is compromised [4]. Polyomaviruses use small circu-
lar double stranded DNA genomes with two non-overlapping protein-coding regions that 
are expressed either early or late in infec  on [5, 6]. Each region includes two ubiquitous 
open reading frames (ORFs), ORF1-ORF2, and ORF3-ORF4, respec  vely, that are expressed 
through alterna  ve splicing to produce the early small and large T an  gens (ST and LT) [5] 
and the late capsid proteins (VP1 and VP2/VP3), respec  vely [7]. Further details regarding 
polyomavirus ORFs and their expression can be found in Chapter 5 [8].
 As pointed out in Chapter 5 [8], mouse (MPyV) and hamster (HaPyV) polyomavi-
ruses encode an extra ORF, called ORF5, that largely overlaps with the 5’-end of ORF2. It 
is merged with the ORF1 in a spliced transcript that directs the synthesis of middle T (MT) 
an  gen [9 - 12]. The ORF5-encoded part of MT-an  gen is enriched with Proline residues [13, 
14] and includes a C-terminal transmembrane domain [10] that is essen  al for the oncogen-
ic func  on of MT-an  gen [11]. This func  on and interac  on of MT-an  gen with diff erent 
cellular proteins may be modulated by phosphoryla  on at several Serine, Threonine and 
Tyrosine residues in MPyV [12]. The ORF5 (named also ALTO, [15]) was recently iden  fi ed 
to be conserved within a monophyle  c cluster of mammalian polyomaviruses that includes 
the Merkel cell (MCPyV) and trichodysplasia spinulosa-associated polyomaviruses (TSPyV) 
[8]. This large cluster comprises most of the Orthopolyomavirus genogroup I [16].
 The human polyomavirus genome could diverge by as much as 5.3% upon virus 
circula  on in a host popula  on, as was shown for Malawi polyomavirus (MWPyV) [17], 
and 0.55% within an individual, as was shown for BK polyomavirus (BKPyV) [18], with mu-
ta  ons preferen  ally accumula  ng in the NCCR [19, 20]. Depending on the method and 
dataset used, es  mated evolu  onary rates of human polyomaviruses varied broadly from 
10-5 to 10-8 subs  tu  ons/site/year. The slow rate es  mates were originally obtained under 
the model of virus-host codivergence [21, 22]. On the other hand, applica  on of Bayesian 
approach to this problem using  me-structured data favors high evolu  onary rates [18, 22, 
23].
 Among the recently discovered human polyomaviruses, TSPyV is associated with a 
rare skin disease, TS, exclusively seen in severely immunocompromized pa  ents (Chapters 2 
and 3) [24 - 32]. E  ologic involvement of TSPyV in TS is evident from high viral load, an  gen 
expression and cell cycle deregula  on in aff ected skin (Chapters 3 and 4) [30]. TSPyV is glob-
ally circula  ng with seroprevalences of approximately 70% in the general adult popula  on, 
as demonstrated in Europe [33, 34] and Australia [35]. In asymptoma  c individuals, healthy 
and immunocompromised, TSPyV DNA is seldom detected [30, 31, 36].
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 Based on phylogene  c analysis of the conserved parts of VP1, VP2 and LT-an  gen, 
TSPyV as well as MPyV, HaPV, and MCPyV belong to the large Orthopolyomavirus-I (Ortho-I) 
genogroup [1, 16]. Most other studied mammalian polyomaviruses, including BKPyV and JC 
polyomavirus (JCPyV) [37] and Simian virus 40 (SV40), belong to the Orthopolyomavirus-II 
(Ortho-II) genogroup, while majority of recently iden  fi ed human polyomaviruses [36, 38 
- 47] belong to either the Malawipolyomavirus (Malawi) or the Wukipolyomavirus (Wuki) 
genogroups (Chapter 1) [1, 16].
 In this chapter, we describe evolu  onary analysis of 13 TSPyV genomes, most new-
ly sequenced and represen  ng ~40% of the reported TS cases world-wide. We demonstrate 
that the newly iden  fi ed ORF5 [8, 15] is the major site of adap  ve non-synonymous sub-
s  tu  ons during highly constrained evolu  on of TSPyV. The non-synonymous subs  tu  on 
fi xed most early in the TSPyV evolu  on involves codon-constrained Val-Ala (COCO-VA) tog-
gling at the site of posi  ve selec  on in the inter-species evolu  on of the Ortho-I polyo-
maviruses, as explained in Chapter 5 [8]. Thus, the combined results reveal a connec  on 
between micro- and macro-evolu  on of polyomaviruses and establish TSPyV as a virus to 
study this connec  on.
Material and Methods
Samples, DNA extrac  on and PCR amplifi ca  on
As described previously [30], DNA was extracted from ten TS samples in our laboratory, and 
extracted DNA was received from three TS samples. An overview of all TSPyV isolates ana-
lyzed in this study and their whereabouts is given in Table 1. The DNA isolates were ampli-
fi ed by PCR with the help of 18 TSPyV-specifi c primer-pairs (Supplementary Table S1). This 
resulted in genera  on of eighteen overlapping TSPyV DNA fragments of 266-613 base-pairs 
in length that cover the whole TSPyV genome (Supplementary Figure S1A). Ten nanogram 
input DNA was used in a total volume of 50 μl containing 15 pmol/μl of each primer, 2.5 
U of Pfu DNA polymerase, 10x Pfu buff er and 15 mM of dNTP’s. A 3-step PCR amplifi ca-
 on was performed; star  ng with 5 minutes at 95°C, followed by 30 cycles of 1 minute at 
95°C, 1 minute at 56°C and 2 minutes at 72°C, and fi nalized with 10 minutes at 72°C. Subse-
quently, one unit of GoTaq DNA polymerase was added to the PCR reac  on, to generate an 
adenine-base overhang for the subsequent TOPO(TA)-cloning (Invitrogen, California, USA), 
and the reac  on was incubated for an addi  onal 10 minutes at 72°C. PCR products were 
assessed for length by gel-electrophoresis (Supplementary Figure S1B) and cloned directly. 
In case of mul  ple, poten  ally nonspecifi c products detected on gel, bands of the expected 
length were isolated from gel using the QIAEX II gel extrac  on kit (QIAGEN, California, USA) 
and then cloned into TOPO(TA) vector. The amplicons generated from samples TSPyV-1211, 
1312 and 1412 were purifi ed with GeneJET PCR Purifi ca  on Kit (Fermentas) and subse-
quently sequenced directly in both direc  ons.
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Cloning, sequencing and SNP analysis
TOPO-cloned plasmid DNA was isolated from at least three independently grown cultures 
and sequenced using the BigDye Terminator v1.1 cycle sequencing kit (Applied Biosystems, 
California, USA) in the ABI Prism 3130 Gene  c analyzer, according to the manufacturer’s 
instruc  ons. M13-forward or M13-reverse primers were used to amplify the fl anking TSPyV 
sequences inserted into the pCRII-TOPO vector. Obtained sequences were assembled into 
one con  g with CLC Main Workbench 6 (CLC Bio; Aarhus, Denmark). All generated com-
plete con  gs, including the sequence of TSPyV-0109 (NC_014361) (also serving as the refer-
ence TSPyV genome) [25] and TSPyV-WK164 (JQ723730 ) [17], were aligned using CLC Main 
Workbench 6 (CLC Bio; Aarhus, Denmark) and SNPs were analyzed. All viral sequences ob-
tained in this study were deposited into GenBank and the corresponding assigned accession 
numbers are documented in Table 1.
Splice-donor and splice-acceptor site predic  on
Puta  ve donor-acceptor splice sites were calculated under default se   ngs using the web-
based Human Splice Finder program (h  p://www.umd.be/HSF) [52]. Sites were searched in 
the ~120 nt sequence separa  ng ORF1 and ORF5. The experimentally iden  fi ed donor-ac-
ceptor sites for the MT mRNAs of HaPyV (NC_001663) (HSF scores: donor, 76% and acceptor, 
92%) and MPyV (NC_001515) (HSF scores: donor, 89% and acceptor, 86%) were predicted by 
Table 1. Overview of all TSPyV genomes analyzed in this study
   -  
 
 Reference 
TSPyV-0109 NLD3, ‘s Hertogenbosch (N-Brabant) FRFR3 7.2x104 NC_014361 [25] 
TSPyV-0203 AUS, Nedlands (Western Australia) FFPE 7.6x105 KF444091 [48] 
TSPyV-0304 USA, New York (New York) FFPE 4.5x106 KF444092 [49] 
TSPyV-0409 USA, Cleveland (Ohio) FFPE 1.2x105 KF444093 [30] 
TSPyV-0510 USA, Cleveland (Ohio) FFPE 4.4x106 KF444094 [30] 
TSPyV-0602 USA, Birmingham (Alabama) FFPE 6.3x104 KF444095 [30] 
TSPyV-0797 USA, Birmingham (Alabama) FFPE 7.8x101 - 4 [50]  
TSPyV-0807 CAN, Toronto (Ontario) FFPE 5.1x104 - 4 [29] 
TSPyV-0910 USA, Dallas (Texas) FFPE 1.4x106 KF444096 [26] 
TSPyV-1008 USA, Charleston (South Carolina) FFPE 5.6x105 KF444097 [51] 
TSPyV-1197 USA, Sea le (Washington) FFPE 1.7x106 KF444098 [24] 
TSPyV-1211 NLD, Ro erdam (Zuid-Holland) FFPE 2.8x104 KF444099 This study 
TSPyV-1312 USA, Dallas (Texas) FFPE 2.1x104 KF444100 This study 
TSPyV-1412 AUS, Melbourne (Victoria) FRFR 9.4x104 KF444101 This study 
TSPyV-WK164 USA, St. Louis (Missouri) - 2.4x104 JQ723730 [17] 
Sample TSPyV GenBank
treatment DNA load2 Ref. Seq.
Name 
isolate Case origin1
1 The fi rst two digits correspond to the trichodysplasia spinulosa (TS) sample number used to describe the TS pa-
 ents in Kazem et al. [30]. The last two digits indicate the year of sampling ranging from 1997 (xx97) to 2012 (xx12). 
TSPyV-WK164 was isolated in 2009 [17]. 
2 TSPyV-load is shown in virus copies/cell, as was calculated and reported previously [25, 30]. For TSPyV-WK164 the 
virus copies was calculated per mL [17]. 
3 Abbrevia  ons: NLD, The Netherlands, AUS, Australia; USA, United States of America; CAN, Canada; FRFR, fresh 
frozen; FFPE, formalin-fi xed paraffi  n embedded




this program as best in-frame sites. For TSPyV (NC_014361), only one in-frame donor-accep-
tor coordinate was observed (HSF scores: donor, 93% and acceptor, 74%). Illustra  on of the 
ORF1 and ORF5 splicing was generated with Adobe Illustrator CS5 so  ware (Supplementary 
Figure S2).
Visualiza  on of ORF organiza  on, transcriptome and gene  c varia  on in 
TSPyV
To facilitate analyses described in this chapter and communica  on of the obtained results, 
we have developed and used a new format for the presenta  on of genomic-based data. The 
currently used formats focus on presen  ng transcripts and diff er primarily in choice of the 
direc  on for the early and late transcripts, either of which can be used as running clock- or 
counter clockwise. On the other hand, presenta  on of ORFs (genomic organiza  on) is given 
less a  en  on in polyomaviruses. In our format, ORFs and transcripts are presented in sepa-
rate layers (Figure 1) that reveal their complexity and rela  on in detail (see also Chapter 5). 
Par  cularly, ORFs are depicted in three posi  ve (+1, +2, + 3) and three nega  ve (-1, -2, -3) 
RFs that encode late and early transcripts, respec  vely. For the purpose of this study, ORF is 
defi ned as a region of a RF that is fl anked by two stop codons; only a por  on of this may be 
actually expressed. As we show elsewhere in this chapter, these details are crucial for un-
derstanding of the biology of TSPyV and other polyomaviruses, par  cularly when combined 
with gene  c varia  on that is presented in another layer separa  ng those for genome and 
transcriptome (Figure 1).
Evolu  onary analyses of TSPyV genomes
Genomes of 13 TSPyV and other polyomaviruses available at the Genbank/RefSeq data-
base on February 2013 were downloaded into the Viralis pla  orm [53]. The Muscle program 
[54] was used to generate family-wide mul  ple amino-acid alignments for VP1, VP2 and LT, 
followed by manual cura  on [8]. The alignment of TSPyV isolates and the closely related 
Bornean orang-utan polyomavirus (OraPyV1) was extended genome-wide at the nucleo-
 de level. Mul  ple sequence alignments of three datasets were submi  ed to phylogeny 
reconstruc  on and other evolu  onary analyses: (i) a complete genome alignment of the 13 
TSPyVs (DS1), (ii) a complete genome alignment of the 13 TSPyVs and OraPyV1 (DS2), and 
(iii) a concatenated codon alignment that included the fi ve ORFs of the 13 TSPyV genomes 
(DS3).
 Phylogene  c analyses were performed by using a Bayesian approach implemented 
in BEAST version 1.7.4 [55]. For DS2 the dates of virus isola  on were incorporated in the 
analysis in order to es  mate the  me of divergence of ancestral nodes in the tree. The dates 
for TSPyV isolates are shown in Table 1; the OraPyV1 isolate originates from 1996 (Ernst 
Verschoor, personal communica  on). The HKY nucleo  de subs  tu  on model [56] (DS1 and 
DS2) was used; for each dataset, rate heterogeneity among sites was modeled using a gam-
ma distribu  on with four categories, and a relaxed molecular-clock approach was tested 
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against the strict molecular-clock approach [57]. The la  er was favored for DS1 [58], where-
as the relaxed molecular-clock approach was superior for DS2. MCMC chains were run for 
20 million steps (DS1 and DS2) and the fi rst 10% were discarded as burn-in. Convergence 
of the runs was verifi ed and parameter es  mates, including evolu  onary rate and tMRCA 
es  mates, were obtained using Tracer [59].
 For calcula  on of evolu  onary rates and tMRCA,  me of virus isola  on from pa-
 ent is used to  me-calibrate changes in genome sequences. The involved analyses saliently 
Figure 1. Genome organiza  on and varia  on, and puta  ve transcriptome of TSPyV. This fi gure has three circular 
layers, inner, intermediate, and outer, respec  vely, as detailed in the key inset at top right. The inner layer depicts 
the six reading frames of the TSPyV genome, frame +1 starts at the fi rst nucleo  de of the linearized genome 
clock-wise and frame -1 at the last nucleo  de in reverse direc  on; the fi ve largest ORFs and other ORFs of at least 
100nts in length are indicated by colors and in gray, respec  vely. The intermediate layer depicts SNPs as circles of 
three shades: gray, SNPs in non-coding regions, NCCR and IR; white, synonymous subs  tu  ons; colored (according 
to the respec  ve ORF), non-synonymous subs  tu  ons. Note the duality of the subs  tu  ons in the ORF2/ORF5 
overlapping region that were colored accordingly. Dele  ons in the NCCR are shown as range symbols. The outer 
layer depicts predicted spliced transcripts; their coding parts are colored according to the respec  ve ORFs, while 



















    
    
    
     
      








    
    
    
     
     













assume that the  me of virus collec  on is very close to the  me of the virus infec  on. That 
link does exist for acute infec  ons, but it may be broken for latent infec  ons in which a virus 
may stay in a pa  ent without replica  ng genome and accep  ng muta  ons for prolonged 
 me (years), possibly since the ini  al infec  on. Polyomaviruses are known to go into latent 
infec  on and TSPyV is not likely to be an excep  on. Consequently, dates of the TSPyV iso-
la  on from pa  ents may misinform  me-dependent evolu  onary analyses. To address this 
complica  on we used DS1 to (re-)es  mate the date of pa  ent primary infec  on for each of 
the 13 TSPyVs and compare it to the respec  ve date of virus isola  on. We treated the dates 
of the pa  ent birth and the virus isola  on as the possible lower and upper limits, respec-
 vely, of the date of the original infec  on for this pa  ent. When the age informa  on was 
not available at the  me of analyses (one pa  ent: TSPyV-1412), we set the pa  ent’s age to 
100 years. These ranges (one for each of the 13 TSPyVs) were used to defi ne uniform priors 
for the dates of the  ps in the TSPyV phylogeny and to subsequently es  mate the posterior 
distribu  on of these dates using BEAST as described above.
 Sites under posi  ve and nega  ve selec  on were iden  fi ed using the Datamonkey 
webserver [60]. The SLAC, FEL, IFEL, REL, MEME, and FUBAR methods were applied under 
default parameters on DS3. These methods implement diff erent approaches for the detec-
 on of posi  ve and nega  ve selec  on, as well as episodic selec  on. For a detailed discus-
sion on the diff erent approaches see publica  ons [60 - 63]. Coevolu  on of genomic posi-
 ons was assessed by using the Spidermonkey method [64] at the Datamonkey webserver 
using DS1.
Phylogene  c associa  on of amino-acid varia  ons and place of TSPyV origin
We used the BaTS tool [65] to test whether there is any associa  on of the observed ami-
no-acid varia  on at a par  cular site with lineages in the underlying phylogeny. To do so, we 
treated the amino acids observed at a par  cular site as the varying trait. Briefl y, BaTS com-
pares the observed distribu  on of the trait values (amino acid residues in this case) among 
the lineages in the phylogeny against the null hypothesis of randomly distributed trait values 
using the following three test sta  s  cs: parsimony score (PS) [66], associa  on index (AI) 
[67], and maximum monophyle  c clade size (MC) [65]. We also used this BaTS-based ap-
proach to analyze the associa  on of the country of residence and gender of pa  ents with 
lineages in the tree.
Bioinforma  cs analyses of the puta  ve ST and MT an  gens
Sequence logos were compiled using the WebLogo server [68, 69]. Mul  ple sequence align-
ment of ST an  gen was generated with the CLC Main Workbench (CLC Bio v6.6; Aarhus, 
Denmark) using the programs default op  ons. Secondary structure, transmembrane helix, 
and disorder predic  on of MT protein sequences were generated using the Disorder Predic-
 on MetaServer [70], which reports consensus results of the following eight predictors: DIS-
EMBL [71], DISOPRED [72], DISpro [73], FoldIndex [74], GlobPlot2 [75], IUPred [76], RONN 
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[77], and VSL2 [78]. The predic  on of disorder was considered signifi cant if at least four 
predictors gave a hit. Amino acid composi  on and other sequence features of MT and LT 
proteins were analyzed and plo  ed using custom R scripts [58, 79].
Accession numbers
Accession numbers of virus genomes u  lized in the study are shown in Table 1.
Results
TSPyV diverged by subs  tu  on across the en  re genome and dele  on in 
NCCR
To gain insight into the role of diff erent genome regions in polyomavirus adapta  on, we se-
quenced and analyzed genomes of a representa  ve set of TSPyV. The viral genomic DNA se-
quences were obtained from thirteen lesional samples, which were collected over 16 years 
from largely previously described TS pa  ents residing in the Northern America, the Neth-
erlands, and Australia (Table 1). Sample DNA was subjected to 18 diff erent TSPyV-specifi c 
PCR reac  ons which created amplicons that covered the en  re TSPyV genome. The target 
sequences were amplifi ed and the products visualized on gel (Supplementary Figure S1). 
Subsequent cloning, sequencing and assembling of the amplicons of every isolate resulted 
Figure 2. Cumula  ve number of single nucleo  de subs  tu  ons in TSPyV pairs. For brevity, the “TSPyV” label was 
omi  ed from the virus names (see Table1). Dele  ons were excluded upon the distance calcula  on. Due to diagonal 
symmetry, distances in the lower triangle of matrix are not shown. Intra-lineage values for the three TSPyV lineages 
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in eleven complete circular con  gs, each represen  ng a TSPyV genome. These genomes, 
together with the previously reported TSPyV-WK164 [17] and TSPyV-0109 [25] formed da-
taset 1 (DS1, see M&M). Analysis of these genomes revealed 30 single (di)nucleo  de pol-
ymorphism (SNP) sites across the en  re 5232 nts genome (<0.6% varia  on). Furthermore, 
genomes of TSPyV-0602 and TSPyV-1312 are 39 and 54 nts, respec  vely, shorter than ge-
nomes of the other viruses; they are therea  er indicated as dele  ons. The total number 
of subs  tu  ons separa  ng TSPyVs was small, in the range from zero to twenty in diff erent 
pairs (Figure 2). 
 All SNPs and dele  ons were mapped on the TSPyV circular genome whose open 
reading frame (ORF) organiza  on has been updated to include fi ve ORFs (ORF1-ORF5) (Fig-
ure 1, internal and intermediate circles), see also Chapter 5 for addi  onal detail [8]. Com-
pared to the genome organiza  on established in our prior analysis [25], it includes a pre-
viously non-recognized, fi  h large ORF with a length of 450nts in the early genome region 
immediately downstream of and in-frame (-1 RF) with the ORF1 (Figure 1, inner circle). This 
ORF5 overlaps ~90% with the 5’-terminal part of the LT-specifi c ORF2 located in the -3 RF 
(Figure 1). The sixth largest ORF (next a  er ORF5) consists of ~300nts. 
 Like with other human polyomaviruses (e.g., JCPyV and BKPyV) [19, 20]), a dispro-
por  onally large frac  on of the SNPs (7 of 30; ~23%) was located in the NCCR that com-
prises only ~12% of the genome (603 of 5232 nts). Three of these SNPs are also part of the 
non-overlapping dele  ons found in TSPyV-0602 (two SNPs) and TSPyV-1312 (one SNP). The 
iden  fi ed SNPs and dele  ons are located outside of counterparts of the known essen  al 
func  onal signals, such as the pentanucleo  de enhancer elements GAGGC and reversed 
GCCTC (Supplementary Figure S3). The other non-coding region, the intergenic region (IR) 
of ~100nts around genomic posi  on 2500 separa  ng the 3’-termini of the early and late 
transcripts, contained one SNP (Figures 1 and 3A). Nine SNPs were iden  fi ed in the late 
genomic region of 2,032 bp: seven in ORF4 and two in ORF3, respec  vely. Further twelve 
SNPs were found in the early genomic region of 2,507 bp: one in ORF1, three in the overlap 
between ORF2 and ORF5, and eight in the unique part of ORF2. All these varia  ons are ex-
pected to be expressed from one or more transcripts. All twenty SNPs in LT ORF2 and in the 
VP ORFs represented synonymous subs  tu  ons. The three SNPs in the ORF2/ORF5 overlap 
were synonymous for the LT ORF2 but non-synonymous for the MT ORF5. The one SNP in 
the ST/MT-specifi c part of ORF1 was also non-synonymous (Figures 1 and 3B).
The  meframe and rate of evolu  on of TSPyV are es  mated with high un-
certainty
Using a Bayesian approach, we found that TSPyV clustered into three monophyle  c lineages 
(TSI, TSII, and TSIII) with high probability support values of 0.9 or higher, with TSPyV-1312 
being the sole representa  ve of TSIII (Figure 4A). No signifi cant associa  on between loca-
 on (country) and phylogene  c lineage was observed (Table 2). We also noted considerable 
overlap between the  meframes of sample collec  on for viruses that comprise the best 
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Figure 3. Nucleo  de and amino acid varia  on in TSPyV. (A) Alignment of SNPs and dele  ons in TSPyV genomes. 
Top, SNP genome loca  on, its respec  ve region and consensus nucleo  de. Bo  om, nucleo  de varia  on in TSPyV 
isolates: dots, nucleo  des iden  cal to the consensus; triangles, mul   nucleo  de dele  ons of 54nts (120-173; 
TSPyV-0602) and 39nts (61-99; TSPyV-1312). Gray shaded part, SNPs resul  ng in aa varia  ons. (B) Amino acid 
varia  ons in TSPyV. Top, SNPs gray-shaded in panel A are shown with fl anking dinucleo  des along with the aff ected 
ORF-specifi c codons. Bo  om, the SNP-containing codons are translated according to respec  ve ORF and colored 




































































































































































































































































































































sampled TSI and TSII lineages, from 2002 to 2011 vs. from 1997 to 2012, respec  vely, indic-
a  ve of co-circula  on of the two lineages.
 To es  mate the  me of divergence of the most recent common ancestor (tMRCA) 
of TSPyV, the 13 TSPyV variants were analyzed together with their closest rela  ve, OraPyV1, 
which was isolated in 1996 [80], in dataset 2 (DS2, see M&M). This analysis resulted in a 
rooted tree with three dis  nct TSPyV lineages (TSI, TSII, and TSIII) (Figure 4B), similar to the 
topology of the DS1-based tree (Figure 4A). The tMRCA of TSPyV and OraPyV1 was es  mat-
ed to be in the range of 538-38890 years (95% confi dence interval, 95% CI) with a median of 
about 4288 years before present (ybp) with respect to the latest TSPyV genome sampled in 
2012. Divergence of TSI, TSII, and TSIII from their common ancestor was es  mated to have 
occurred in the 95% CI period of 26-2356 ybp (median: 236 ybp). Subsequently, the TSI and 
TSII lineages separated from each other in the 95% CI period of 22-1317 ybp (median: 147 
ybp), while members of the TSI and TSII lineage shared a MRCA in the 95% CI periods of 11-
644 and 16-531 ybp, respec  vely, (median: 72 and 64 ybp, respec  vely). Using the  mes of 
isola  on of the 13 TSPyVs, we es  mated the evolu  onary rate of TSPyV to be in the 95% CI 
range of 1.2x10-7 - 2.0x10-5 subs/site/year (median: 9.2x10-6 subs/site/year).
 Our es  mates of the tMRCA and evolu  onary rate are associated with ~2 orders 
of magnitude confi dence intervals. One possible source of this large uncertainty is that the 
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Figure 4. Phylogeny and evolu  on of TSPyV. (A) TSPyV phylogeny. Depicted is the pseudo-rooted tree based on 
the complete TSPyV genome sequences, with three groups highlighted. The country of pa  ent residence and four 
variable aa residues in MT and ST/MT are shown next to the virus names (colored according to Figure 3B). Traits 
that are signifi cantly associated (α≤0.05; Table 2) with lineages in the tree are indicated by asterisks (top). The 
scale bar, the average number of subs  tu  ons per site. Probability support values for internal nodes smaller than 
1 are shown. (B) TSPyV evolu  on. Presented is the rooted tree; tree branches represent  me (years), which were 
es  mated using the sampling dates of the TS materials (Table 1) and that of OraPyV1 (1996). Numbers to the le   
of (some) branching events represent es  mated median  me to the most recent common ancestor (tMRCA) of the 
respec  ve ancestors, with confi dence intervals (95% highest posterior density) depicted in parentheses. The scale 



























































































dates of sample collec  on at  me of symptoma  c viral (re)ac  va  on may deviate consider-
ably from the dates when the pa  ent was primarily infected with the polyomavirus. Using 
BEAST, we es  mated the dates of the pa  ent infec  on for each TSPyV isolate (see M&M for 
details; Supplementary Figure S4). In most cases, the obtained es  mates remained associ-
ated with large confi dence intervals that o  en spanned the full range of possible dates. On 
the other hand, median numbers deviated considerably from the collec  on dates and for 
some isolates (see for example TSPyV-1211 and 1312; Supplementary Figure S4) this inter-
val did not include the date of sample collec  on. Collec  vely, these data support the no  on 
that the date of sample collec  on deviates from the date of primary infec  on.
Non-synonymous SNPs in MT ORF5 are strongly associated with three phy-
logene  c clusters of TSPyV and co-evolve with SNPs in other regions
Next, we asked whether amino acid subs  tu  ons at the four posi  ons in the TSPyV vari-
ants (Figure 3B) are the result of adap  ve evolu  on of the virus to humans. Posi  ve selec-
 on was favored by analyses using random eff ect likelihood method (REL, p=0.99) and fast 
unconstrained Bayesian approxima  on method (FUBAR, p=0.95) [60 - 62] for the G4638A 
varia  on in ORF1 that results in the H133Y subs  tu  on in the common ST/MT domain. How-
6
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ever, the gene  c diversity and the size of our dataset may be too small to assess selec  on 
accurately at all sites using these methods [63]. Therefore, we used three sta  s  cal tests 
(see M&M) to es  mate the associa  on between a trait (the amino acid varia  ons in this 
case) and the phylogeny. We reasoned that sta  s  cally signifi cant associa  on would be in-
dica  ve for the analyzed sites being constrained in a lineage-specifi c fashion (selected) [81]. 
Before conduc  ng these analyses, the three TSPyV lineages were reproduced with a modi-
fi ed DS1 that did not include the SNPs with non-synonymous subs  tu  ons (data not shown). 
This observa  on implied that the observed lineages are independent from the MT codons 
encoding the I242T, A245V and H280R varia  on. Consequently, the tree (Figure 4A) could 
be used in the associa  on test.
 All three amino acid varia  ons in the ORF5 (but not that of ORF1) were found to be 
signifi cantly associated (p≤ 0.002) with the three major phylogene  c lineages of TSPyV (Fig-
ure 4A): two varia  ons by the three test sta  s  cs and one varia  on by two sta  s  cs (Table 
2). Given this strong associa  on, we then asked whether the non-synonymous ORF5 SNPs 
coevolve with other SNPs. To this end, we tested all pairs of the 30 SNPs (435 pairs in total) 
for coevolu  on using a Bayesian evolu  onary framework as implemented in the Spider-
monkey tool [60, 64]. Strikingly, T4145C (H280R) and A4259G (I242T) were among two out 
of the three networks (Figure 5A) that were supported with the top 2.7% of the posterior 
probabili  es values for network edges (Figure 5B). For T4145C, the coevolving synonymous 
SNP T1409C is located in the VP1 ORF4. For T4259G, three coevolving SNPs (G99A, G161A, 
and G230C) are located in the NCCR and one (synonymous A3131G) in the LT ORF2. Accord-
Table 2. Support values for phylogene  c associa  ons of amino acid varia  ons observed 
among the 13 TSPyV isolates.
1 Country of origin: the home country of the pa  ent; observed amino acid varia  ons: The respec  ve amino acids 
are shown, separated by a dash; nega  ve control: To each  p of the phylogeny one of two arbitrary amino acids 
was assigned randomly. The average p-value among 10 itera  ons is shown; posi  ve control: Each of the three 
TSPyV lineages was assigned a diff erent amino acid, and each member of the same lineage was assigned the same 
amino acid.
2 Coordinate of the SNP causing the amino acid varia  on in the genome of TSPyV-0109.
3 P-values of the null hypothesis (random associa  on of the amino acid varia  on with the phylogeny) are shown for 
the following test sta  s  cs: associa  on index (AI), parsimony score (PS), maximum monophyle  c clade size (MC). 
For MC, the minimum value over the MC values of the single amino acid states is shown. Signifi cant values under 
the confi dence level of α=0.05 are in bold.
    
Varia on1 Genomic pos on2 
A ed 
ranscrip  AI PS MC 
USA-NLD-AUS / / 0.143 1 0.121 
      
      
H-Y 4638 ST, MT 0.124 0.072 0.051 
I-T 4259 MT 0 0.001 0.002 
A-V 4250 MT 0 1 0.001 
H-R 4145 MT 0 0 0.001 
      
Nega ve control / / 0.503 0.642 0.383 
Posi ve control / / 0 0 0.001 
Suppor  by cri rion3
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ing to parsimonious reasoning, amino acid changes at the three posi  ons in the ORF5 (and 
the coevolving nucleo  des outside ORF5) were most likely fi xed in the MRCA of TSI (R280H), 
TSII (I242T), and either TSI/TSII (A245V) or TSIII (V245A). It is noteworthy that the ancestral 
and the newly acquired amino acids (nucleo  des) persisted in all characterized variants of 
the respec  ve two lineages, TSI and TSII, for which more than one sequence was available 
(Figures 3 and 4A). The third network involves the NCCR G158A and the IR A2459T (Figure 
5A) that is observed only in TSPyV-0109 (Figures 3A and 4A) sugges  ve of a recent fi xa  on. 
These results reveal highly constrained evolu  on of the TSPyV variants indica  ve of strong 
selec  on.
Gene  c constraints on the non-synonymous subs  tu  ons in ST and MT an-
 gens of TSPyV
Next we analyzed the nature of these constraints. The ORF1-encoded H133Y varia  on is 
observed at the most variable posi  on of the highly conserved region in polyomaviruses, in 
which it is located between the two CXCXXC Zinc-fi nger mo  fs and adjacent to the invariant 
His residue (Supplementary Figure S5). Thus, the 133 posi  on is constrained diff erently and 
less compared to other neighboring posi  ons. 
Figure 5. The genome-wide networks of coevolving nucleo  des. (A) The 12 top scoring pairs (top 2.7%; see panel B) 
form three networks involving diff erent types of SNPs (nodes) defi ned by color in Figure 1 and numbered according 
to Figure 3A. Each edge is provided with its support value. (B) Distribu  on of the marginal posterior probability of 
network edges. The histogram depicts the normalized distribu  on of probability values for 435 pairs formed by the 
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 The ORF5-encoded H280R varia  on is located in the most divergent region of TSPyV 
and its two most closely related viruses, OraPyV1 and AtPPyV1 (Supplementary Figure S6). 
In contrast, the I242T varia  on is adjacent to the A245V varia  on within the ORF5m2, one 
of the four most conserved mo  fs of ORF5 (from ORF5m1 to ORF5m4) (Chapter 5) [8]. The 
evolu  on of this mo  f is highly constrained by the LT LXCXE mo  f in the overlapping ORF2. 
Par  cularly, the A245V varia  on represents the full spectrum of residue varia  on possible 
at this posi  on, which was iden  fi ed under posi  ve selec  on in the inter-species evolu  on 
of ORF5-encoding polyomaviruses and was named the COCO-VA toggling [8] (see also “Dis-
cussion”).
Structural context of the non-synonymous subs  tu  ons in ST and MT an-
 gen of TSPyV
Ter  ary structure of the H133Y variants of the TSPyV ST/MT domain was modeled using the 
solved structure of this domain for SV40, but this did not reveal any notable diff erences that 
could be a  ributed to the Tyr/His varia  on (data not shown).
 The amino-acid varia  ons I242T, A245V and H280R were found in the Proline-rich 
and intrinsically disordered region of the MT an  gen (Figure 6). Also, this domain contains a 
large number of Serine, Threonine and Tyrosine residues par  ally conserved in TSPyV, Ora-
PyV1 and AtPPyV1 (Supplementary Figure S6), which could be targets for regulatory phos-
phoryla  on as was demonstrated for MPyV [12]. Because of this characteris  c sequence 
context and a rela  vely high local sequence conserva  on of ORF5m2, the la  er may be re-
garded as a short linear mo  f (SLiM) [82]. Consequently, the I242T and A245V subs  tu  ons 
could aff ect MT an  gen through the ORF5m2 SLiM (see “Discussion”).
Discussion
In this Chapter, we provide gene  c evidence for strong and mul  -direc  onal selec  on pres-
sure ac  ng at the MT-specifi c ORF5 in TSPyV. Our results implicate MT an  gen in the adap-
ta  on of TSPyV to humans by a new mechanism that includes COCO-VA toggling in a SLiM 
of a disordered protein region [8].
 TSPyV is one of only four polyomaviruses with either established or highly probable 
link to pathology in humans. In total, we have analyzed TSPyV genome sequences from 12 
TS pa  ents that represent ~40% of the reported TS cases worldwide, making this dataset 
highly inclusive for individuals suff ering from TS, despite it being small compared to those 
of other characterized polyomaviruses [23, 83, 84]. We also believe that the obtained re-
sults are relevant beyond this pa  ent cohort. Indeed, another sequence (TSPyV-WK164) 
was reported from a TS-asymptoma  c immunocompromised pa  ent [17] carrying only one 
unique A224T subs  tu  on in the NCCR region, and otherwise diff ering just by two subs  -
tu  ons from TSPyV-0510 (Figures 2 and 3). Furthermore, unless the immunocompromised 
(TS) pa  ents are epidemiologically isolated from the rest of human popula  on known to 
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be up to 70% TSPyV-seroposi  ve [33, 34], immunocompetent individuals must have been 
involved in virus transmission between the surveyed pa  ents. In this respect we note that 
only viruses forming a monophyle  c cluster could be implicated in the direct transmission 
between two pa  ents from whom they were isolated. This transmission is limited by the 
 me-window opportunity, which is defi ned by the smallest diff erence between the  me of 
the sample collec  on from one pa  ent and the date of birth of the other pa  ent. Striking-
ly, this window was just one year for the two pa  ents who resided in diff erent USA states 
and carried monophyle  c TSPyV-0910 and TSPyV-0304, respec  vely (Supplementary Figure 
S4). If other individuals were involved in the transmission, this strict window limit would no 
longer apply. On the other hand, the more people involved in the transmission the more 
likely that the virus must have evolved slowly to fi t the observed small gene  c varia  on, 
which is none (zero) for the above two TSPyV isolates. 
 Although our samples were collected over 16 years, the actual  me-frame of sub-
s  tu  on accumula  on due to polyomavirus biology may be as large as the  me diff erence 
between the years of the most recent sample collec  on (2012) and the birth of the oldest 
pa  ent (1940), which is 72 years (Supplementary Figure S4). The large diff erence between 
Figure 6. Structural context of non-synonymous muta  ons in puta  ve MT of TSPyV. The posi  on of four non-syn-
onymous muta  ons in ORF1 and ORF5 are shown against plots for the MT of TSPyV-0109 (from top to bo  om and 
drawn to scale) predicted secondary structure score ranges: from yellow (low) to red (high) for helix, and from 
green (low) to blue (high) for beta-sheet; transmembrane helices (magenta); intrinsic structural disorder, scores for 
disordered regions were calculated as a consensus over eight predictors; and Pro residue density distribu  on. The 
top three assignments were assisted with the Disorder Predic  on MetaServer. The Pro distribu  on was calculated 
using a three-amino-acid window along the MT sequence of TSPyV. Dashed line, the average number of Pro resi-
dues according to ST, LT, MT, VP1, and VP2 sequences. For more details see M&M and Chapter 5.
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the above two numbers (16 and 72) is likely to be a major source of uncertainty for our es-
 mates of the high evolu  onary rate and the recent tMRCA of TSPyV (~200 years ago) by a 
relaxed molecular-clock framework, which used the dates of sample collec  on. Without the 
assump  on of virus-host codivergence, the dominant evolu  onary model un  l recently [83, 
85, 86], similar es  mates for recent emergence were reported for other human polyomavi-
ruses, including JCPyV [23] and BKPyV [18, 84] of the Orthopolyomavirus II genogroup [16].
 Our es  mates of mean and upper limit values of the evolu  onary rate are rela  vely 
close to those published for JCPyV in a similarly executed study [23]: 9.2x10-6 and 2.0x10-5 
subs/site/year vs. 1.7x10-5 and 3.1x10-5 subs/site/year, respec  vely. A similar median es  -
mate was also reported for BKPyV [84]. However, a diff erence between these viruses for 
the lower limit of the 95% CI for evolu  onary rate was considerable: 1.2x10-7 vs 2.1x10-6 
subs/site/year for TSPyV and JCPyV, respec  vely; in fact, the lower CI limit es  mate approx-
imates the mean evolu  onary rate es  mates for JCPyV and BKPyV calculated under the 
assump  on of virus-host codivergence. The extremely large uncertainty about the obtained 
median values in our study could be due to the small size of the TSPyV dataset. On the oth-
er hand, the especially large diff erence between the low-end CI values of the evolu  onary 
rate for TSPyV and JCPyV may be explained by the low rate of evolu  on of TSPyV. Indeed, 
the scale of genome varia  on in TSPyV isolated from 13 individuals in our study was an 
order of magnitude smaller than those obtained for other polyomaviruses isolated from hu-
man popula  on, while being remarkably close to that in BKPyV isolated from a single adult 
individual [17, 18]. Furthermore, genomes of the two TSPyV pairs, 0910-0304 and 1197-
1412, are iden  cal or diff er by just a single nucleo  de subs  tu  on, respec  vely, while being 
collected from infected pa  ents six and fi  een years apart. Similarly, striking examples of 
extraordinary pairwise similarity could be iden  fi ed for other human polyomaviruses, in-
cluding BKPyV [87], MCPyV [41], WU polyomavirus [88], and KI polyomaviruses [89], which 
were isolated from individuals residing in diff erent countries and/or at diff erent  me points. 
These observa  ons could be explained by very low muta  on rate, prolonged virus latency, 
strong purifying selec  on, or a combina  on of either of these factors [84, 90].
 Reliable es  mates of the background muta  on rate for polyomaviruses are lacking, 
although the host DNA polymerase media  ng polyomavirus genome replica  on is of high 
fi delity. Also unknown is the replica  on rate (genera  on  me) of polyomaviruses during 
natural infec  on that may be primarily determined by the dura  on of virus latency in the in-
fected individual. However, virus latency alone may not explain the observed extraordinary 
similarity between some TSPyV variants. Based on the strong co-evolu  on of many SNPs, 
including two out of four non-synonymous SNPs, we implicate purifying selec  on in the 
evolu  on of TSPyV. 
 We observed very limited amino acid varia  ons in TSPyV. The ones iden  fi ed af-
fected only ORF1 and ORF5, which are known to jointly encode MT an  gen in MPyV and 
HaPyV [9 - 12]. To iden  fy ORF5 in TSPyV, unknown at the start of this study and disserta-
 on, and explore its implica  ons we developed a new format of depic  ng genome-related 
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informa  on of polyomaviruses in a plot that separated genome organiza  on from genome 
expression (Figure 1). Adop  ng this format broadly could facilitate further explora  on of 
polyomaviruses, since even very small ORFs (below the ORF5-size threshold) could be ex-
pressed jointly with other ORF(s) using alterna  ve splicing. Our preliminary experiments 
reveal mRNA and protein expression from ORF5 in primary and immortalized human kera  -
nocytes transfected or transduced with TSPyV early region, as well as ORF5-encoding mRNA 
expression in a TS pa  ent sample (Van der Meijden et al., unpublished results). 
 ORF5 is the predominant place of non-synonymous subs  tu  ons during evolu  on 
of TSPyV as well as of most profound genomic changes that were accumulated during evolu-
 on of polyomaviruses. Despite this excep  onal fast pace, the evolu  on of ORF5 is evidently 
coordinated with that of other regions. We iden  fi ed sets of coevolving sites represent-
ing diff erent regions in TSPyV, as well as the associa  on of ORF5 with the phylogene  cally 
compact majority of Ortho-I polyomavirus cluster that was delineated using other genome 
regions [8]; the la  er result was also reported by Carter and coworkers [15]. This agreement 
at the levels of micro- and macro-evolu  on reveals ORF5 as a major locus media  ng host 
adapta  on and driving specia  on in a large subset of polyomaviruses.
 According to our phylogene  c analysis, the H133Y varia  on in ST and MT of TSPyV 
resulted from recurrent fourth/back muta  on in the ORF1-encoded posi  on producing a 
typical signature of posi  ve selec  on. In contrast, the observed amino acid diversity in ORF5 
of the TSPyV isolates could have been generated with just a single subs  tu  on at the MT 
posi  on 242, 245, and 280 in three respec  ve ancestors. The evolu  onary origin of this 
pa  ern is opened to two interpreta  ons. These replacements could have been fi xed as a 
result of three bo  le-neck events during neutral evolu  on. Alterna  vely, they could have 
been driven by episodic posi  ve selec  on. The la  er scenario is supported by considera-
 ons listed below. First, these subs  tu  ons were accepted in the most prominent interme-
diate ancestors leading to the three major contemporary lineages of TSPyV. Second, they 
are clustered within a small region of 114nts (~2.5% of the genome) rather than sca  ered 
over the genome. Third, they are observed in a single ORF, ORF5, while three major ORFs, 
ORF2-ORF4, remain unaff ected. Fourth, under the model of neutral evolu  on and with the 
constraints by ORF5 codons, the frequency of synonymous subs  tu  on in the ORF2 region 
overlapping with ORF5 is expected to be lower than that in the downstream part of ORF2, 
according to prior research with overlapping genes [91, 92]. However these frequencies 
in the two regions are rather similar in TSPyV: three subs  tu  ons per 450nts of the ORF2/
ORF5 overlap vs. nine subs  tu  ons per 1450nts of the ORF2-only. Fi  h, one of the three 
ORF5 aa varia  ons, A245V, occurred in one of the most constrained posi  on of the ORF2/
ORF5 overlap that encodes the conserved Cys of the LT pRB-interac  ng site and subject to 
posi  ve selec  on in inter-species evolu  on (COCO-VA toggling) [8]. Thus, our data strongly 
suggest that all four non-synonymous replacements observed during the TSPyV evolu  on 
were driven by (episodic) posi  ve selec  on that promoted adapta  on of TSPyV to the hu-
man popula  on. 
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 TSI and TSII viruses, the two most populous lineages of TSPyV according to its phy-
logeny, use the Ala allele at MT245. Thus, the acquisi  on of the Ala allele may have pro-
vided a fi tness gain that facilitated further direc  onal evolu  on elsewhere in the genome 
observed in these lineages. Because of the availability of viruses with each allele, Ala and 
Val, at MT245 and the overall low sequence diversity in the TSPyV isolates, TSPyV off ers a 
unique model to study the molecular basis of the COCO-VA toggling for host adapta  on of 
polyomaviruses in general.
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Supplementary Figure S1. Amplicons used to sequence TSPyV genomes. (A) Loca  on of the eighteen (1 to 18) 
overlapping amplicons that were generated with primer-pairs specifi ed in Supplementary Table S1 and used for 
sequencing of TSPyV genomes. (B) Gel-electrophoresis of amplicons. The amplicons size is indicated, including a 














Supplementary Figure S2. Donor-acceptor splice sites predicted for TSPyV MT mRNA. Shown are predic  on of 
the donor-acceptor splice sites for MPyV, HaPyV and TSPyV using the web-based Human Splice Finder predic  on 
program (see M&M). Splice-donor, GU and AG signals, and splice-acceptor coordinates are depicted in bold. Se-
quences indicated by // are not shown. Reading frames (RF) are shown at the top of the mRNA sequence and the 












 CACAGCGUGUAUAAUCCAA GUAAGUAUCA//CUCCCCCUAG AACGGCGGAGCGAGGAACUG
UACAAUCCGGCCUCAGGUAU GUAUGAAUAU//CUUUUUUCAG GACCCUAAUGCUUCCACCU
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Supplementary Figure S3. SNPs and dele  ons located in the NCCR. Linear projec  on of the TSPyV NCCR posi  ve 
stand from the start-codon of the early T-genes (green arrow, posi  on 5035) un  l the start-codon of the late VP2 
gene (turquoise arrow, posi  on 406). The SNPs are depicted in red. The 54nts dele  on found in TSPyV-0602 and 
the 39nts dele  on found in TSPyV-1312 are red underlined. Highlighted are TSPyV conserved pentamer enhancer 
elements. The puta  ve early and late gene enhancers GCC(T/C)C and G(A/G)GGC are highlighted in green and tur-
quoise, respec  vely. The closed black box depicts the poly(A/T) track where the TATA-box may be located. Down-
stream of the puta  ve ori region (posi  on 5180 -5200) is a perfect 20-nucleo  de true-palindrome (TP) located 
(do  ed black box).
CA T T T T GC T GAA T GCACCAGAAGACAGG T A AGGGGAGAAA T GAAGAAA T GAAGA T GGGAGC T T T T
T GGAGCCC T T T T AAAGCC T C T G T G T GCC T CAA T T AA T T T T CA T CAGA T T T GGC T T ACA T AAAAGGGAGGAAG T GC
CAAGCC T CAAGAGGCC TCCGGAGGCCTCTCC
A
C T C T A T G T C T G T G T CAAGAGGGGGCAGGAAGCC T CAGCC T C C TGG
T AA T AC T GAGAAAAAACAAGA T T T CCA T AG T AACCCCC T A T T AGGAA T T T GAGGAAC T A T AC T T AGAG T G T T GAC
A T AAA T AG AT CA T T G T T T GC T T AAGACCG T T A T CC T GAGGAAGC T CG T GCGCCACC T A T C
G A T T T G T T GT GAAAAA
T GC T G T G T CAG T T AG T C T CA AGGGGA T G T T T G T CA T AC T GCCACAAACACAGGAAGGCAGCCAA CAGACAAGAGG
A G
G
AAGCCAGCCAAA T CCCG T GA T T G T T T T T G T A T A T T C T T AAGA T AGCAC T T G T C T AAC T GC T C T CA T CC T G T CCG T
CCGG T C T CCA T AACA
406
ACACA T CC T CCCGC T C T G T G T T C T CACGCGGCAAA T T CAAA T T C T AA T GG T AAG T T T T T C







Supplementary Figure S4. Dates of sample collec  on and primary TSPyV infec  on. The date of virus isola  on (grey 
dots), the possible range of the date of primary infec  on (grey lines), and the es  mated date of primary infec  on 
(black dot) as well as its confi dence interval (black lines) are shown for each of the 13 TSPyVs.
Year




Observed dates: Estimated dates (BEAST):
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Constrained TSPyV evolu  on in human popula  on
16
5
Supplementary Figure S5. Local sequence conserva  on around the H133Y varia  on in the ST/MT ORF1-encod-
ed domain. Shown is a mul  ple sequence alignment around the TSPyV H133Y varia  on (red arrow) located in 
between two Zink-fi ngers (CXCXXC mo  f) in mammalian polyomaviruses, and its conserva  on profi le. Alignment 
of the upstream highly conserved J-domain (HPDKGG mo  f) is shown for comparison at le  . The selec  on of pol-
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Supplementary Figure S6. Amino acid conserva  on of the ORF5 in TSPyV, OraPyV1 and AtPPyV1. Shown is a mul  -
ple amino-acid alignment of the ORF5 of the three viruses. Genomic coordinates are indicated. Asterisk, conserved 
amino-acids; single and double dots, similar amino-acids; arrowhead, loca  on of the predicted splice donor site; 
gray highlight, Serine, Threonine and Tyrosine residues conserved among the three viruses as possible phospho-
ryla  on sites; green, amino acid residues varying in TSPyV isolates (see Figures 1 and 3); bold, Proline residues. 
Loca  on of the puta  ve transmembrane domain (TM) is indicated.
TSPyV       -KVGK-LQVLCTYINLVFPFSMMFQPRMEEIYLPMGTPPGPAGGKASIKNGTTCLTPCRT 
OraPyV1     VRDGGDTNIVKHVIIVVFPFSMMFQPRTEETYLPMGTPPGPPGGKASIGIGTTSLKTSKT 
AtPPyV1     -NGGRGGKAVSLHLIIAFPFSMMFQAGAQEMYLHMAPESGMHGGQPSTQSGTPCSITLMT 
. *   : :   : :.********.  :* ** *.. .*  **:.*   **..  .  * 
 TSPyV       QISSAMNPPFPLMNLDLQAPLRDPLLNLARRIQEEEELPHQRTPPAAPRAPSLPPPQSQK 
OraPyV1     QTFSVMNPPFPLMNLDLQAPLRAPLHNLARRIQEEEEVR---TPRLAASPPSQQPHQNQR 
AtPPyV1     PTSSAMSPPFPLIHLDQTAQLRPSLEILARRIQESEDLLTLTAARVR----SLQPPPSLK 
*.*.*****::**  * ** .*  *******.*::    :.       *  *  . : _
 TSPyV       NLSMTLSLMIFLICCGLFFLMLSIVIKLYHLF (4437 - 3988)
OraPyV1     NLSMTLSLMIFLMSCGLFFLLLSIVIRLYHLS (4574 - 4128)
AtPPyV1     SLKMIMCLAIFLMVLGASCLVLSIVIRLYLHS (4679 - 4239)
.*.* :.* ***:  *   *:*****:**   ________________________ 
TM
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General aspects of TSPyV infec  on 
Discovery of the trichodysplasia spinulosa-associated polyomavirus (TSPyV) in 2010 paved the way for research focusing on the role of this virus in the pathogenesis of trichodysplasia spinulosa (TS) [1, 2]. When one considers a causal rela  onship be-tween a pathogen and a certain (prolifera  ve) disease, as proposed by Fredericks 
and Relman for instance [3], the prevalence of the puta  ve pathogen is expected to be high-
er in the specifi ed pa  ent group compared to a healthy popula  on (Chapters 2 and 3) [2, 
4], and the pathogen (viral)-load of symptoma  c  ssue is expected to signifi cantly exceed 
that of healthy  ssue (Chapter 3) [4]. Equally important, by ac  on of its encoded proteins, 
the pathogen should possess specifi c pathogenic (transforming) proper  es that render the 
infected cell,  ssue or organ in a state reminiscent of the indicated disease (Chapter 4) [5]. 
In the process, these interac  ng viral proteins responsible for adapta  on in the host may 
mutate (Chapter 6). Some of these muta  ons may be recurrent in the virus family arguing 
for a conserved mechanism of virus adapta  on (Chapters 5).
 In this summarizing chapter, most of these aspects of TSPyV infec  on, including its 
prevalence, localiza  on, latency, and persistence, as well as viral pathogenesis and TSPyV 
host adapta  on and evolu  on will be discussed in the light of available literature to estab-
lish a causa  ve role for TSPyV in the development of TS.
Virus reservoir for latency/persistence
TSPyV is a ubiquitous virus similarly to most other human polyomaviruses (HPyVs) as can 
be concluded from its high seroprevalence (Table 1). In addi  on, the intensity of measured 
TSPyV an  body responses is high [8 - 10]. Apparently, TSPyV infec  on creates suffi  cient viral 
an  gen to promote strong, possibly lifelong, an  body responses, sugges  ng that effi  cient 
TSPyV replica  on takes place at compartment(s) in the body where virus progeny is pro-
duced. Whether replica  on takes place only in the skin, or elsewhere in the body as well, is 
unclear at the moment. The intensity of the measured seroresponses, to some extent com-
parable with BKPyV-seroresponses, might indicate circula  on of TSPyV in blood (viremia).
 In contrast to its high seroprevalence (~75%), the TSPyV DNA prevalence analyzed 
with PCR in skin-derived samples of groups of asymptoma  c (healthy and immunocompr-
omized) individuals is much lower (<5%) (Table 1 and Chapter 2) [2, 11 - 14]. When TSPyV 
is detected on the skin, its load is usually very low (Chapters 2 and 3). The discrepancy 
between DNA-prevalence and seroprevalence is evident for many polyomaviruses, for in-
stance KIPyV and WUPyV, and HPyV9 (Table 1).
 Despite explana  ons of a technical nature, such as diff erences in sensi  vity to de-
tect TSPyV infec  on, this discrepancy might be explained by persistent infec  on of body 
site(s) other than the skin, for instance of internal organs a  er dissemina  on. In this regard, 
it is worthwhile to note that for instance JCPyV persistently infects lymphocytes and urothe-





in immunocompromized hosts [16, 41]. A recent fi nnish study suggested that TSPyV might 
persist in lymphoid  ssues, specifi cally the tonsils, of healthy individuals [11], and an ameri-
can study showed the presence of TSPyV in a kidney biopsy [42]. Nevertheless, the detected 
percentage in these  ssues did not exceed the prevalence found on the skin. Previous stud-
ies that looked into lymphoid systems or mucosa (e.g., tonsils) as a residence or reservoir for 
HPyV infec  ons suggested that these body compartments might play a role in polyomavirus 
latency/persistence [43 - 46], which might be the case for TSPyV as well. Alterna  vely, these 
fi ndings may simply imply a respiratory transmission route for these viruses, which results 
in transient detec  on in these lymphoid systems or mucosal  ssues (e.g., tonsils).
A possible mechanism of polyomavirus latency/persistence
In general, it is believed that par  cular virus infec  ons may reside in two dis  nct non-patho-
logical or asymptoma  c states, namely the (non-replica  ve) latency and low-level persistent 
replica  on state, together designated latency/persistence. For this state of latency/persis-
tence, viruses have evolved mechanisms that focus on evading detec  on and clearance by 
the host immune system. For instance, viruses encode microRNAs that interfere with host 
cellular processes [47, 48]. These small non-coding RNAs [49] are normally u  lized by pol-
yomaviruses to regulate their own transcriptome, but can also target the host transcrip-
tome, for example involved in cellular innate and adap  ve immune responses (Figure 1) 
[50]. Thus, next to virus transcriptome auto-regula  on – shown for MCPyV [51, 52], BKPyV 
Table 1. Prevalence of human polyomavirus infec  on in immunocompetent individuals 
measured by PCR and serology
*, For polyomavirus name abbrevia  on see Chapter 1, Table 1
**, HPyV10 includes MWPyV and MXPyV
GI-tract, Gastro-intes  nal tract; N/A, No data available so far
   
Polyomavirus* 
Viral DNA 
Range in % (major detec on site) [Ref] 
Viral serum an bodies 
Range in % [Ref] 
BKPyV 30 - 50  (Kidney) [15] 80 - 100 [16 - 19] 
JCPyV 10 - 40 (Kidney) [20] 40 - 70 [16 - 19] 
KIPyV 1 - 12 (Respiratory tract) [21 - 23] 55 - 90 [17, 18, 24, 25] 
WUPyV 1 - 16 (Respiratory tract) [22, 26] 70 - 100 [17, 18, 24, 25] 
MCPyV 60 - 80 (Skin) [27 - 29] 40 - 80 [9, 17, 18, 30 - 32] 
HPyV6 14 - 50 (Skin) [30, 33] 50 - 80 [9, 30] 
HPyV7 11 - 17 (Skin) [30, 33] 35 - 60 [9, 30] 
TSPyV 2 - 4 (Skin/Tonsil) [2, 11 - 14] 70 - 80 [8 - 10] 
HPyV9 1 - 17 (Skin) [33, 34] 30 - 50 [9, 34] 
HPyV10** 1 - 5 (Stool) [35 - 37] N/A 
STLPyV 0 - 1 (Stool) [35] 60 - 70 [38] 
HPyV12 1 - 11 (GI tract) [39] 17 - 23 [39] 
NJPyV N/A (Endothelial cells) [40] N/A 
omavirus infec onPrevalence of poly
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[53] and JCPyV [50, 54] – microRNAs play most probably key roles in controlling specifi c host 
factors to evade the immune system, which could promote latency/persistence (Figure 1) 
[50, 52, 55]. In this context, preliminary genome analysis of TSPyV suggests that it might 
express a microRNA compa  ble with regula  on of its early transcripts (Chapter 2, Figure 2; 
Chapter 5, Supplementary Figure S2). Whether this microRNA also targets host cell factors, 
specifi cally those involved in immune recogni  on, is unknown.
TSPyV ac  ve infec  on and trichodysplasia spinulosa
From immunosuppression to disease development; a causal rela  onship
It seems apparent that all other established pathogenic HPyVs described so far, i.e., JCPyV, 
BKPyV and MCPyV, follow similar rules; i) an asymptoma  c primary ini  al infec  on at an 
early age, ii) widespread prevalence in human popula  ons, and iii) upon reac  va  on patho-
genic consequences observed only in the elderly and/or immunocompromized individuals. 
TSPyV, with its described (sero)prevalence and its pathogenic consequences in severely im-
munocompromized hosts, seems to fi t these rules.
Figure 1. Schema  c overview of puta  ve func  on of polyomavirus microRNA related to infec  on. Polyomavi-
rus-encoded microRNAs exert an auto-regulatory role by targe  ng their own early messengerRNAs. Upon viral 
infec  on, the innate immune response produces factors, such as the stress-induced ligand ULBP3, which are essen-
 al for recogni  on of infected cells by the immune system (e.g., NK cells). This viral microRNA plays also a puta  ve 



























 One of the aims described in this disserta  on was to study and describe the path-
ogenic consequences of TSPyV infec  on. In Chapter 3 it was reported that high viral loads 
were exclusively measured in lesional samples origina  ng from TS pa  ents, which indicates 
that TSPyV is ac  vely replica  ng in these lesions [4]. In healthy subjects and  ssues, TSPyV 
was almost undetectable (Chapters 2 and 3). Another indica  on that ac  ve TSPyV infec-
 on is involved in the development of TS was the detec  on of viral proteins VP1 solely in 
the aff ected hair follicles (Chapter 3). Furthermore, TSPyV LT-an  gen was expressed in all 
lesional TS samples analyzed, lesions which are known to be hyperprolifera  ve (Chapter 4) 
(discussed in next paragraph) [5, 56].
 For BKPyV and JCPyV it is well established that when higher viral loads are reached 
in aff ected organs, this could have pathogenic consequences [57 - 59]. According to Roth-
man et al., this could fi t the complete causal eff ect, which states that “an agent that causes 
disease should be both necessary and suffi  cient for the disease to occur and should be 
reproducible and consistent in diff erent se   ngs, and in studies performed by diff erent in-
ves  gators” [60]. In this regard, hypothe  cally speaking, it could be stated that, when i) the 
correla  on is strong – all TS cases tested are posi  ve for TSPyV, compared to healthy sub-
jects, ii) reproducible – other research groups repor  ng TSPyV presence in TS lesions, and 
iii) predic  ve – when detec  on of high TSPyV loads in TS lesions is evident, then a causa  ve 
conclusion is highly probable [4, 42, 61, 62]. Equally important iv) would be the molecular 
evidence of ac  ve infec  on in this regard (discussed next). Furthermore, other criteria’s 
could be considered for tes  ng to establish a causal rela  onship between a microbe and a 
disease, which in this case would also be in line with the Koch’s postulates, by inves  ga  ng 
the TSPyV infec  on and pathogenesis in animal models. 
 Altogether, despite the limita  ons in number of TS cases described and available 
worldwide, and the number of  ssue samples analyzed, the studies described in Chapter 2 
and par  cularly in Chapter 3 provide strong evidence that ac  ve TSPyV infec  on is associat-
ed with TS, and TSPyV is most probably the causa  ve agent of this disease. Obviously, more 
studies are needed from independent laboratories that further confi rm the epidemiological 
and experimental studies to underscore causality.
Molecular pathology of trichodysplasia spinulosa
Possible pathogenic events in polyomavirus-associated disease develop-
ment
During polyomavirus-associated human disease development, a complex interplay takes 
place between mul  ple factors, like host immunity, ageing and gene  cs, and environmental 
exposure. In addi  on, virus-host molecular interac  ons occur, which can induce changes in 
viral and cellular expression profi les and poten  ally disrupt physiological cellular pathways. 
This issue is best illustrated by MCPyV, the HPyV associated with Merkel cell carcinoma 
(MCC) [63, 64], a skin tumor already introduced in Chapter 1 [65]. While MCPyV infects 
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humans early in life in a fashion comparable to many others, including non-pathogenic pol-
yomaviruses, several successive events (although very rare) can result in neoplasm develop-
ment. At fi rst, an exogenous mutagenic exposure such as UV-radia  on causes DNA damage, 
for instance DNA double-strand breaks. The subsequent repair of this damage could facili-
tate virus genome integra  on into the host DNA [66] (Figure 2A). Addi  onal successive mu-
ta  ons, for instance also as a result of UV-radia  on, that abrogate the LT-an  gen func  on 
involved in viral DNA replica  on without disturbing the pathogenic (transforming) domains 
(e.g., the LXCXE pRB binding site), is an important event in MCC cell survival and prolifera-
 on (Figure 2A).
 Comparable to MCPyV, TSPyV induces robust prolifera  on of its host cells located 
in the hair follicles (see Chapter 4 and discussion next) (Figure 2B) [5]. Whether TSPyV can 
integrate into the host genome is unknown so far. In symptoma  c TS disease, however, the 
measured high TSPyV loads argue against integra  on in the produc  ve stage of infec  on 
(Chapter 3).
Viral-host molecular interplay
Historically, polyomavirus research has repeatedly revealed iden  fi ca  on of specifi c vi-
ral-protein and host-protein interac  ons that lead to important insights into mammalian 
cell biology [70, 71]. Polyomaviruses have evolved mechanisms that enable them to hijack 
host regulatory cell factors for the sake of fulfi lling their life cycle (Figure 3). The ability of 
a polyomavirus to oncogenically transform its host cells was fi rst demonstrated for SV40. 
Inocula  on of SV40 DNA into rat and mouse cells resulted in uncontrolled cell growth and 
prolifera  on [72]. Ever since, large tumor (LT), middle tumor (MT) and small tumor (ST) an-
 gen of several polyomaviruses have been inves  gated and were postulated as prototype 
virus oncoproteins that can abrogate several host cell regulatory factors (Figure 3). Un  l 
recently, MT-an  gen expression was demonstrated only for rodent polyomaviruses [71]. 
New data shows that MT-an  gen and/or its deriva  ve ALTO are expressed also by MCPyV 
[73] and TSPyV (Van der Meijden and Feltkamp et al., unpublished observa  ons), as briefl y 
men  oned in Chapters 5 and 6.
Figure 2. Molecular events in the (puta  ve) pathogenesis of MCC and TS. (A) (1) In general, MCPyV infec  on (red 
par  cles) is acquired at early childhood. (2) In a state of decreased immunity (either iatrogenic or age-related), 
reac  va  on and replica  on of MCPyV may occur. (3) At some stage, such a burst of infec  ve virus produc  on 
could facilitate viral integra  on in suscep  ble cells. (4) Mutagenic events could result into replica  on-competent 
virus infec  on. (5) Expression of MCPyV muta  on-truncated LT-an  gen that provides pro-prolifera  ve signals (e.g., 
phosphoryla  on of pRB) leading to clonal expansion and MCC development [67]. Figure adapted from [68]. (B) (1) 
Also TSPyV infec  on (blue par  cles) is acquired at early childhood. (2) During decreased immunity, TSPyV reac  -
va  on and replica  on may occur. (3) Alongside high viral replica  on, tumor an  gens are expressed that provide 
pro-prolifera  ve signals (e.g., phosphoryla  on of pRB) [5]. (4) Hair follicles accumulate with viral par  cles – which 
are also shed from the skin – and trichohyalin-protein aggregates resul  ng into kera  nized, spiny structures pro-


































































































































































































































































































































































 The patho/oncogenicity of the polyomavirus-encoded transforming proteins, most 
notably the LT-an  gen, in cell culture and in animal models has been known for decades. 
Cellular interac  ng proteins in this regard are the re  noblastoma tumor suppressor protein 
(pRB) and its family members (p107 and p130) (discussed next) [74]. The poly-func  onal 
LT-an  gen is expressed at early stages of the viral life cycle and is involved in both viral repli-
ca  on (ori-binding and helicase ac  vity [75]) and virus-induced cellular transforma  on and 
growth [74]. In addi  on to the full-length LT-an  gen, alterna  ve splicing of the LT-an  gen 
messengerRNA can occur, as well as premature termina  on of transla  on because of muta-
 ons (discussed before). Trunca  on of LT-an  gen usually causes removal of the helicase and 
puta  ve p53-binding domains, but preserves most of its other domains, for instance the LX-
CXE domain important for interac  on with the RB family members [76]. Preliminary fi ndings 
suggest that the LT-an  gen of TSPyV, comparable to other in vitro studied polyomaviruses, 
demonstrates comparable versa  lity which expression is regulated through the alterna  ve 
splicing of TSPyV pre-T-an  gen messengerRNA (Van der Meijden and Feltkamp, personal 
communica  on). The regula  on of (L)T-an  gen expression emphasizes that TSPyV, just like 
other polyomaviruses, has developed an evolu  onary feature that enables switching be-
tween roles in both viral replica  on and cellular transforma  on using diff erent versions of 
the same protein (other polyomavirus evolu  onary aspects are discussed next).
 Probably one of the most described interac  ons and a key mechanism in cellular 
transforma  on caused by polyomaviruses is the LT-an  gen interac  on with the RB family 
proteins (Figure 3). RB family proteins (i.e., pRB, p107 and p130) are important regulators 
of the G1- (rest) to S-phase (DNA synthesis) transi  on of cells during cell cycling ini  a  on 
[99]. Hypophosphorylated pRB, for instance, inhibits func  on of the E2F transcrip  on factor 
that regulates gene expression required for host DNA synthesis, whereas hyperphospho-
rylated pRB induces pRB–E2F complex dissocia  on and cell-cycle entry. The la  er can be 
reverted by several inhibitory proteins such as p16ink4a and p21waf [5, 99]. For MCPyV it was 
shown that ST- and LT-an  gen, including its deriva  ve 57kT that bears also the pRB-binding 
LXCXE mo  f, are required for the prolifera  on of MCC cells [91, 96, 100 - 102]. The TSPyV 
LT-an  gen also contains the conserved LXCXE mo  f iden  fi ed in silico (Chapter 5) [1, 6]. The 
colocaliza  on of phosphorylated pRB with prolifera  on marker Ki-67 observed in TS lesions 
could indicate that pRB is inac  vated, which explains the hyperprolifera  ve nature of these 
lesions (Chapter 4). Thus, through its LT-an  gen or one of its truncated deriva  ves, TSPyV 
might induce cell cycle progression through disrup  on of the RB-regulatory pathway, and 
create a reservoir of prolifera  ng cells that permit viral DNA replica  on. This puta  ve mech-
anism could be assessed in future in vitro studies – aside other factors indicated in Figure 
3 – that may be involved in the pathogenic process of cellular transforma  on.
 The characteris  c TS phenotype observed repeatedly and most notable on the face, 
remains unexplained so far. However, terminal diff eren  a  on of the large prolifera  ng pool 
of cells into inner root sheath (IRS) might explain the accumula  on of trichohyalin-posi  ve 
cells that facilitate forma  on of the characteris  c spicules (Figure 2B, Chapters 3 and 4). IRS 
Chapter 7
180
cells are known to produce kera  ns and trichohyalin that serve as an intracellular “cement”, 
which gives strength to the IRS layer of a hair follicle to support and mold the growing and 
protruding hair sha   [103]. Hypothe  cally, the excess amounts of kera  ns and trichohyalin 
produced could shape the spicule on the skin when the cells have undergone diff eren  a-
 on. To inves  gate spicule forma  on and involvement of TSPyV T-an  gens in more detail, 
TSPyV T-an  gen-expressing organotypic ra   culture systems could be exploited, which mim-
ic skin growth in a sophis  cated 3D-Skin culture system [104].
Figure 3. A selec  on of host cellular factors targeted by polyomavirus early proteins. So far known, polyomavirus 
LT- (red), ST- (blue) and MT-an  gen (yellow), as shown in the inner circle for each virus protein, interact with many 
cellular proteins (colored according viral proteins), as depicted in the outer circle with their func  on at cellular level 
on top (see also inset, top-right). For LT- and ST-an  gen, most experiments that have iden  fi ed these interac  ons 
have been shown around SV40 polyomavirus [74, 77]. The J-domain, shared by all early T-an  gens, recruits Hsp70 
protein homologues that aids in protein folding [78 - 80]. Other regions inside LT-an  gen have been shown to bind 
other important factors, like CREB-binding protein (CREBBP) [81], TOP1 [82], p53 [74, 76, 83], Cul7 [84], Bub1 [85] 
and FBXW7 [86]. MCPyV LT-an  gen, in addi  on, can probably alter hVam6p protein func  on that is important in 
lysosome regula  on [87]. LT-an  gen of the human pathogenic polyomaviruses (JCPyV, BKPyV and MCPyV) has been 
shown to abrogate func  ons of RB proteins (i.e., pRB, p107 and p130), which probably includes TSPyV LT-an  gen 
(Chapter 4) [5, 88 - 91]. A major func  on of ST-an  gen is ascribed to its ability to modulate PP2A cellular signaling 
protein [92 - 94]. Aside that, recently NEMO [95] and 4EBP1 [96] modula  on was iden  fi ed for MCPyV ST-an  gen. 
MT/ALTO-an  gen, expressed by MPyV, HaPyV, MCPyV, TSPyV and likely other members of the Orthopolyomavirus-I 
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TSPyV evolu  on and host adapta  on
Molecular signatures/footprints of polyomavirus host-adapta  on
Virus host adapta  on facilitates virus dissemina  on, which could also promote virus spe-
cia  on. Virus adapta  on to the host involves fi xa  on of benefi cial muta  ons under the se-
lec  on pressure imposed by the host. Successful adapta  ons may eventually lead to estab-
lishment of a new virus species that is gene  cally fi t to occupy a separate niche in the host 
or mul  ple hosts. Virus evolu  on is constrained by host environment and many structural 
and gene  c factors [105], including overlapping genes [106, 107]. Overlap regards to the 
expressible nucleo  de sequence of one gene that can be part of expressible nucleo  de se-
quence of another gene in an alternate reading frame, which may contribute to the expres-
sion and func  on of one or more gene products. The overlapping gene is always de novo, 
in case of polyomaviruses the ALTO/MT-an  gen, which overlaps an ancestral gene, i.e., the 
LT-an  gen, and the evolu  onary forces ac  ve on these genes may diff er [108]. When the 
ancestral gene product regions are evolu  onary conserved - called the short linear mo  fs 
(SLiMs) - because of their cri  cal role in regulatory func  on, protein-protein interac  on or 
signal transduc  on [109, 110], selec  on pressure may act more me  culous on that genomic 
region.
 In Chapter 5, we studied an overlapping open reading frame (ORF), called ORF5, 
that is conserved in a large monophyle  c lineage of polyomaviruses designated the Ortho-I 
genogroup of the Polyomaviridae family (Chapter 1, Figure 8) [111], which includes four 
human viruses, i.e., MCPyV, TSPyV, HPyV12 and NJPyV. We have discovered this conserva-
 on independently from Carter et al. [73], who designed and called this overlapping ORF 
ALTO in their study on MCPyV. Besides the above viruses, Ortho-I genogroup includes two 
rodent polyomaviruses whose ORF5 encodes the second exon of MT-an  gen (Figure 3) [71]. 
Sequence region of ORF2 that encodes the N-terminal part of LT-an  gen, and the overlap-
ping ORF5 encoding the ALTO or second exon of MT-an  gen, encompasses the LXCXE do-
main and the ORF5m2 mo  f, respec  vely, both of which are considered SLiMs. Accelerated 
switching between Valine and Alanine was shown in this SLiM of ORF5 in ORF5-plus viruses 
as a result of the Cysteine residue conserva  on in LXCXE domain (Chapter 5). This was also 
the predominant site of amino-acid-changing muta  ons in TSPyV (Chapter 6). This switching 
between residues – called the COCO-VA toggling – implied a posi  ve (purifying) selec  on on 
this site of ORF5m2, indica  ng the importance of this SLiM to preserve the overall func  on 
of the ALTO/MT-an  gen. This observa  on lends support to ORF5 expression – either “direct-
ly” through the synthesis of MCPyV ALTO protein [73] or upon alterna  ve splicing events 
direc  ng the synthesis of TSPyV MT-an  gen [71] (Van der Meijden and Feltkamp, personal 
communica  on).
 The MPyV and HaPyV MT-an  gens have been inves  gated for decades now. It is 
generally accepted that MT-an  gen is involved in cellular transforma  on through modu-
la  on of several cellular protein kinases and signal transduc  on mediators (Figure 3) [71]. 
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The observed toggling in ALTO/MT-an  gen could emphasize a site-reversion muta  on that 
involves, for instance, escape from immunological pressure facilita  ng adapta  on of the 
protein to its niche [112]. S  ll, many ques  ons remain unanswered. How common is CO-
CO-VA toggling in other (overlapping) SLiMs? Is it one of many only in polyomaviruses or 
also evident even beyond this virus family? These are just few ques  ons for future research. 
Finally, as an extreme case of adap  ve evolu  on, COCO-VA toggling may enlighten evolu-
 onary thinking and s  mulate development of applica  ons to extend the research on other 
(polyoma)virus (overlapping) SLiMs.
TSPyV evolu  on as an example of polyomavirus host-adapta  on
Polyomaviruses do not encode viral DNA polymerase enzymes, but rather rely on host-cell 
enzymes for their replica  on [75, 82]. Only during cellular DNA synthesis-phase, an op  mal 
condi  on is created that facilitates viral replica  on because of excess supply of host pol-
ymerases and deoxyribonucleo  des [113]. Human DNA polymerase enzymes are of high 
fi delity and therefore HPyV DNA muta  on rates are expected similar to the host muta  on 
rates. For TSPyV was calculated that it indeed has low intra-host viral DNA subs  tu  ons per 
site per year [114], comparable to those established for BKPyV and JCPyV [115, 116]. Taken 
into account the host DNA subs  tu  on rate and the  me-span over which these viral subs  -
tu  ons could have taken place, it was calculated that BKPyV and JCPyV may have diverged 
recently from a common ancestor – less than 1000 and 350 years, respec  vely, which on the 
evolu  onary scale is comparable to what we found for TSPyV – less than 4300 years. S  ll, 
these data on TSPyV es  ma  on of divergence (Chapter 6), and notably also on BKPyV and 
JCPyV [115, 116], should be sought with cau  on because of the large uncertainty as a result 
of extremely large confi dence intervals of the calculated evolu  onary rates.
 The dominant evolu  onary model of polyomavirus divergence un  l recently was 
virus-host co-evolu  on [117 - 119]. On the contrary, recent studies showed that polyoma-
virus evolu  on could have taken place at least two orders of magnitude faster making the 
assump  ons of a zoono  c transmission of primate polyomaviruses more probable. The cal-
culated  me of divergence of the most recent common ancestor (tMRCA) of TSPyV and its 
closest polyomavirus rela  ve OraPyV1, provided that it may be valid to assume that these 
two viruses emerged recently from a common ancestor [114]. Similar assump  ons exist 
for JCPyV [116] and BKPyV [115, 120], viruses that most probably have emerged from a 
common ancestor closely related to SV40 and SA12 – both baboon viruses – with a phyle  c 
posi  on in the Ortho-II polyomavirus genogroup (Chapter 1, Figure 8) [111]. Although sim-
ilar es  mates are lacking for most of the recently iden  fi ed HPyVs, when analysing the pol-
yomavirus phylogene  c tree and looking at the Ortho-I genogroup, one can note that many 
HPyVs appear to be closely related to viruses isolated from non-human primates (Chapter 
1, Figure 8) [111]. In this regard, HPyV9 is very similar to the B-lymphotropic polyomavi-
rus (LPyV, also known as the African green monkey polyomavirus, AGMPyV). Furthermore, 





troglodytes verus polyomaviruses (PtvPyV). As indicated above and assessed in Chapter 6, 
TSPyV resembles Bornean orangutan polyomavirus 1 (OraPyV1). Finally, the recently iden-
 fi ed NJPyV shows close rela  onship to the Chimpanzee polyomavirus (ChPyV) [40]. Thus, 
both virus-host co-evolu  on as well as a zoono  c non-human to human jump of most (if 
not all) primate polyomaviruses should be considered. Which of these hypothe  cal sce-
narios may be true for TSPyV and new HPyVs, awaits future es  ma  ons with the help of 
larger cohorts of virus genome isolates and sophis  cated polyomavirus evolu  onary es  -
ma  on-models.
 As discussed in the previous paragraph, genome and proteome adapta  on of 
viruses to the host involve muta  ons because of the selec  on pleasure imposed by the 
host. In Chapter 5, we described COCO-VA toggling as a probable evolu  onary selec  on 
mechanism. In Chapter 6, we provided gene  c evidence for this mechanism with ORF5 be-
ing the predominant place of non-synonymous subs  tu  ons during TSPyV evolu  on. The 
four iden  fi ed mo  fs in this ORF5 are under selec  on pressure because they overlap with 
the conserved ORF2 mo  fs. The mo  f involved in COCO-VA mechanism was located in the 
ORF5m2 mo  f. Out of three TSPyV lineages (TSI, TSII and TSIII), the TSI and TSII viruses used 
the Alanine residue most frequently at the COCO-VA site, implying that the Alanine residue 
provided a fi tness-gain for the virus to adapt to its human host and may have facilitated 
addi  onal TSPyV specia  on (see Chapter 6 and previous discussion). Experimental studies 
on TSPyV ALTO/MT-an  gen could reveal molecular forces that drive toggling in this protein, 
in par  cular in the concerning SLiMs that facilitate in protein func  on by playing cri  cal 
roles in protein regula  on, protein-protein interac  on or signal transduc  on. Taken togeth-
er, without restraint one could hypothesis that the puta  ve ALTO/MT-an  gen of TSPyV is 
ac  ng as a cellular protein kinase and signal transduc  on protein to s  mulate cell growth 
and cellular transforma  on and future in vitro studies could prove this proposi  on.
Concluding remarks and future perspec  ves
We are only beginning to comprehend the basics regarding TSPyV and many knowledge 
gaps remain. One of the unknowns in TSPyV research is the mechanism(s) underlying laten-
cy/persistence and reac  va  on. In this regard, it is s  ll unknown whether TS disease is the 
result of a primary TSPyV infec  on in the midst of immunosuppression or whether it con-
cerns a reac  va  on from a latent site, be it skin or another not yet iden  fi ed body loca  on. 
Especially, limita  ons in the number of TS pa  ents and availability of follow-up samples 
obtained a  er primary infec  on from diff erent organs and sites have prevented further in-
sights in this ma  er. In vitro study of (puta  ve) TSPyV microRNA regula  on, which is known 
to play a key role in latency/persistence and reac  va  on in other (polyoma)viruses, might 
off er addi  onal opportuni  es in this regard.
 As indicated in Figure 3, the knowledge about (puta  ve) molecular interac  ons be-
tween T-an  gens of polyomaviruses and cellular pathways is fragmented. Many factors have 
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been analyzed only for SV40 and needs to be validated for other (human) polyomaviruses 
as well. The lack of an experimental model for TSPyV makes answering these ques  ons dif-
fi cult. Skin-mimicking organotypic culture models could provide means for inves  ga  ng the 
TSPyV and other cutaneous polyomaviruses. Knowledge about the cell type(s) that serve as 
the viral reservoir(s) could help to study specifi c mechanisms and pathways locally in mon-
olayers, for instance IRS cells for TSPyV. With these specifi c and tailored in vitro culture sys-
tems at hand for research, one could iden  fy interac  ng host molecular partners of TSPyV 
T-an  gens in vivo.
 Bioinforma  cs analysis of the polyomavirus evolu  on is an area of inves  ga  on 
that is gradually evolving and recent discoveries highlight that a broader taxonomic range of 
hosts may exist. The Polyomaviridae family tree may grow beyond what is known. The close 
rela  onship of primate polyomaviruses may provide interes  ng leads for further studies 
into inter- and intra-specifi c evolu  on of this virus family, as well as virus adapta  on and 
specia  on. First, with regard to virus-host evolu  on, TSPyV is probably a good example be-
cause of its possible recent zoono  c ancestry. Together with OraPyV1 they could be used 
as a model to elucidate intra-host evolu  on and adapta  on of other HPyVs that also close-
ly resemble non-human primate polyomaviruses. Second, with regard to host adapta  on 
and specia  on, the novel evolu  onary mechanism called COCO-VA toggling described in 
this disserta  on, could be an excellent star  ng point for studies inves  ga  ng the poten  al 
eff ect of protein-residue toggling on mechanisms that circumvent host defenses. In silico, 
one could try to iden  fy how common this COCO-VA toggling mechanism is in other (viral) 
proteins that show overlapping ORFs, whether it involves SLiMs and what it means for virus 
adapta  on and specia  on. These are just few experimental and bioinforma  cs ques  ons for 
future research that have surfaced from research described in this disserta  on.
Altogether, the research described in this disserta  on provided many new insights regarding 
the prevalence, pathogenesis, evolu  on and host adapta  on of TSPyV, which is one of the 
newer human polyomaviruses. These insights have substan  ally increased our understand-
ing of TSPyV and the e  ology of trichodysplasia spinulosa. Furthermore, they will allow us 
to be  er comprehend the clinical impact of polyomavirus infec  ons in general, and provide 
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Leden van de Polyomaviridae familie, waarvan één ervan ten grondslag lag aan dit doctoraalonderzoek, behoren tot de kleinste virussen en zijn ongeveer 45 nanom-eter groot. Humane polyomavirussen komen wereldwijd voor. Sinds 2007 zijn er 11 nieuwe soorten ontdekt. Hun erfelijke materiaal bestaat uit DNA1  dat ongeveer 5000 
basenparen2  omvat. Dit erfelijke materiaal codeert voor twee soorten eiwi  en die te eni-
ger  jd  jdens een infec  e tot expressie kunnen komen. De eiwi  en die vroeg  jdens een 
polyomavirus infec  e worden aangemaakt, worden tumor (T)-eiwi  en genoemd. Hier zijn 
er drie van: groot (LT), medium (MT) en kleine (ST). Deze eiwi  en zijn noodzakelijk voor de 
levenscyclus van het virus. De eiwi  en die later  jdens een infec  e worden aangemaakt, 
zijn de “structurele” virale eiwi  en (zoals VP1 en VP2) die de virale eiwitmantel vormen.
 Polyomavirussen zijn over het algemeen goedaardige infec  euze virussen waar 
naar scha   ng 50-100% van de mensen mee geïnfecteerd is. De eerste twee humane polyo-
mavirussen, die al in 1971 waren ontdekt, zijn JCPyV en BKPyV. Epidemiologische en klinis-
che studies tonen aan dat infec  es met deze twee virussen meestal vóór het 4de levensjaar 
optreden. Hierna kunnen de virussen zich levenslang in het lichaam nestelen en voor aan-
houdende infec  es zorgen zonder dat er ziekte te constateren valt. Echter, bij transplan-
ta  epa  ënten (bij wie het afweersysteem bewust wordt verminderd om afsto  ng van het 
getransplanteerde orgaan te voorkomen), bij pa  ënten met AIDS (bij wie het afweersys-
teem verzwakt is door het HIV virus), of bij Mul  ple Sclerose pa  ënten die worden be-
handeld met Natalizumab (een afweermodulerend geneesmiddel), kan een reac  va  e van 
BKPyV en JCPyV tot erns  ge en soms levensbedreigende complica  es leiden. Dus een goed 
func  onerend afweersysteem is een sterk wapen tegen polyomavirus reac  va  e en het ont-
staan van ziekte. Hierom worden de polyomavirussen ook wel opportunis  sch genoemd.
 De recente ontdekkingen van nieuwe humane polyomavirussen hebben ervoor ge-
zorgd dat deze groep van DNA (tumor) virussen en hun poten  ële bijdragen aan ziektes bij 
mensen, meer onder de aandacht is gekomen. In 2008, bijvoorbeeld, werd voor het eerst 
aangegeven dat MCPyV3  polyomavirus de oorzaak is van de meerderheid van Merkelcelcar-
cinomen. Merkelcelcarcinomen zijn agressieve huidtumoren die een s  jgende inciden  e4 
vertonen als gevolg van bijvoorbeeld veroudering van mensen (bij wie het afweersysteem 
geleidelijk met de lee  ijd is afgezwakt) of door de toegenomen frequen  e aan orgaantrans-
planta  es in de ontwikkelde landen. Het virus dat door ons werd ontdekt in 2010 binnen 
de groep van Dr. Feltkamp, was ook een polyomavirus dat betrekking had op een huidaan-
doening. Dit virus dat trichodysplasia spinulosa-geassocieerde polyomavirus (TSPyV) werd 
genoemd, gedraagt zich eveneens goedaardig bij een goed func  onerend afweersysteem, 
maar kan ziekteverschijnselen veroorzaken bij pa  ënten met een erns  g verzwakt immu-
  1 Desoxyribonucleïnezuur, de blauwdruk voor virale eiwi  en, ook wel erfelijk materiaal genoemd
  2 DNA bestaat uit een combina  e van vier verschillende nucleobasen: Adenine, Thymine, Guanine en Cytosine
  3 Een polyomavirus dat kwaadaardige veranderingen van Merkel cellen teweeg brengt
  4 Het aantal nieuwe gevallen per  jdseenheid, per aantal mensen binnen een bevolking




unsysteem. Deze aandoeningen veroorzaakt door deze twee nieuwe virussen zijn zeer 
zeldzaam.
 In Hoofdstuk 1 van dit proefschri  , werden de ontwikkelingen in het kader van 
recentelijk geïden  fi ceerde humane polyomavirussen samengevat, hetgeen de start betek-
ende voor dit promo  eonderzoek naar TSPyV infec  es, pathogenese5  en virusgastheer 
aanpassing en virusevolu  e6. Vervolgens werd er in Hoofdstuk 2 nader ingegaan op de 
klinische en virologische eigenschappen van TSPyV, waar ook epidemiologische, diagnos-
 sche en therapeu  sche aspecten van de infec  e met TSPyV werden belicht. Kort samen-
gevat, TSPyV is betrokken bij het ontstaan van een zeer zeldzame huidaandoening genaamd 
trichodysplasia spinulosa (TS). TS is een huidziekte van pa  ënten met een erns  g verzwakt 
afweersysteem, bij wie kenmerken van haarfollikel vergro   ng en harde kerato  sche huidu-
itstulpingen (vooral op het gezicht) waarneembaar zijn. Ongeveer 75% van de mensen zijn 
met TSPyV besmet op jonge lee  ijd, maar slechts een heel klein percentage ervan vertoont 
de symptomen ervan na afweersysteem verzwakking.
 In het onderzoek beschreven in Hoofdstuk 3, werd geprobeerd om de rela  e tus-
sen TSPyV infec  e en de huidziekte TS uitvoeriger te beschrijven door een analyse van de 
aanwezigheid en de hoeveelheid van viraal DNA, en de precieze lokalisa  e van TSPyV ei-
wi  en in huidcellen van TS-pa  ënten. Daartoe is er gebruik gemaakt van gearchiveerde 
TS laesionale7  en niet-laesionale huidbiopten. De verkregen resultaten toonden aan dat 
het detecteren van viraal DNA een nauw verband laat zien met de ziekte TS, aangezien 
100% van de aangedane- en maar 2% van de controle-monsters een posi  eve testuitkomst 
boden. Kwan  fi cering van TSPyV DNA liet hoge virale aanwezigheid zien in de laesionale 
huidbiopten, met enkele miljoenen virale DNA kopieën per cel. Ook de virale deeltjes (gea-
nalyseerd door elektronenmicroscopie8) en eiwitexpressie (geanalyseerd door immuunofl u-
orescen  e9) werden slechts in de laesionale huidbiopten aangetroff en, welk beperkt bleven 
tot bepaalde soort haarfollikel cellen. Beslissend voor dit hoofdstuk is het feit dat de aan-
wezigheid van veel TSPyV DNA, en de overvloedige expressie van TSPyV eiwit in de getrof-
fen haarfollikel cellen, aantonen dat er een sterke rela  e bestaat tussen een ac  eve TSPyV 
infec  e en het ontstaan van deze ontsierende TS huidziekte.
 In voorafgaande onderzoeken door anderen werd gesuggereerd dat in TS laesies 
de haarfollikel cellen sterke prolifera  e10 vertonen. Conform de mechanismen van andere 
polyomavirussen, zoals MCPyV die de veroorzaker is van Merkelcelcarcinomen, werd er in 
Hoofdstuk 4 verondersteld dat ook TSPyV soortgelijke mechanismen hanteert om prolif-
  5 Bestuderen van ontstaan, ontwikkelen en verloop van een aandoening of ziekte
  6 De geleidelijke verandering van een soort of popula  e door gene  sche overerving
  7 Weefsels die kenmerken van ziekte vertonen
  8 Een vorm van microscopie waarbij tot aan nanometer groo  e gevisualiseerd kan worden
  9 Een methode waarbij virale eiwi  en gevisualiseerd kunnen worden met kleurgekoppelde an  lichamen 
  10 Vermenigvuldiging of deling van cellen
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era  e van haarfollikel cellen te induceren. Daarom hebben we TS laesies op verschillende 
cellulaire markers (zoals Ki-67), die een indica  e kunnen geven van celprolifera  e, met be-
hulp van immuunofl uorescen  e onderzocht. Daarnaast hebben we naar de betrokkenheid 
van het (vermoedelijk) celtransformerende LT eiwit van TSPyV in dit proces gekeken. We 
toonden aan dat het expressie van TSPyV LT eiwit inderdaad samenkomt met de toege-
nomen prolifera  e markers in haarfollikel cellen, ondanks de toegenomen cellulaire defen-
sie eiwi  en die dit proces van prolifera  e juist tegen horen te gaan. Kortom, de verkregen 
resultaten uit dit hoofdstuk suggereren dat er een scenario mogelijk is waarbij TSPyV LT 
eiwit prolifera  e induceert, mogelijk om een popula  e van delende cellen te creëren die 
de vermenigvuldiging van het viraal DNA kan ondersteunen. Door het ontregelen van dit 
cellulaire proces door dit virus voor zijn eigen belang, ontstaan er bij TS pa  ënten de vaak 
waargenomen symptomen.
 Een ander doel van dit promo  eonderzoek was om meer inzicht te krijgen in virus-
gastheer aanpassing en virusevolu  e van dit snel groeiende Polyomaviridae familie. Daar-
toe hebben we in Hoofdstuk 5 het genoom van alle polyomavirussen bij elkaar genomen en 
deze so  warema  g geanalyseerd. Uit ons onderzoek bleek, wat tot dusver onbekend was 
voor de meeste polyomavirussen, dat het genoom van een grote groep polyomavirussen 
een extra coderend stuk bevat dat de aanmaak van MT11 (of ALTO) eiwit verzorgt. Expressie 
van dit eiwit was tot nu toe alleen bekend bij twee knaagdier polyomavirussen. Nu blijkt 
dus dat dit coderende stuk geconserveerd is in het genoom van tweeëntwin  g van de totaal 
vijfenvij  ig polyomavirussen, waaronder twee humane soorten. Uit een modelberekening 
komt tot ui  ng dat een deel van dit eiwit hoogstwaarschijnlijk een belangrijke rol speelt (of 
hee   gespeeld) bij de aanpassing van het virus tot zijn gastheer. Dit nieuwe mechanisme 
genaamd COCO-VA, zoals beschreven in dit hoofdstuk, zou de aanpassing van deze polyo-
mavirussen tot hun gastheren bevorderen en zou dus een belangrijke rol kunnen spelen in 
de evolu  e van polyomavirussen.
 In Hoofdstuk 6 is er vervolgens onderzoek verricht naar de evolu  e van TSPyV. 
Hier werden de door ons der  en nieuw verkregen TSPyV genomen uit Hoofdstuk 3 geanal-
yseerd die a  oms  g waren van TS pa  ënten over de hele wereld en die ongeveer 40% van 
alle gerapporteerde TS gevallen vertegenwoordigen. Uit onderlinge genoomvergelijkingen 
bleek dat deze TSPyV genomen een beperkte varia  e vertonen. Toch konden we door die 
minieme varia  es het geheel van TSPyV genomen fylogene  sch12 in drie aparte groepen 
verdelen. Genoom varia  es in eiwitcoderende stukken die voor eiwit veranderingen zouden 
kunnen zorgen, waren voornamelijk gesitueerd in het gedeelte dat codeert voor MT eiwit. 
Zoals uit het onderzoek in Hoofdstuk 5 naar voren kwam, bleek ook in Hoofdstuk 6 dat het 
MT eiwit van TSPyV betrokken is bij virusgastheer aanpassing en dat het een belangrijke rol 
11 Een eiwit dat tumoren indiceert door bijvoorbeeld groei factoren na te bootsen in experimentele muizen
12 Een schema dat de evolu  onaire geschiedenis of biologische verwantschap weergee  




zou kunnen spelen in de evolu  e van dit virus. Gecombineerde resultaten van beide studies 
tonen aan dat de evolu  e van een groep polyomavirussen, inclusief TSPyV, hoogstwaarschi-
jnlijk het beste te traceren valt via hun MT eiwit.
 Tot slot, middels in dit proefschri   beschreven promo  eonderzoek, hebben we 
veel inzichten kunnen verkrijgen met betrekking tot de prevalen  e , pathogenese en evo-
lu  e van het polyomavirus TSPyV. Eventueel gecombineerd met toekoms  ge onderzoeken 
aan dit virus, draagt deze informa  e substan  eel bij aan ons kennis en begrip over deze ziek-
teverwekker. Ontdekkingen van nieuwe aanknopingspunten betreff end virusmechanismen 
die betrekking hebben tot ziekteprocessen, zullen ons in staat stellen om klinische aspecten 
beter te kunnen begrijpen. Deze aanknopingspunten zouden in latere studies ook gebruikt 
kunnen worden om an  virale middelen te ontwikkelen ter voorkoming of genezing van pol-
yomavirus geassocieerde ziektes bij mensen.
13 Aantal infec  egevallen op een specifi ek moment in een specifi ek popula  e
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List of Abbrevia  ons
A AelPyV   African elephant polyomavirus 
 AI   Associa  on index
 ALL  Acute lymphocy  c leukemia
 ALTO  Alternate frame of the large T open reading frame
 APPyV1  Ar  beus planirostris polyomavirus
 APPyV2  Ar  beus planirostris polyomavirus
 APyV   Avian polyomavirus
 AtPPyV1  Ateles paniscus polyomavirus
B BatPyV   Bat polyomavirus
 BKPyV   BK polyomavirus
 BPyV   Bovine polyomavirus
C CAPyV1  Cebus albifrons polyomavirus
 CaPyV   Canary polyomavirus isolate
 CDK   Cyclin dependent kinases
 CdPyV   Cardioderma polyomavirus
 ChPyV   Chimpanzee polyomavirus
 CLL  Chronic lymphocy  c leukemia
 COCO-VA   Codon-constrained Valine-Alanine
 CoPyV1  Chaerephon polyomavirus
 CPPyV   Carollia perspicillata polyomavirus
 CPyV   Crow polyomavirus
 CSLPyV   California sea lion polyomavirus
D dsDNA   Double-stranded DNA
 DRPyV   Desmodus rotundus polyomavirus
 DS  Dataset
E EiPyV1  Eidolon polyomavirus
 EM   Electron microscopy
 EPyV   Equine polyomavirus
F FFPE  Formalin-fi xed paraffi  n-embedded
 FPyV   Finch polyomavirus
 FRFR  Fresh frozen
 FUBAR  Fast unconstrained bayesian approxima  on




G GE  Gastroenteri  s
 GggPyV1  Gorilla gorilla gorilla polyomavirus
 GHPyV   Goose hemorrhagic polyomavirus
 GI-tract  Gastro-intes  nal tract
 GST  Glutathione-S-transferase
H HaPyV   Hamster polyomavirus 
 H&E  Hematoxylin and eosin
 HPV   Human papillomavirus
 HPV16  Human papillomavirus type 16
 HPyV6  Human polyomavirus type 6
 HPyV7  Human polyomavirus type 7
 HPyV9  Human polyomavirus type 9
 HPyV10  Human polyomavirus type 10
 HPyV12  Human polyomavirus type 12
 HPyVs   Human polyomaviruses
 HSF  Human Splice Finder
I ICTV   Interna  onal commi  ee on taxonomy of viruses
 IDRs   Intrinsically disordered regions
 IFA  Immunofl uorescence assay
 IHC  Immunohistochemistry
 IR  Intergenic region
 IRB  Ins  tu  onal review board
 IRS  Inner root sheath
J JCPyV   JC polyomavirus
K KIPyV   KI polyomavirus
L LGN  Lupus glomerulonephri  s
 LPyV   B-lymphotropic polyomavirus
 LT-an  gen  Large tumor an  gen
M MasPyV   Mastomys polyomavirus
 MC  Maximum monophyle  c clade size
 MCC   Merkel cell carcinoma
 MCMC  Markov chain monte carlo
 MCPyV   Merkel cell polyomavirus
 MDA   Mul  ple displacement amplifi ca  on
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 MFPyV1  Macaca fascicularis polyomavirus
 MiPyV   Miniopterus polyomavirus
 M&M  Material and Methods
 MMPyV   Molossus molossus polyomavirus
 MptV   Murine pneumotropic virus
 MPyV   Murine polyomavirus
 MT-an  gen Middle tumor an  gen
 MWPyV   Malawi polyomavirus
 MXPyV   Mexico polyomavirus
N NCCR   Non-coding control region
 NHL  Non-Hodgkin’s lymphoma
 NJPyV   New Jersey polyomavirus
 NLS  Non-lesional skin
 nts  Nucleo  des
O OPTN  Organ procurement and transplanta  on network
 OraPyV1  Orang-utan polyomavirus Bornean
 OraPyV2  Orang-utan polyomavirus Sumatran
 ORF  Open reading frame
 Ortho-I  Orthopolyomavirus-I
 Ortho-II  Orthopolyomavirus-II
 OtPyV1  Otomops polyomavirus
P PDPyV   Pteronotus davi polyomavirus
 PED  Pair-wise evolu  onary distance
 PHK  Primary human kera  nocytes
 PML   Progressive mul  focal leukoencephalopathy
 PPPyV   Pteronotus parnellii polyomavirus
 PRPyV1  Piliocolobus rufomitratus polyomavirus
 PS  Parsimony score
 PtvPyV1a   Pan troglodytes verus polyomavirus
 PtvPyV2c   Pan troglodytes verus polyomavirus
R RacPyV   Raccoon polyomavirus
 RB  Re  noblastoma
 RCA   Rolling-circle amplifi ca  on
 RefSeq  Reference sequence
 REL  Random eff ect likelihood
 RF  Reading frames
 RTR  Renal transplant recipients




S SA12  Baboon polyomavirus 1
 SLiMs  Short linear mo  fs
 SLPyV   Sturnira lilium polyomavirus
 SNP  Single (di)nucleo  de polymorphism
 SPED  Smallest pair-wise evolu  onary distance
 SqPyV   Squirrel monkey polyomavirus
 ST-an  gen  Small tumor an  gen
 STLPyV   St. Louis polyomavirus
 SV40  Simian virus 40
T TCHH  Trichohyalin
 TM  Transmembrane domain
 tMRCA  Time to the most recent common ancestor
 TOI  Trichodysplasia of immunosuppression
 TP  True-palindrome
 TS  Trichodysplasia spinulosa
 TSPyV   Trichodysplasia spinulosa-associated polyomavirus
 TX  Transplant pa  ent
V VATD  Viral-associated trichodysplasia of immunosuppression
 VATS  Virus associated trichodysplasia spinulosa
 VePyV1  Vervet monkey polyomavirus
 VP1  Viral capsid protein 1
 VP2  Viral capsid protein 2
 VP3  Viral capsid protein 3
W WUPyV   WU polyomavirus
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Fly me to the moon
Let me play among the stars
Let me see what spring is like on
Jupiter and Mars
In other words, hold my hand
In other words, baby, kiss me
Fill my heart with song
And let me sing forever more
You are all I long for
All I worship and adore
In other words, please be true
In other words, I love you ~ BeBe ~
Frank Sinatra (1964)

